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ABSTRACT 
 The cytotoxic effects of exposure to low concentrations of the herbicide, 2,4-
dichlorophenoxyacetic acid (2,4-D) that are typically found in groundwater were 
investigated, in vitro.  Most 2,4-D toxicology studies use high concentrations of the 
herbicide that are above those typically found in groundwater and measure overt 
biological endpoints.  In contrast, this thesis examines the effects of low concentrations 
of 2,4-D and measures more subtle and sensitive endpoints such as gene expression and 
the generation of reactive oxygen species.  This work derives from recent cDNA 
microarray analysis conducted in our laboratory that revealed significant alterations in 
the expression of 238 genes in cells exposed to nanomolar (nM) concentrations of a 
commercial formulation of 2,4-D.  These findings are extended in this thesis to include 
the in vitro cytotoxic effects of low concentrations of both technical and commercial 
2,4-D on two cell lines.  Cells derived from liver (HepG2) and kidney (HEK293) 
respectively, were chosen, since liver and kidney are known to metabolize 2,4-D in vivo.  
Cell viability was measured using the Resazurin assay, reactive oxygen species (ROS) 
were measured with 2’,7’-dichlorofluorescin diacetate (2’,7’-DCFH-DA), and real time–
polymerase chain reaction (RT-PCR) was used to assess changes in mRNA expression 
while protein expression was examined by Western blot.    
 Cell viability studies revealed that low environmental concentrations (0.1 to 100 
nM) of 2,4-D induced small, but statistically significant decreases in cell viability.  No 
concentration or time-dependent decreases in cell viability were observed in cells 
exposed to either forms of low environmental 2,4-D concentrations.  HEK293 cells were 
more susceptible than HepG2 cells to the toxic effects of both forms of 2,4-D, having 
statistically significant lower viability at all exposure concentrations and durations.  
Both forms of 2,4-D reduced cell viability in both cell lines, suggesting that cytotoxicity 
was induced directly by 2,4-D, and not by the ‘inert ingredients’ in the commercial 
formulation. 
  The ROS assays illustrated that 2,4-D induced statistically significant ROS 
production in HepG2 and HEK293 cell cultures at concentrations greater than 10 µM 
and 100 nM respectively.  This was both a concentration and time-dependent effect in 
 ii
both cell lines.  Although HEK293 cells were more susceptible to 2,4-D, they had 50 to 
70% less ROS production than HepG2 cells, at all exposure concentrations and times.   
 The RT-PCR and Western blot analyses showed that exposure of HepG2 and 
HEK293 cells to low 2,4-D concentrations induced (< 2 fold) alterations in mRNA and 
protein levels of FTL, FTH1 and PCNA however these changes did not consistently vary 
with concentration. 
 Taken together, cell viability, ROS and gene expression studies show that low 
environmental 2,4-D concentrations induced subtle in vitro cytotoxic effects.  However 
we have no evidence that these subtle changes pose a serious health threat to exposed 
humans.  
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1. INTRODUCTION 
 In 1944 (PAN Database, 2004), 2,4-dichlorophenoxyacetic acid (2,4-D), a 
chlorophenoxy herbicide (Li et al., 2003) was introduced into the commercial market.  
The herbicide is extensively used in the control of woody plants (Li et al., 2003), 
broadleaf (Environment Canada, 1991) and aquatic weeds (Environment Canada, 1991).  
It has been described as the most widely used herbicide in the world (Holland et al., 
2002; Kwan and Chu, 2004; WSDOT, 2006).   
         The herbicide typically does not accumulate in the environment (air, water or 
soil), as it is readily degraded by biological, chemical and physical processes (WHO, 
1984).  However, alterations in biological, chemical and physical factors may result in 
the increased persistence of the herbicide in the environment.  For instance, anaerobic 
conditions favours the persistence of 2,4-D in aquatic environments (WHO, 2003), such 
as groundwater.  The persistence of 2,4-D in the environment questions the potential 
adverse human health effects that may occur following exposure to the chemical for 
acute or chronic durations of time.  This is especially true with respect to its persistence 
in groundwater; since groundwater may be a significant and possibly the sole source of 
water for humans residing in rural areas.     
         Approximately one quarter of Canadians depend on groundwater, of which two-
thirds of these are rural habitants (Environment Canada, 2004a).  Groundwater is a vital 
resource (Environment Canada, 2004b) for rural residents (Rudolph et al., 1998), for all 
of their daily water needs, such as drinking (Environment Canada, 2004b).  
Unfortunately, groundwater contamination with chemicals, such as 2,4-D, has become 
an increasing problem in Canada (Environment Canada, 2004c).  The herbicide, 2,4-D, 
has been one of the most frequently detected herbicides in groundwater (Grover et al., 
1997).   
         Since, chemical contamination of groundwater may pose a human health threat,  
regulatory agencies such as the Canadian Federal-Provincial-Territorial Committee on 
Drinking Water (CDW), United States Environmental Protection Agency (US EPA) and 
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World Health Organization (WHO) have established guideline levels for contaminants 
in drinking water to protect exposed individuals.  Thus, it is important to determine the 
levels of contaminants, such as 2,4-D, that may be found in groundwater and address the 
potential adverse human health effects that may be associated with exposure to these 
contaminants.  The herbicide is usually found in groundwater at concentrations (<100 
nM (<22 µg/L)) that are below established drinking water guidelines.  However, the 
potential adverse human health effects associated with acute and chronic exposure to 
low environmental 2,4-D concentrations has not yet been evaluated.          
         Results from previous in vivo and in vitro toxicological studies that have tested 
high doses (1 to 600 mg/kg) or concentrations (1 µM to 45 mM) of the herbicide, 
suggest that the chemical may induce a plethora of adverse human health effects.  These 
adverse human health effects include; neurotoxicity (Bortolozzi et al., 1999, 2004; 
Garcia, 2001, 2004; Rosso et al., 2000), immunotoxicity (de la Rosa, 2003; Lee et al., 
2001), genotoxicity  (Amer and Aly, 2001; Holland et al., 2002; Madrigal-Bujaidar et 
al., 2001; González et al., 2005; Zeljezic and Garaj-Vrhovac, 2004; Venkov et al., 
2000), carcinogenesis (Ge et al., 2002; Holland et al., 2002; Ozaki et al., 2001), 
reproductive toxicity (Amer and Aly, 2001; Madrigal-Bujaidar et al., 2001), 
developmental toxicity (Alpöz et al., 2001; Bortolozzi et al., 2004; Charles et al., 2001; 
Lee et al., 2001) cytotoxicity (Bharadwaj et al., 2005; De Moliner et al., 2002; 
Duchnowicz and Koter, 2003; Kaioumova et al., 2001a; Palmeira et al., 1995; Tuschl 
and Schwab, 2003, 2004, 2005; Venkov et al., 2000) to organ toxicity, including 
hepatotoxicity (Bharadwaj et al., 2005; Charles et al., 1996a; Paulino et al., 1996; 
Tuschl and Schwab, 2003, 2004, 2005) and nephrotoxicity (Ozaki et al., 2001).   
         In contrast to 2,4-D toxicology, the cell and molecular mechanism(s) of 2,4-D 
toxicity has not been extensively studied.  The results from some existing in vivo and in 
vitro studies suggest that the mechanisms of 2,4-D toxicity may include apoptosis (de 
Moliner et al., 2002;  Kaioumova et al., 2001a, 2001b; Tuschl and Schwab, 2003, 2004; 
2005; Zychlinski and Zolnierowicz, 1990),  alteration of cell physiology (uncoupling of 
oxidative phosphorylation, depression of transmembrane potential) (Kaioumova et al., 
2001b; Palmeira et al., 1994; Tuschl and Schwab, 2003), formation of a reactive 
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metabolite (Li et al., 2003) and ROS mediated oxidative stress (Bukowska, 2003; 
Duchnowicz and Koter, 2003; Palmeira et al., 1995; Teixeira et al., 2004).  
         Thus, although the above findings are intriguing and provide evidence of its 
toxicology and mechanisms of toxicity, the findings were primarily derived from 
classical toxicological studies that tested high doses and concentrations that do not 
reflect 2,4-D concentrations that are typically found in the environment.  Furthermore, 
previous studies concentrated on overt biological endpoints, and have not considered 
subtle cell and molecular changes, such as alterations in gene expression patterns, which 
are more often sensitive, than currently employed biological endpoints (Aardema et al., 
2002).      
         Recently, in our laboratory, it was illustrated that exposure to low nanomolar 
(nM) environmentally relevant concentrations of a commercial formulation of 2,4-D 
(containing the dimethylamine salt of 2,4-D; 2,4-D DMA) for 24 hrs resulted in 
decreased human hepatocellular carcinoma (HepG2) cell viability (Bharadwaj et al., 
2005).  Additionally, cDNA microarray analyses illustrated significant alterations in 238 
genes.  These genes included those associated with DNA repair and cancer  genes 
(proliferating cell nuclear antigen (PCNA)), immune response genes (interleukin 1 
receptor-like 1), cell cycle control genes (CDC-like kinase 1) and stress response genes 
(ferritin light polypeptide (FTL), ferritin heavy polypeptide 1 (FTH1)).  The expression 
levels of FTL, FTH1 and PCNA genes were consistently up-regulated (approximately 2 
fold) over the range of 2,4-D concentrations.  The up-regulation of FTL, FTH1 and 
PCNA genes has been suggested to play a protective role in response to oxidative stress 
(Balajee et al., 1999; Balla et al., 1992; Epsztejn et al., 1999; Holmes et al., 2002; Lin 
and Girotti, 1997; Orino et al., 2001; Regan et al., 2002; Savio et al., 1998).  Therefore, 
based on previous cDNA microarray analysis and in vivo and in vitro studies, it is 
possible that ROS mediated oxidative stress may be one potential mechanism of 2,4-D 
toxicity. 
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      1.1 Hypotheses 
            Based on previous in vivo and in vitro studies, in this thesis it was hypothesized                      
               that: 
(I) Exposure to environmental 2,4-D concentrations will result in cytotoxicity in 
exposed human cell cultures. 
(II) Reactive oxygen species are produced in human cell cultures exposed to 
environmental 2,4-D concentrations. 
(III) Exposure to environmental 2,4-D concentrations will induce up-regulation of 
FTL, FTH1 and PCNA gene expression detectable at the level of mRNA and 
protein accumulation. 
 
      1.2 Objectives 
            The main objectives of this study were to determine: 
(I) If environmentally realistic concentrations of 2,4-D will induce                        
cytotoxicity in exposed human cell cultures 
 
            To achieve this objective, human HepG2 and embryonic renal (HEK293) cell 
cultures were exposed to increasing concentrations of a technical grade or commercial 
formulation of 2,4-D.  Technical and commercial 2,4-D form were utilized to determine 
if cytotoxic effects are enhanced by the presence of ‘inert ingredients’ in the commercial 
formulation or a result of the active ingredient; 2,4-D.  To determine if there were 
concentration-dependent cytotoxic effects, cell cultures were exposed to 0.1nM to 1mM.  
Cells were exposed for 6, 24, 48 and 72 hrs to determine if more pronounced toxic 
effects would be produced with longer durations of exposure.  Cytotoxicity was 
determined as a measurement of cell viability, using the dye, Resazurin (Sigma-Aldrich 
Canada Ltd.).  
 
(II) If ROS are produced in human cell cultures exposed to environmental             
2,4-D concentrations  
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            To achieve this objective, HepG2 and HEK293 cell cultures were exposed to 
increasing concentrations of commercial 2,4-D for 2 to 6 hrs.  Production of ROS was 
measured fluorometrically, using 2’,7’-dichlorofluorescin diacetate (2’,7’- DCFH-DA) 
(Sigma-Aldrich Canada Ltd.).  
  
(III) If environmentally realistic 2,4-D concentrations induce up-regulation of 
FTL, FTH1 and PCNA gene expression detectable at the level of mRNA 
accumulation in exposed human cell cultures 
 
            To achieve this objective, HepG2 and HEK293 cell cultures were exposed to      
increasing concentrations of commercial 2,4-D for 24 hrs.  The RNA extracted from cell 
cultures was used in first-strand cDNA synthesis.  Synthesized cDNA was used as the 
template in real time – polymerase chain reaction (RT-PCR) assays to measure FTL, 
FTH1 and PCNA mRNA accumulation levels.    
 
(IV) If environmentally realistic concentrations of 2,4-D induce up-regulation of 
FTL, FTH1 and PCNA gene expression detectable at the level of protein 
accumulation 
 
            To achieve this objective, HepG2 and HEK293 cell cultures were exposed to      
increasing concentrations of commercial 2,4-D for 24 hrs.  Protein extracted from cell 
cultures was subjected to sodium dodecyl sulfate – polyacrylamide gel electrophoresis 
(SDS-PAGE) and FTL, FTH1 and PCNA protein expression was detected using 
conventional western blot analysis and quantified densitometrically.  
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2. LITERATURE REVIEW 
 The main objective of the research completed in this thesis was to assess the 
adverse human health effects that may be caused by exposure to low concentrations of 
2,4-D that are typically found in groundwater.  Therefore, in order to understand the 
significance and rationale for conducting this current study, a review of 2,4-D 
(development and use, mechanism of action, environmental fate, relationship with 
groundwater, 2,4-D toxicology, mechanism of toxicity) is presented in the following 
paragraphs.  A review of ferritin and PCNA gene (structure, function, relationship 
between gene expression and oxidative stress) is also presented that will allow for an 
understanding of why, in this thesis; (1) it was hypothesized that, 2,4-D exposure will 
induce intracellular ROS production, and (2) increases in the expression of ferritin and 
PCNA mRNA and protein in response to 2,4-D exposure may suggest ROS mediated 
oxidative stress as a mechanism of 2,4-D toxicity.  Finally, a brief review of ROS is 
presented.  The review of ROS is intended for the reader to attain some degree of 
understanding of ROS, its formation, sources, and association with oxidative stress.  The 
review also includes information on the intricate relationship between iron, ROS and 
oxidative stress that will enable for an understanding of why the particular up-regulation 
of intracellular ferritin mRNA or protein expression in the present study may suggest 
chemical insult via the mechanism of ROS mediated oxidative stress.  Thus, taken all 
together the following literature review allows for a better appreciation, and 
understanding of why this current study was conducted.           
 
      2.1 2,4-Dichlorophenoxyacetic acid  
            2.1.1 2,4-D: development and use 
 The herbicide, 2,4-D, a chlorophenoxy compound (Li et al., 2002; PAN Pesticide 
Database, 2004) was introduced as the first phenoxy herbicide, or hormone weed killer 
(Ware, 1978).  Additional members of the chlorophenoxy family of herbicides include; 
2-(2,4-dichlorophenoxy) propionic acid (dichloroprop, 2,4-DP), 4-(2,4-
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dichlorophenoxy) butyric acid (2,4-DB), 2-(2,4,5-trichlorophenoxy) propionic acid 
(fenoprop, silvex, 2,4,5-TP), α-(4-chloro-2-methylphenoxy) propionic acid (mecoprop, 
MCPP), 2,4,5-trichlorophenoxyacetic acid (2,4,5-T) and 4-chloro-2-methyl-
phenoxyacetic acid (MCPA) (WHO, 1984).  The herbicide, 2,4-D was synthesized in 
1942 and introduced into the commercial market over 60 years ago (WSDOT, 2006).  It 
is currently used in the control of: (1) broadleaf weeds (Environment Canada, 1991; 
Stevens and Sumner, 1991; US EPA, 2005; Li et al., 2003) that are found in cereal crops 
(Kaioumova et al., 2001; WHO, 1984) (i.e wheat and corn (US EPA, 2005), pastures, 
lawns (Kaioumova et al., 2001; WHO, 1984) and recreational areas (i.e parks and golf 
courses (Kaioumova et al., 2001; Kwan and Chu, 2004; WHO, 1984)), (2) aquatic 
weeds (WHO, 1991; Zeljezic and Garaj-Vrhovac, 2004) and (3) woody plants (Li et al., 
2003; US EPA, 2005) that are found along roadsides, railways and utilities right of way 
(US EPA, 2005).  The herbicide is the third most widely used herbicide in the USA and 
Canada (WSDOT, 2006).  For instance, as much as 20 million kilograms of 2,4-D are 
annually applied to the Canadian prairies (Grover et al., 1997).  This suggests that there 
may be a high risk of human exposure to the chemical from the environment.   
The application rate of 2,4-D is dependent upon a combination of (1) the 
physical and chemical formulation of the herbicide and (2) the target.  For example, 
amine salts of 2,4-D are applied at a rate of 0.2 to 2.0 kg active ingredient per hectare to 
control broad-leaved weeds in cereal crops, pastures, lawns, golf courses and parks 
(WHO, 1989).  Ester formulations of 2,4-D are applied at a higher rate of up to 6.0 kg 
active ingredient per hectare to suppress weeds, brush and deciduous trees along rights-
of-way, conifer plantations and conifer reafforestation areas (WHO, 1989).  Granular 
forms of 2,4-D may be applied at rates ranging from 1 to 122 kg active ingredient per 
hectare to aquatic weeds (WHO, 1989). 
The herbicide is commercially available to the public and is considered a general 
use pesticide (GUP) (Beyond pesticides, 2004; EXTOXNET, 1996).  Thus, a license is 
not required to use or purchase this herbicide (Beyond pesticides, 2004).  It is 
commercially prepared as esters and amine salts (EXTOXNET, 1996; PMRA, 2005; 
WHO, 1984).  The herbicide is available to consumers (i.e. farmers and homeowners) 
for purchase under commercial trade names such as agent white, bladex-B, red devil dry 
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weed killer, weedar (EXTOXNET, 1996; US EPA, 2005), weedone (EXTOXNET, 
1996; Stevens and Summer, 1991), savage, planotox, aqua-kleen, barrage, malerbane, 
lawn-keep, salvo, weedtrine-II and plantguard (EXTOXNET, 1996).  Commercial 
formulations of 2,4-D are found as  emulsions, aqueous solutions and dry compounds 
(EXTOXNET, 1996). 
  
            2.1.2 Mechanism of action of 2,4-D as a herbicide 
The parent compound of 2,4-D is an acid (Charles et al., 1996; PMRA, 2005).  
The parent 2,4-D acid has an empirical formula of C8H6Cl2O3 and a molecular weight of 
221.04 (PMRA, 2005; Stevens and Sumner, 1991).  Physically, the acid is a white 
powder with a slight phenolic odor (Stevens and Sumner, 1991).  It is the parent acid 
that is the active ingredient in 2,4-D commercial formulations (PMRA, 2005).  An active 
ingredient in herbicide products is one that induces the desired effect (i.e. plant 
regulation, defoliation) (US EPA, 2006) on the plant.  The parent acid binds to target 
sites on plants, while the amine or ester portion of the chemical allows for absorption of 
the herbicide into plants (PMRA, 2005).  The commercial forms of 2,4-D differ in their 
ability to facilitate absorption into the plant (PMRA, 2005).  For instance, the more 
hydrophobic form (i.e. ester form) of 2,4-D allows for easier penetration of the herbicide 
into the waxy cuticle of the leaves of plants, while the more hydrophilic form (i.e. amine 
form) allows for easier uptake of the herbicide from the roots of plants  (PMRA, 2005).   
The herbicide functions as a systemic herbicide (EXTOXNET, 1996), and is thus 
translocated throughout the plant (Ware, 1978).  It is a chlorinated form (WHO, 1984) or 
structural analogue of the natural plant hormone, auxin indole-3-yl-acetic acid (Venkov 
et al., 2000).  Auxin indole-3-yl-acetic acid plays an integral role in the division, 
differentiation and elongation of plant cells (Venkov et al., 2000).  Thus, since it is a 
synthetic ‘auxin-like’ (Reuber, 1983) herbicide, the primary mode of action of 2,4-D is 
to alter plant metabolism (Li et al., 2003).  The alteration of plant metabolism results in 
over stimulation of plant growth and ultimately plant death (Chu et al., 2004; Holland et 
al., 2002). 
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            2.1.3 Environmental fate of 2,4-D in water 
The herbicide is considered a biodegradable compound (Industry Task Force II 
on 2,4-D Research Data, 1999) as it is readily degraded by biological, chemical and 
physical processes (WHO, 1984).  Thus, 2,4-D is believed to be non-persistent or non-
accumulative in the environment (atmosphere, soil and aquatic (i.e. surface and 
groundwater)) (WHO, 1984).  However, the chemical has been found to have a half-life 
of approximately 800 to 1900 days in experimental groundwater environments 
(reviewed by Cox. (1999)); suggesting that 2,4-D may be quite persistent in 
groundwater.   
The rate of 2,4-D degradation in water is dependent upon several factors (i.e. 
(water type, temperature, nutrient levels, sunlight and oxygen content) (reviewed by 
Environment Canada, 1991).  For instance 2,4-D is more persistent in groundwater, than 
surface water, possibly due to increased photolysis of 2,4-D residues in surface waters 
(i.e. lakes, ponds, streams (Cox, 1999)).    Extreme low or high water temperatures 
(Rushings et al., 2007) and low nutrient concentrations (Government of Ontario, 2003) 
also favor 2,4-D persistence in water.  These conditions inhibit the growth of 
microorganisms, and microorganisms are responsible for the biodegradation of 2,4-D in 
water (WHO, 2003).  Oxygen content also plays a crucial determinant factor in the rate 
of 2,4-D degradation in water.  Under aerobic conditions, the half-life of 2,4-D in water 
can be equal to or greater than 7 days (reviewed by Environment Canada, 1991).  In 
contrast, under anaerobic conditions, the half-life of 2,4-D in water may be greater than 
80 to 120 days (reviewed by Environment Canada, 1991).  Thus, depending upon 
biological, chemical and physical factors (mentioned above), 2,4-D may be fairly 
persistent in aquatic environments, such as groundwater.  This is a grave health concern 
for humans who may be acutely or chronically exposed to the chemical via consumption 
of groundwater.       
 
            2.1.4 2,4-D and groundwater 
Groundwater, described as one of nature’s hidden treasures (Environment 
Canada, 2004b) is the world’s largest reservoir of fresh water (Environment Agency, 
2007).  It is located below the earth’s water table (Environment Agency, 2007; 
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Environment Canada, 2004; U.S. Geological Survey, 2005) and is contained in bodies of 
rocks below the earth’s surface, known as aquifers (Environment Agency, 2007).  This 
body of water can be accessed; (1) anthropogenically (i.e. by digging wells (U.S. 
Geological Survey, 2005) and dugouts (Grover et al., 1997)) or (2) naturally (i.e. 
springs, swamps, lakes and rivers (U.S. Geological Survey, 2005).   
Groundwater serves as an essential and vital source of water (Environment 
Canada, 2004b) to some individuals (Rudolph et al., 1998) for all of their daily water 
needs (i.e. drinking, washing, cooking, farming (Environment Canada, 2004b)).  Rural 
Canadians account for the largest percentage of Canadians that depend on groundwater.  
Approximately 9 million Canadians depend on groundwater, and 6 million of these are 
rural habitants (Environment Canada, 2004a).  The natural filtering of groundwater 
through aquifers typically renders it free of disease-causing microorganisms 
(Environment Canada, 2004d).  However, human use of contaminants (industrial 
chemicals, pesticides) in close proximity to groundwater sources, such as wells, may 
pollute (via run-offs, spray-drifts, spills, leaks) these sources (Environment Canada, 
2004c, 2004e).  Pollution of groundwater renders it unsuitable for use and increases the 
risk of occurrence of adverse health effects in humans that consume the contaminated 
water.  Unfortunately, due to the increased used of toxic chemicals in industries and 
agriculture; groundwater contamination has become an increasing problem in Canada 
(Environment Canada, 2004c).  Even more worrisome, is the fact that, the overall extent 
of the problem of groundwater contamination is currently unknown and some 
contamination even goes unnoticed until populations fall ill following consumption of 
the contaminated water (Environment Canada, 2004c).  Contamination of groundwater 
can occur from either point or non-point sources (Environment Canada, 2004c, 2004e).  
Accidental spills, leaks from septic systems, livestock wastes and effluents from mining 
processes serve as point sources of groundwater (Environment Canada, 2004c, 2004e).  
In contrast, non-point, or distributive sources of groundwater include run-offs of 
fertilizers and pesticides (i.e 2.4-D) from agricultural land, and contaminants from the 
rain, snow and dry atmosphere (Environment Canada, 2004c, 2004e).   
Previously mentioned, 2,4-D has been one of the most frequently detected 
herbicide in groundwater (Grover et al., 1997).  The ability of 2,4-D to contaminate 
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groundwater is most likely associated with its leaching from soil environments 
(reviewed by Cox et al., 1999).  The herbicide has an increased potential to leach into 
groundwater from soils that are coarse-grained, sandy with low organic content, and 
basic (US EPA, 2005).  However, in general, little run-off from the soil into 
groundwater environments occurs with 2,4-D acid or its amine salts (US EPA, 2005).  
The US EPA has classified 2,4-D as a marginal leacher (reviewed by Environment 
Canada, 1991) from soil.  The leaching potential of chemicals from soil is a result of its 
adsorption and persistence properties (Gan, 2002).  The leaching rating of pesticides are 
assigned based on the groundwater ubiquity score (GUS), which is calculated using the 
adsorption coefficient (Koc) and dissipation half-life (DT½) of the pesticide in soil (Gan, 
2002).  A non-leacher is a pesticide that has a GUS <1.8 and a marginal leacher is a 
pesticide that has a GUS between 1.8 and 2.8 (Gan, 2002).   
Groundwater is a significant source of water for rural habitants (Environment 
Canada, 2004b).  Therefore, it is important to acknowledge the concentrations of 
contaminants, such as pesticides, found in groundwater and address the adverse human 
health effects that may occur from exposure to these contaminants.  In groundwater, 2,4-
D is usually detected at concentrations that are below established drinking water 
guidelines.  For instance, in a groundwater monitoring study (total of 21 rural 
Saskatchewan farm dugouts sampled between the fall of 1987 and the spring of 1989), 
2,4-D residues were detected in 75% of the total dugouts that were sampled (Grover et 
al., 1997).  Concentrations of 2,4-D were below (median and maximum 2,4-D residue 
concentrations were determined as 0.07 and 2.67 µg/L, respectively (Grover et al., 
1997)) established guideline values for the herbicide in drinking water (see below for 
established guideline values for 2,4-D in drinking water).  However, there have been 
some studies that have found 2,4-D in well water samples at concentrations that were 
alarmingly approaching and exceeding established drinking water guideline values for 
the widely used herbicide.  For example, in an investigation of pesticide contamination 
in 359 rural wells in Ontario over a duration of 5 years (1979 and 1984), the authors 
found that 71% of the wells were contaminated with pesticides and 2,4-D was involved 
in 30% of those well contaminations at concentrations ranging from 0.1 to 60 µg/L 
(Frank et al., 1987).  In a survey conducted in 6 Canadian provinces from 1971 to 1986, 
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2,4-D residue was found at a concentration of approximately 29 µg/L in 52 out of 805 
samples of raw and treated drinking water (reviewed by Environment Canada, 1991; 
WHO, 2003).  A concentration that was approaching the international WHO drinking 
water guideline for 2,4-D (see below).     
The herbicide has been suggested to induce a plethora of adverse human health 
effects (see sections 2.1.6.1 to 2.1.6.9), thus regulatory guideline levels for 2,4-D in 
drinking water have been established by both national and international agencies to help 
protect the health of humans who may be exposed to the chemical via drinking water.  
There are vast variations between individual regulatory guidelines established for 2,4-D 
in drinking water.  Regulatory guidelines for water contaminants, such as 2,4-D are 
established by agencies based on the best available scientific research conducted on the 
potential adverse human health effects that may be associated with consumption of high 
concentrations of the chemical over a chronic period of time (Health Canada, 2006).  
Currently, the highest guideline level for 2,4-D in drinking water has been established by 
Canada.  The Canadian CDW has established an interim maximum acceptable 
concentration (IMAC) for 2,4-D in drinking water of 100 µg/L (Environment Canada, 
1991).  Other agencies have established guideline levels that are well below that of 
Canada.  For example, the US EPA has established a maximum contaminant level 
(MCL) for 2,4-D in drinking water of 70 µg/L (US EPA, 2005).  In contrast, WHO has 
established an international drinking water guideline of 30 µg/L (WHO, 2003), while the 
European council of agriculture ministers has established a maximum admissible 
concentration (MAC) for all pesticides in drinking water of 0.1 µg/L (Harrison et al., 
2000).    
 
            2.1.5 Exposure to and fate of 2,4-D in humans 
 Humans may be exposed to 2,4-D via several routes.  These include the 
respiratory, dermal, eyes and oral routes (PAN Pesticide Database, 2004).  The oral 
route is the most significant route of exposure to 2,4-D from groundwater.  Although 
water represents a significant source, it is not the sole source of 2,4-D exposure.  Soil 
(contaminated during herbicidal application (WHO, 2003)) and air (contaminated 
through spray drifts and volatilization of the herbicide (reviewed by Cox et al., 1999)) 
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are also sources of 2,4-D exposure to humans.  Consumption of foods (i.e. alfalfa, apple, 
apricot, cranberry, flax, maple, pear, peach and plum (PMRA, 2005)) contaminated with 
2,4-D also exposes humans to the herbicide.  Other sources of 2,4-D exposure may 
include occupational and bystander exposure.  Personnel occupationally responsible for 
handling and applying 2,4-D may unintentionally be exposed to high concentrations of 
the herbicide (PMRA, 2005; WHO, 1984) via all routes.  For instance the herbicide has 
been found at concentration of up to 453.6 µg/L in the urine of backpack sprayers of 2,4-
D (Garry et al., 2001).  Homeowners who apply 2,4-D to their lawns may be also be 
unintentionally exposed to the chemical (PMRA, 2005) via all routes of exposure.  
Finally, bystanders, such as persons (adults, children) who enter an area (residential 
lawns, parks, golf-course) where 2,4-D has been applied may also be exposed to the 
herbicide through similar routes (PMRA, 2005).   
 In humans, once orally ingested, as would occur with consumption of 
groundwater, the esters and amine forms of 2,4-D rapidly undergo hydrolysis to yield 
the parent 2,4-D acid (BC Ministry of Forests, 2003; Garabrant and Philbert, 2002).  The  
parent 2,4-D acid has been described to be well absorbed from the gastrointestinal tract 
following oral ingestion (Sauerhoff et al., 1977).  However, at human physiological pH 
(pH 7.4), the parent acid exists predominantly in the ionized form (Garabrant and 
Philbert, 2002).  Thus, ionization of the 2,4-D acid molecule at human physiological pH 
limits the diffusion across cell membranes (Garabrant and Philbert, 2002), suggesting 
that in humans, the probability of 2,4-D to enter, accumulate and induce adverse effects 
in cells and/or tissues is low.   
 Excretion of 2,4-D occurs mainly in the urine via first-order rate kinetics, with an 
average half-life of approximately 17 hrs (Sauerhoff et al., 1977).  The majority of 
absorbed 2,4-D (82.3%) is excreted in the urine mainly unchanged.  A small portion 
(12.8%) is excreted as an unidentified 2,4-D conjugate (Sauerhoff et al., 1977).  Thus, 
due to its pharmacokinetic properties, accumulation of 2,4-D in human organs and 
tissues is considered highly unlikely (Garabrant and Philbert, 2002).  However, several 
studies have illustrated that 2,4-D may accumulate at high concentrations in humans 
through multiple exposure sources (i.e via consumption of groundwater, occupational 
and bystander).  For instance, in a study conducted in rural Saskatchewan, during spring 
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application (June-July 1996) of the herbicide, 2,4-D was detected at a maximum 
concentration of  230 µg/L in the plasma of rural residents (Semchuk et al., 2004).  In 
these cases, the residents may have been unintentionally exposed to 2,4-D via multiple 
routes (i.e. oral, dermal, respiratory, eyes) and sources (groundwater consumption for 
drinking, washing, and cooking, bystander, air and food).  The accumulation of high 
concentrations of 2,4-D in humans have also been observed in persons working with the  
herbicide (Arbuckle et al., 1999; Garry et al., 2001; Holland et al., 2002).  Results from 
a study performed in Ontario also reported high 2,4-D concentrations of up to 106.9 
µg/L in the semen of farmers (Arbuckle et al., 1999) occupationally exposed to the 
herbicide.  High concentrations of 2,4-D have also been detected at maximum levels of 
240 µg/L (Holland et al., 2002) and 453.6 µg/L (Garry et al., 2001) in the urine of 
backpack sprayers who were occupationally exposed to the herbicide.  The results of 
these studies are worrisome, since the entrance and accumulation of toxicants (i.e. 2,4-
D) into cells may induce toxicity in cells and tissues (Gregus and Klaassen, 2001).  A 
review of studies that have examined the adverse human health effects of 2,4-D will now 
be presented.     
 
            2.1.6 Toxicological evidence of the adverse human health effects induced by                
                      2,4-D exposure   
The toxicology of 2,4-D has been well studied and its current literature is 
overwhelming.  In the following review of 2,4-D toxicology, several studies that have 
used in vivo and in vitro experimental models to assess the adverse human health effects 
(i.e. cytotoxicity, organ toxicity, genotoxicity, carcinogenesis, neurotoxicity, 
immunotoxicity, developmental toxicity and reproductive toxicity) that may occur 
following 2,4-D exposure will be discussed.  The purpose of this comprehensive review, 
is to illustrate that although 2,4-D toxicology has been well studied, the majority of 
previous studies failed to assess the adverse human health effects of low concentrations 
(<100 nM) of the herbicide; concentrations that are typically found in the environment 
and hence to which humans may more likely be exposed to from the environment over 
acute, subacute, subchronic and chronic durations of time.  
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However, before commencing the review, the following paragraphs consist of a 
dissection of some information that will allow for better interpretation of the studies 
reviewed.  Firstly, in most in vivo studies reviewed, doses of 2,4-D have reported in 
mg/kg units.  Additionally, some in vitro studies that were reviewed expressed 2,4-D 
concentrations in µg/L units.  Therefore, in order to attain an understanding of the 
difference between the low 2,4-D concentrations that was used in this present study and 
the high concentrations that were used in those particular in vivo and in vitro studies, 
below is a presentation of the conversion of the 2,4-D concentration range used in the 
current study to the equivalent dose (mg/kg) or concentrations (µg/L) units.  The 
conversion from molar concentration to dose assumed that adult male rats were exposed 
to a single dose of commercial 2,4-D (containing 2,4-D DMA) from their drinking 
water.  The average weight of an adult male rat is 250-550 g and drinks an average of 
10-12 mL of water per 100 g per day (Grant, 2000)  Thus, the conversion assumed that 
the average weight of a rat was equal to 250 g and drank an average of 25 mL of water 
per day.  Therefore, 0.1 nM to 1 mM of commercial 2,4-D in the present study is 
equivalent to 2.2 x 10-6 to 22 mg/kg of 2,4-D acid.  The concentration range of 0.1 nM to 
1 mM of commercial 2,4-D in the present study is equivalent to 0.022 to 2.2 x 105 µg/L 
of 2,4-D acid.      
  Secondly, different forms (i.e. acid, amine or ester forms) of 2,4-D are used in 
2,4-D toxicological studies.  However, from the review of toxicity data, the toxic effects 
induced by this herbicide are through the actions of the parent 2,4-D acid, regardless of 
the 2,4-D form used in experimental studies.  It was reported that, in humans, the esters 
and amine forms of 2,4-D undergo hydrolysis to yield the parent 2,4-D acid (BC 
Ministry of Forests, 2003).  Additionally, in experimental studies performed in animals, 
similar toxicity has been produced by 2,4-D acid, 2,4-D DMA and 2,4-D ester (Charles 
et al., 2001).  It has been suggested that those observations confirm previous suggestions 
of the rapid metabolic conversion of 2,4-D salts to 2,4-D acid in vivo (Charles et al., 
2001).  Similarity between 2,4-D acid and commercial formulations containing 2,4-D 
DMA have also been observed (González et al., 2005).  The authors observed that the 
two compounds exerted similar genotoxic effects.  Therefore, based on its metabolism, 
any adverse human health effects associated with 2,4-D acid or commercial forms is 
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most likely due to the parent 2,4-D acid.  In the current review, studies that have 
employed technical 2,4-D acid or commercial forms containing 2,4-D DMA were 
discussed, since a commercial form of 2,4-D containing 2,4-D DMA was used in the 
present study. 
 
                     2.1.6.1 Cytotoxic effects of 2,4-D 
Cytotoxic effects are defined as the adverse effects that result from the disruption 
of structures and processes that are essential for cell survival, proliferation and function 
by exposure to chemical agents (Tuschl and Schwab, 2004).  Several investigators have 
assessed the cytotoxic effects of 2,4-D.  A review of the in vivo, followed by the in vitro 
studies is presented below.    
The cytotoxic effects of 2,4-D have been assessed using an in vivo model (rats) 
(Kaioumova et al., 2001a).  Rats were orally gavaged with single high doses of 2.8, 
22.8, 228 mg/kg of 2,4-D DMA.  Thymus, spleen and blood were obtained 4, 8, 12 or 24 
hrs after 2,4-D treatment.  The DNA laddering pattern (produced by DNA gel 
electrophoresis) demonstrated that exposure to 2,4-D induced dose- and time-dependent 
cell death in the thymus, spleen and blood.  The results suggest that 2,4-D may induce 
cytotoxic effects in various organs in humans.  However, the study examined 2,4-D 
doses (2.8 to 228 mg/kg) that reflects concentrations of the herbicide that are more than  
100 fold higher than that typically found in the  environment.  Thus, the results of the 
study failed to elucidate the adverse human health effects of low 2,4-D concentrations 
that are routinely found in the environment.  A review of the in vitro 2,4-D cytotoxicity 
studies that have been conducted will now commence.     
Various in vitro models (HepG2, human cerebellar granule, human 
lymphoblastoid, human histocytic lymphoma and chronic myeloid leukemic, human 
erythrocytes, rat hepatocytes, mouse lymphoma cells) have been utilized to assess the 
cytotoxic effects of 2,4-D.  Similar to this thesis, the cytotoxic effects of low 2,4-D 
concentrations were assessed using HepG2 cells (Bharadwaj et al., 2005).  The 
researchers were the first to examine the cytotoxic effects of low concentrations (0.1 to 
100 nM) of the herbicide (commercial 2,4-D (containing 2,4-D DMA)).  Cell viability 
was determined using the neutral red uptake assay.  Results illustrated that acute 
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exposure (24 hrs) to low 2,4-D concentrations (0.1 to 100 nM) induces cytotoxicity, 
reflected by non concentration-dependent cell death (10 to 15% decreases in cell 
viability).  The results suggest that low 2,4-D concentrations may induce cytotoxic 
effects in humans.   
 In contrast to the above study and this current study, the cytotoxicity of high 
concentrations (>100 nM) of 2,4-D has been evaluated by several other in vitro studies 
(De Moliner et al., 2002; Duchnowicz and Koter, 2003; Palmeira et al., 1995; Tuschl 
and Schwab, 2003, 2004, 2005;  Venkov et al., 2000).  Similar to this present research, 
Tuschl and Schwab used HepG2 cells to investigate 2,4-D cytotoxicity (Tuschl and 
Schwab, 2003, 2004, 2005).  The authors used flow cytometry and the annexin-V assay 
to determine cell death.  Cells were exposed for 24 and 48 hrs to 2,4-D acid 
concentrations (4, 8 and 16 mM) that were more than 1000 fold higher than that 
typically found in the environment (Tuschl and Schwab, 2003).  Exposure resulted in a 
concentration-dependent prolongation of the GI phase of the cell cycle and an increase 
in cell death (Tuschl and Schwab, 2003).  Effects were exacerbated following exposure 
to 16 mM.  At 16 mM, more than 50% of cells were dead and a total disruption of the 
cell cycle was observed after 48 hrs of exposure (Tuschl and Schwab, 2003).  Similar  
results were obtained in later studies, where HepG2 cells were exposed to 4, 8 and 16 
mM of 2,4-D acid for 24 hrs (Tuschl and Schwab, 2004; 2005).   
The cytotoxicity of high 2,4-D concentrations (>100 nM) that are 1000 fold or 
higher than that found in the environment, has also been evaluated using other in vitro 
cell models (De Moliner et al., 2002; Duchnowicz and Koter, 2003; Palmeira et al., 
1995; Tuschl and Schwab, 2004, 2005;  Venkov et al., 2000).  For instance, results from 
flow cytometry and the 3-(4,5-dimethylthazol-2-yl)-2,5 diphenyltetrazolium bromide 
(MTT) assays illustrated that exposure to 1 and 2 mM of 2,4-D acid for 12, 20 or 24 hrs 
induced non concentration- and time-dependent decreases in human cerebellar granule 
cell viability.  In cytotoxicity studies performed by Tuschl and Schwab, comparative 
effects were observed in human lymphocytes isolated from whole blood (Tuschl and 
Schwab, 2005), human lymphoblastoid (AHH-1) and mouse lymphoma (YAC-1) cells 
(Tuschl and Schwab, 2004, 2005).   
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In vitro studies were also performed using high concentrations (>100 nM) of 2,4-
D to assess cytotoxicity in human histocytic lymphoma (U937) and chronic myeloid 
leukemic (LAMA-84) cells (Venkov et al., 2000).  Results from MTT assays 
demonstrated that exposure to 0.16 mM of 2,4-D acid for 48 hrs induced a 40% decrease 
in cell viability in U937 and LAMA-84 cells.   Complete cell death was observed in cells 
exposed to 1.6 mM of 2,4-D for 48 hrs.   
The cytotoxic effects of high concentrations of 2,4-D have also been investigated 
using human erythrocytes cultures (Duchnowicz and Koter, 2003) and primary rat 
hepatocytes (Palmeira et al., 1995).  Spin probe analysis revealed that exposure to 1 mM 
of 2,4-D acid for 1 hr induced hemolysis of human erythrocytes (Duchnowicz and Koter, 
2003).  Results from trypan blue exclusion assay demonstrated that 0 to 200 min 
exposure to 2,4-D acid concentrations (1, 5 and 10 mM) induced concentration- and 
time-dependent decreases in the viability of rat hepatocytes (Palmeira et al., 1995).     
Thus, taken all together, the above review illustrates that; although the 
cytotoxicity of 2,4-D has been investigated by several researchers who used various 
models (in vivo (rats) and in vitro (HepG2, human cerebellar granule, human 
lymphoblastoid, human histocytic lymphoma and chronic myeloid leukemic, human 
erythrocytes, rat hepatocytes and mouse lymphoma cells)), assays (annexin-V, flow 
cytometry, MTT, neutral red uptake, spin probe, trypan blue exclusion and TUNEL 
assays), durations of exposure (12 to 72 hrs) and forms (technical 2,4-D acid or 
commercial 2,4-D (containing 2,4-D DMA)), most studies used overt concentrations 
(>100 nM) and did not examine the cytotoxic effects of low 2,4-D concentrations (<100 
nM).  This is an alarming finding that warrants attention, since humans are typically 
exposed to low concentrations of 2,4-D in the environment.  The research conducted in 
this thesis assesses the cytotoxicity of low 2,4-D concentrations.   
 
                     2.1.6.2 Hepatotoxic effects of 2,4-D  
The hepatotoxic effects of 2,4-D have been assessed by several investigators.   
However, many researchers failed to examine the hepatotoxic effects that may be 
associated with exposure to low environmental concentrations of 2,4-D.  A review of 
some in vivo, followed by the in vitro studies is presented below.    
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In an in vivo study, rats were exposed (via drinking water) to doses (600 mg/kg 
for 1 day) or concentrations (200,000 µg/L for 30 and 180 days) of commercial 2,4-D 
(containing 2,4-D DMA) (Paulino et al., 1996) that are more than 1000 fold higher than 
would be typically encountered by humans in the environment.  Spectrophotometric 
analyses demonstrated that acute exposure to such a high dose of 2,4-D induced 
disruption of hepatic function, indicated by elevated levels of several hepatic enzymes 
markers (i.e. aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate 
dehydrogenase (LDH) and alkaline phosphatase (AP)) that are routinely used for 
determination of hepatic dysfunction.  Interestingly, subchronic and chronic exposure to 
2,4-D induced lesser degrees of the above effects.  This may have been an adaptive 
response to longer exposure to the herbicide.  Subchronic exposure induced an increase 
in AST levels, while chronic exposure induced increases in AST, AP and LDH levels.  
A greater degree of hepatic dysfunction may have been observed following chronic, 
compared to subchronic exposure due to saturation of repair and/or detoxification 
mechanisms following chronic, compared to sub-chronic exposure to the herbicide.  
Sub-chronic exposure refers to exposure to a chemical for no longer than 3 months 
(Eaton and Klaassen, 2001).  Chronic exposure refers to exposure to a chemical for more 
than 3 months (Eaton and Klaassen, 2001).  
The adverse hepatic effects of high concentrations of 2,4-D has also been 
documented by Charles and colleagues.  In a subchronic experimental study, rats were 
exposed to doses of 2,4-D (1, 15, 100 and 300 mg/kg/day of 2,4-D acid or 2,4-D DMA 
from their feed for 3 months (Charles et al., 2001)) that were equal to one half or less 
than that used by Paulino and co-workers.  Histopathology revealed that the highest 
dose, a dose that humans are not likely to be exposed to from the environment, of 2,4-D 
induced centrilobular hepatocellular hypertrophy.  Thus, the above in vivo studies have 
examined and illustrated the adverse hepatic effects of high 2,4-D doses (1 to 600 
mg/kg) or concentrations (200,000 µg/L).  However, humans are not likely to be 
exposed to such high doses or concentrations of 2,4-D from the environment.  A review 
of the in vitro studies will now be presented.  
In vitro studies have assessed the hepatotoxic effects of 2,4-D concentrations (2 
to 16 mM) that are more than 1000 fold or higher than that encountered by humans in  
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the environment.  The in vitro cytotoxic effects that were reported by Tuschl and 
Schwab (see section 2.1.6.1) were observed in HepG2 cells (Tuschl and Schwab, 2003; 
2004; 2005), cells that are derived from human liver (ATCC, 2004).  Therefore, the 
results also suggest that high 2,4-D concentrations (≥2 mM) may induce hepatotoxic 
effects (i.e. cell death) in humans.  The results from the cytotoxicity study (see section 
2.1.6.1) that was conducted by Palmeira et al. (1995) and illustrated that 2,4-D induced 
death of rat hepatocytes, also suggest the same; that is,  high 2,4-D concentrations (≥ 
1mM) may induce hepatotoxic effects (i.e. cell death) in humans.  In addition to the 
studies performed by Tuschl and Schwab, the results from the in vitro study conducted 
by Bharadwaj and colleagues also suggest 2,4-D may induce hepatotoxic effects, since 
the study was also conducted using HepG2 cells (Bharadwaj et al., 2005).  In contrast to 
the studies conducted by Tuschl and Schwab, and similar to this thesis, the authors 
tested low environmental 2,4-D concentrations that humans are more likely to be 
exposed to from the environment.  The study illustrated that low 2,4-D concentrations 
induced cell death and gene alteration.  Genes whose expression levels were altered 
included those involved in stress response (FTL, FTH1, PCNA), for example.  An 
intriguing finding that, for the very first time showed that low 2,4-D concentrations may 
induce adverse human health effects.   
Taken altogether, the majority of previous in vivo and in vitro studies failed to 
assess the hepatotoxic effects of low environmental concentrations of 2,4-D.  Studies 
examined 2,4-D doses (1 to 600 mg/kg) and concentrations (2 to 16 mM) that reflects 
2,4-D concentrations that are more than 100 fold higher than that found in the 
environment, and hence to which humans are not typically exposed to.  Thus, the results 
of such studies may not accurately predict the adverse human hepatic effects of exposure 
low environmental 2,4-D concentrations over acute or chronic durations of time. 
 
                     2.1.6.3 Nephrotoxic effects of 2,4-D  
 The nephrotoxic effects of 2,4-D have been evaluated by some researchers, using 
in vivo models.  In the first study reviewed, histopathological examination revealed that 
subchronic (3 months) exposure (via oral ingestion from feed) to a 2,4-D acid 
concentration (2,500,000µg/L (≈11 mM)), that is more than 1000 fold higher than 
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concentrations of the herbicide typically encountered by humans from the environment, 
induced structural changes (i.e. decreased cytoplasm and cytoplasmic granules, reduced 
mitochondria organelles and increased nuclear density of cells) in the proximal 
convoluted tubule segment of the nephron (Ozaki et al., 2001).  The nephron is the 
functional unit of the kidney (Silverthorn, 1998).  The nephrotoxic potential of high 
doses of 2,4-D was also investigated by Charles and co-workers in an earlier study.  
Histopathological studies revealed that there was loss of the brush border in proximal 
tubular cells and vacuolization of all tubular cells in rats subchronically exposed to 300 
mg/kg/day 2,4-D acid or 2,4-D DMA from their feed for 3 months (Charles et al., 1996).   
Thus, taken together, the above studies have investigated the nephrotoxic effects 
of high 2,4-D doses (300 mg/kg) and concentrations (≈11 mM) that reflects 
concentrations that are more than 1000 fold higher than that typically found in the 
environment.  Therefore, although the results from the above studies provide useful 
information for elucidating the adverse effects that may occur in the kidney of humans 
exposed to high concentrations of 2,4-D, the results are not likely to predict the 
nephrotoxic effects that may occur following typical, everyday exposure to low 
concentrations (<100 nM) of the herbicide that are usually found in the environment.  
          
                     2.1.6.4 Genotoxic effects of 2,4-D  
 The genotoxic effects of 2,4-D have been assessed using both in vivo and in vitro 
experimental model systems.  A review of the in vivo studies, followed by the in vitro 
studies is presented below.  Several researchers have assessed the genotoxic effects of 
2,4-D, in vivo, using high doses (1.7 to 200 mg/kg) of the chemical (Amer et al., 2001; 
Madrigal-Bujaidar et al., 2001; Venkov et al., 2000) that reflects concentrations that are 
more than 100 fold higher than that found in the environment.  Chromosomal 
aberrations (i.e. gaps, fragments, breaks, translocations and poly-ploid metaphases) have 
been reported to occur in the bone marrow and spermatocytes of rats exposed (oral 
gavage) to 3.3 mg/kg of 2,4-D acid for 3 and 5 consecutive days (Amer et al., 2001).  
Comparative effects were also observed in rats that orally ingested 33 mg/kg of 2,4-D 
acid for 1 day.  Significant chromosomal aberrations, including sister chromatid 
exchanges have also been observed in bone marrow cells that were isolated from mice 
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exposed (intraperitoneal injection) to 3.5 mg/kg of 2,4-D acid for 12 hrs (Venkov et al., 
2000).  Chromosomal aberrations induced by 2,4-D exposure have also been reported by 
researchers who used doses of the herbicide that were more than 100 fold higher than 
that used by the previously described studies (Madrigal-Bujaidar et al., 2001).  Rats 
were orally exposed to single doses 100 and 200 mg/kg of 2,4-D acid.  Dose-dependent 
increases in sister chromatid exchanges in isolated bone marrow and spermatogonial 
cells were observed.   
Thus, the results from the in vivo studies suggest that 2,4-D doses that are equal 
to or greater than 3.3 mg/kg may induce genotoxic effects (i.e. chromosomal 
aberrations) in humans.  However, humans are not likely to be exposed to such high 
doses, since 2,4-D concentrations in the environment are typically less than 100 nM.  A 
review of the in vitro genotoxic studies will now commence.   
The genotoxic effects of 2,4-D concentrations (1 µM to 45 mM) that are more 
than 10 fold or higher than that encountered by humans in the environment have been 
assessed, in vitro (González et al., 2005; Holland et al., 2002; Zeljezic and Garaj-
Vrhovac, 2004).  Concentration-dependent increases in the number of chromatid and 
chromosome breaks, micronuclei and nuclear buds was observed in human lymphocytes 
cultures exposed to concentrations (400 and 4000µg/L (≈ 2 to 20 µM of 2,4-D acid)) of 
commercial 2,4-D (containing 2,4-D acid) that are more than 10 fold higher than that 
found in the environment (Zeljezic and Garaj-Vrhovac, 2004).  Concentration-dependent 
genotoxic effects (i.e. micronucleus proliferation, frequency) of high 2,4-D 
concentrations (1 µM to 1 mM) have also been observed in human whole blood or 
isolated lymphocyte cultures exposed to technical 2,4-D acid or commercial 2,4-D for 
48 hrs (Holland et al., 2002).  Using Chinese hamster ovary cell cultures, the genotoxic 
effects of high 2,4-D concentrations have also been evaluated (González et al., 2005).  
Concentration-dependent increases in the frequency of DNA-strand breaks were 
observed in cell cultures exposed to 2000 to 10,000 µg/L (≈ 9 to 45 µM of 2,4-D acid) of 
either 2,4-D acid or commercial 2,4-D (containing 2,4-D DMA) for 1.5 hrs.  
Concentration- and time-dependent increases in sister chromatid exchange were 
observed in cell cultures exposed to a similar range of 2,4-D concentrations for 24 and 
36 hrs.   
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Thus, from the above review of 2,4-D genotoxicity studies, it can be concluded 
that although the genotoxic effects of 2,4-D have been assessed using various 
experimental models (in vivo (rats and mice) and in vitro (human whole blood, human 
isolated lymphocytes and Chinese hamster ovary cell cultures)), endpoints 
(chromosomal aberrations, micronucleus proliferation) and durations of exposure (1.5 
hrs to 5 days), the studies did not assess the human genotoxic effects that may associated 
with exposure to low environmental concentrations (<100 nM) of 2,4-D.  the above in 
vivo and in vitro studies used 2,4-D doses (1.7 to 200 mg/kg) and concentrations (1 µM 
to 45 mM), respectively, that reflects concentrations of the herbicide that are more than 
10 fold higher than that typically found in the environment, and hence to which humans 
are not likely exposed to over acute or chronic periods of time.   
 
                     2.1.6.5 Carcinogenic effects of 2,4-D  
Several in vivo studies have assessed the carcinogenic effects of 2,4-D by using 
high concentrations (>1 µM) of the herbicide (Amer et al., 2001; Ge et al., 2002; 
Holland et al., 2002; Madrigal-Bujaidar et al., 2001; Ozaki et al., 2001; Venkov et al., 
2000).  Results from these studies suggest that overt 2,4-D concentrations (<1 µM) may 
induce carcinogenesis in humans.  For instance, 2,4-D has been reported to induce 
significant increases in replicative indices of lymphocyte cultures isolated from whole 
blood obtained from twelve spray applicators (mean urine level of 2,4-D acid was 240 
µg/L (≈ 1 µM)) exposed solely to the herbicide for 3 months (Holland et al., 2002).  In 
another in vivo study, southern blot analysis demonstrated that exposure to high 2,4-D 
doses (daily oral dose of 1.7 x 106 µg/L (≈ 8mM) of 2,4-D acid through feed for a period 
of 6 days) induced DNA hypomethylation of the proto-oncogene, c-myc, in hepatocytes 
of mice (Ge et al., 2002).  An inverse relationship exists between DNA methylation and 
transcription of genes (Ge et al., 2002), therefore, hypomethylation of the proto-
oncogene, c-myc suggests possible increased transcription of the gene, with subsequent 
translation.  The alteration of the regulation of proto-oncogenes is one mechanism 
involved in the activation of proto-oncogenes to oncogenes (Kumar et al., 1997).  
Oncogenes are genes that are involved in the process of carcinogenesis by inducing 
uncontrolled cell proliferation (King and Stansfield, 1997; Kumar et al., 1997).  
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Furthermore, the dysregulation of the myc gene is known to be involved in Burkitt’s 
lymphoma (a B-cell tumor) (Kumar et al., 1997).   
The carcinogenic potential of high 2,4-D concentrations have also been 
illustrated in an in vivo subchronic toxicity study, where rats were orally exposed to high 
concentrations of 2,4-D acid (1.7 x 104, 8.5 x 104, 2.5 x 105, 1.2 x 106, 2.5 x 106 µg/L (≈ 
80 µM, 380 µM, 1 mM, 6 mM and 11 mM)) through their feed for a period of 3 months 
(Ozaki et al., 2001).  Results from histopathological studies demonstrated that exposure 
to 2,4-D induced a concentration-dependent increase in hyperplasia of cells of the outer 
medulla.  Pathological hyperplasia is suspected to lead to cancerous proliferation 
(Mitchell and Cotran, 1997).   
In addition to the above studies and since genetic damage is known to play an 
integral role in carcinogenesis (Kumar et al., 1997), the results from the previously 
reviewed in vivo genotoxicity studies (Amer et al., 2001; Madrigal-Bujaidar et al., 2001; 
Venkov et al., 2000) (see section 2.1.6.4) also suggest that 2,4-D may induce 
carcinogenesis in human bone marrow, germ cells and lymphocytes.  However, these 
studies tested high 2,4-D doses (≥3.3 mg/kg) that do not reflect environmental 2,4-D 
concentrations that humans are exposed to.  Thus, all of the above studies have failed to 
address the carcinogenic potential of low 2,4-D concentrations in humans.   
The results from previously reviewed in vitro studies (González et al., 2005; 
Holland et al., 2002; Zeljezic and Garaj-Vrhovac, 2004) (see section 2.1.6.4) that also 
tested high 2,4-D concentrations (1 µM to 45 mM) and illustrated that exposure to the 
herbicide may induce genotoxicity in humans, also suggest that 2,4-D may induce 
carcinogenesis in human lymphocytes and germ cells at those high concentrations.  
However, humans are not typically exposed to such high environmental concentrations 
of 2,4-D.  Thus taken all together, previous in vivo and in vitro studies have tested the 
carcinogenic potential of 2,4-D using doses (≥3.3 mg/kg) or concentrations (1 µM to 45 
mM) that do not reflect concentrations of the herbicide that are typically found in the 
environment, and hence to which humans may not be exposed to.  Thus, the results from 
these studies may not accurately predict the carcinogenic potential of low environmental 
concentrations of the herbicide in humans.    
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                     2.1.6.6 Neurotoxic effects of 2,4-D  
The neurotoxicity of 2,4-D has also been evaluated.  However, similar to all of 
the above reviewed studies, researchers failed to assess the neurotoxic effects of low 
environmental concentrations of the herbicide.  Pregnant rats were chronically exposed, 
in vivo, to high dietary 2,4-D acid (70 mg/kg/day) from gestation day (GD) 16 to 
postpartum day (PD) 23 (Bortolozzi et al., 2004).  Following weaning (PD 23), offspring 
were divided into 2 groups, where one group was fed 2,4-D treated diets, and the other 
was fed 2,4-D free diets until PD 90.  The results of rapid filtration assays illustrated that 
2,4-D disrupted the dopamine (DA) neurotransmitter system of the brain, reflected by 
increased density of DA D2-type receptors in the prefrontal cortex, striatum and 
cerebellum areas of the brain.  These effects were irreversible in rats that were exposed 
to 2,4-D until PD 90.  The results from the study are intriguing and illustrate that high 
doses of the widely used herbicide may induce irreversible neurotoxic effects.  However, 
doses as high as those are not reflective of true environmental levels of 2,4-D, and hence 
to which humans are exposed, thus the results may not reflect the neurotoxic potential of 
2,4-D concentrations that are typically found in the environment. 
The neurotoxic effects of only high environmental 2,4-D concentrations (1 and 
2mM) have been evaluated, in vitro (Rosso et al., 2000)   Immunofluorescence and 
microtubule polymerization assays illustrated that exposure to 2,4-D acid for 24 hrs 
induced a concentration-dependent inhibition of neurite extension and reduced 
microtubule assembly in human cerebellar granule cell cultures, respectively.   
Thus, taken all together, results from the above in vivo and in vitro 2,4-D studies, 
suggest that high doses (70 mg/kg/day) or concentrations (1 and 2 mM) of 2,4-D may  
induce neurotoxic effects (disruption of neurotransmitter systems, inhibition of neurite 
extension and microtubule assembly) in humans.  However, doses or concentrations as 
high as those reflects concentrations that are at least 1000 fold higher than that typically 
encountered by humans in the environment, therefore, the results from the above studies 
does not elucidate the neurotoxic potential of true environmental concentrations of 2,4-
D.   
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                     2.1.6.7 Immunotoxic effects of 2,4-D  
The immunotoxicity of 2,4-D has been assessed.  Rats were exposed (via 
intraperitoneal injection) to single doses of 50, 100, 150 or 200 mg/kg of commercial 
2,4-D (containing 2,4-D DMA) (de la Rosa et al., 2003).  Flow cytometry analyses 
revealed decreases in pre-B and IgM+ cell population in the bone marrow of rats exposed 
to 200 mg/kg for 7 days.   In another study, the immune responses in the offspring of 
rats whose dams were exposed on GD 6 to GD 16 to dietary doses (8.5, 37 and 370 
mg/kg/day of 2,4-D acid) of commercial 2,4-D (containing 2,4-D DMA) in their 
drinking water were evaluated (Lee et al., 2001).  Flow cytometric analyses 
demonstrated that exposure to the highest dose of 2,4-D resulted in a decrease in T-
lymphocyte mitogen responses and an increase in B cell population.  The T cytotoxic or 
suppressor cell counts were also suppressed in the highest dose groups.  Results suggest 
that high 2,4-D doses may be immunotoxic to humans.  However, doses used in the 
above in vivo studies are unreflective of 2,4-D concentrations that are typically found in 
the environment.  Thus, the studies may not accurately predict the immunotoxic effects 
in humans of low 2,4-D concentrations.   
The immunotoxic effects of 2,4-D were assessed in vitro, using concentrations of 
the herbicide that were more than 10 fold higher than that typically encountered by 
humans in the environment.  Exposure (2, 4, 6 and 24 hrs) to 2,4-D concentrations (0.1 
to 5 mM) induced concentration- and time-dependent increases in the death of human 
peripheral blood lymphocytes and Jurkat T cells (Kaioumova et al., 2001b).  Results 
suggest that high 2,4-D concentrations may be immunotoxic to humans.  However, 
humans do not encounter such high 2,4-D concentrations in the environment.  Thus, 
results from the above studies suggest that high 2,4-D doses (>8.5 mg/kg) or 
concentrations (0.1 to 5 mM) may induce immuntoxicity in humans, however, doses or 
concentrations as high as those do not reflect concentrations of the herbicide that are 
typically found in the environment, and hence, to which humans are exposed to.  Thus, 
the results from the above studies may not accurately predict the adverse immune effects 
of low 2,4-D concentrations that are routinely encountered by humans in the 
environment. 
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                     2.1.6.8 Adverse reproductive effects of 2,4-D  
The adverse human reproductive effects that may be induced by 2,4-D exposure 
have been evaluated.  Via microscopic examination, a dose-dependent increase in the 
percentage of sperm head abnormalities (i.e. amorphous sperm head, sperm head 
without hook, triangular and banana shaped sperm head, small, big and double sperm 
heads) were observed in mice exposed daily to high doses of 33 and 82.5 mg/kg of 2,4-
D acid for 3 and 5 days (Amer et al., 2001).  The potential adverse reproductive effects 
of 2,4-D were also illustrated from the work conducted by a group of investigators that  
orally dosed mice with single doses of 50, 100 and 200 mg/kg of 2,4-D acid (Madrigal-
Bujaidar et al., 2001).  Scoring of the frequency of sister chromatid exchanges revealed 
that exposure to 100 and 200 mg/kg of 2,4-D acid induced a dose-dependent induction 
of sister chromatid exchanges in mice spermatogonial cells.  Thus, while the above in 
vivo studies illustrate that 2,4-D may induce adverse reproductive effects (germ cell 
abnormalities) in humans, the studies tested doses of 2,4-D that reflect concentrations of 
the herbicide that were more than 1000 fold higher than that encountered by humans in 
the environment.  The results of the study may not accurately predict the adverse 
reproductive effects of low 2,4-D concentrations in the environment.   
In vitro, the adverse reproductive effects of high concentrations (≈ 9 to 45 µM) 
(González et al., 2005) of the herbicide that are not typically found in the environment 
have been assessed.  Exposure of Chinese hamster ovary cells to 2,4-D concentrations (≈ 
9 to 45 µM) induced concentration-dependent increases in the frequency of DNA-strand 
breaks and sister chromatid exchanges in human female reproductive organs (González 
et al., 2005).   
Therefore, similar to the previous toxicity studies reviewed, the adverse 
reproductive effects of only high doses (≥33 mg/kg) or concentrations (≈ 9 to 45 µM) of 
2,4-D have been tested in in vivo and in vitro studies, respectively.  Those doses and 
concentrations are more than 10 fold higher than that typically encountered by humans 
in the environment.  Thus, while the results are intriguing, they are not likely to predict 
the adverse human reproductive effects that may be induced following exposure to 2,4-D 
in the environment.   
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                     2.1.6.9 Adverse developmental effects of 2,4-D  
The adverse developmental effects on various systems or organs that may be 
induced following 2,4-D exposure has been assessed in in vivo studies.  Below is a 
review of some such studies.  Using a high dose (370 mg/kg) of the herbicide, it was 
illustrated that the herbicide alters the development of the immune system in offsprings 
of rats (Lee et al., 2001) (see section 2.1.6.7 for details of study).  Decreases in T-
lymphocyte mitogen responses and increases B cell population were observed.  The 
developmental effects in the central nervous system (CNS) induced by 2,4-D exposure 
have also been tested.  The adverse CNS effects that were observed in offsprings 
(exposed to 70 mg/kg/day of 2,4-D acid) of rats in the neurotoxicity study conducted by 
Bortolozzi et al. (2004) (see section 2.1.6.6 for details of study) also illustrates the 
adverse developmental effects on the CNS of high doses of the chemical.  Adverse 
developmental effects on the CNS of offsprings of rats have also been reported by 
Duffard et al. (1996).  In the study, lactational exposure to 2,4-D (dams were 
intraperitoneally injected with 100 mg/kg of 2,4-D acid from PD 15 to 25 (period of 
rapid myelination) induced myelin deficit (assessed via histopathology) in the brain of 
rat offspring (Duffard et al., 1996). 
In addition to the immune system and CNS, 2,4-D has also been shown to induce 
adverse effects on tooth development.  Pregnant rats were exposed daily to 
concentrations (25,000, 50,000 and 100,000 µg/L (0.11, 0.23 and 0.45 mM) of 
commercial 2,4-D (containing 2,4-D DMA) (Alpöz et al., 2001) that are more than 1000 
fold higher than that typically found in the environment.  Rats were exposed to the 
herbicide in their food for 15 days prior to pregnancy and throughout pregnancy.  
Following birth, the offspring continued to be exposed to 2,4-D through lactation for 30 
days.  Histological examination revealed that exposure to 2,4-D induced dose-dependent 
increases in abnormal dentin formation.  Exposure to 50,000 and 100,000 µg/L resulted 
in decreased enamel thickness.   
Thus, results from the above studies suggest that high 2,4-D doses (≥70 mg/kg) 
or concentrations (≥25,000 µg/L) may induce adverse developmental effects on various 
organs or systems (CNS, immune system, and tooth) in humans.  However, doses and 
concentrations as high as those, reflect 2,4-D concentrations that are more than 1000 
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fold higher than that typically encountered by humans in the environment.  The results 
of the studies may not accurately predict the adverse development effects that may occur 
in humans exposed to 2,4-D from the environment. 
  
In summary, a review of the above studies illustrates that although the toxicity of 
2,4-D has been extensively investigated, the majority of in vivo and in vitro studies 
tested overt, unrealistic doses (1 to 600 mg/kg) or concentrations (1 µM to 45 mM) of 
the herbicide, that reflects concentrations that are 10 fold or higher than that encountered 
by humans in the environment.  Ideally, in vivo studies should have employed 2,4-D 
doses within the range of 2.2 x 10-6 to 2.2 x 10-3 mg/kg, while in vitro studies should 
have tested 2,4-D concentrations within the range of 0.1 to 100 nM, or 0.022 to 22 µg/L.  
Testing of these doses or concentrations would have been reflective of 2,4-D 
concentrations (0.1 to 100 nM) that are typically encountered by humans in the 
environment, and thus, would have aided in elucidating the adverse human health effects 
that are associated with acute or chronic environmental exposure to low concentrations 
of the herbicide.  This thesis addresses the adverse human health effects that may be 
associated with exposure to low concentrations of the herbicide.   
  
            2.1.7 2,4-D and gene expression 
 The majority of the above studies that were conducted to investigate the toxicity 
of 2,4-D share two factors common with classical toxicology studies; that is the use of 
(1) high 2,4-D concentrations (>1 mM) and (2) overt endpoints (i.e. cell death, 
pathological aberrations).  Toxicogenomics is an emerging technique in toxicology 
research (Aardema and MacGregor, 2002).  It is the study of alteration of gene 
expression patterns (Aardema and MacGregor, 2002).  The alteration of gene expression 
pattern is considered to be a more sensitive endpoint than currently employed 
pathological endpoints (Aardema and MacGregor, 2002).  Thus, due to its sensitivity, 
the alteration of gene expression pattern may be a better endpoint for assessing the 
toxicity of low concentrations of toxicants, such as 2,4-D, as low concentrations of 
toxicants may induce more subtle effects than high concentrations.  Toxicogenomics is a 
relatively novel tool that has only begun to gain merit in 2,4-D toxicology research 
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within the last few years.   Below is a review of some existing in vivo (yeast cells, rats) 
and in vitro (HepG2) experimental studies that have employed toxicogenomics (cDNA 
microarray analysis, 2-dimensional gel electrophoresis, RT-PCR) to assess 2,4-D 
toxicity.   
Most recently, cDNA microarray analysis was employed to study the acute 
effects of 2,4-D (0.3 mM of 2,4-D acid for 15 min) on early transcriptional responses in 
yeast (Teixeira et al., 2006).  Acute exposure to 2,4-D resulted in alterations in the  
expression patterns of 820 genes.  Significant increases (at least 2 fold) in the mRNA 
expression levels of antioxidant oxidative stress response (glutathione), chaperones and 
heat shock protein (heat shock protein (Hsp) 12 and 104) genes were observed.  
 Toxicogenomics was also employed to evaluate the transcriptional responses to 
high 2,4-D exposure in rats (Badawi et al., 1999).  Rats were exposed to a single oral 
dose of 375 mg/kg of 2,4-D acid for 72 hrs.  The analysis (via RT-PCR) of the liver, 
kidney and mammary glands illustrated that 2,4-D induced the up-regulation mRNA 
expression of several cytochrome P450 biotransformation enzymes (i.e. CYP1A1, 
CYP1A2 and CYP1B1) that are involved in estrogen metabolism (Badawi et al., 1999). 
The authors explained that the increased estrogen metabolism may suggest 2,4-D – 
induced carcinogenesis.   
In addition to the transcriptional responses, the translational responses to 2,4-D 
exposure have also been investigated, in vivo (Teixeira et al., 2005).  Using 2-
dimentional gel electrophoresis, it was illustrated that exposure (1.5 hrs) to 0.3 mM of 
2,4-D induced alteration in the expression patterns of 26 proteins in yeast.  Proteins, 
whose expression were significantly up-regulated (at least 2-fold) included those 
associated with stress response (i.e. Hsp12), mRNA and protein degradation (i.e. mRNA 
decapping enzyme). 
Thus, the above in vivo studies illustrates that 2,4-D induces alterations in gene 
expression at the level of mRNA and protein accumulation.  More importantly, and as 
illustrated in the studies conducted by Teixeira and colleagues, is the finding that 
alteration of gene expression, at the level of mRNA and protein accumulation can be 
detected following very acute (15 min or 1.5 hrs) exposure to a moderate concentration 
(0.3 mM) of 2,4-D.  This illustrates the sensitivity of the endpoint, in contrast to more 
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over biological endpoints (i.e. cell death) that are typically used to assess 2,4-D toxicity.  
However, similar to the majority of previous studies, the above studies failed to examine 
the adverse effects of low 2,4-D concentrations (0.1 to 100 nM).  Our laboratory was the 
first to take advantage of toxicogenomics to asses the adverse human health effects of 
low environmental 2,4-D concentrations (Bharadwaj et al., 2005).  The hypotheses of 
this present study were partially derived from results reported from that study, where 
acute exposure (24 hrs) to 0.1 nM to 1 mM of commercial 2,4-D (containing 2,4-D 
DMA) induced alteration in the gene expression pattern of 238 genes, including FTL, 
FTH1 and PCNA.  Results suggest; (1) low concentrations of 2,4-D may be cytotoxic, 
reflected by alteration in gene expression patterns, at the level of mRNA accumulation 
and (2) in contrast to overt biological endpoints (i.e. cell death), gene expression may be 
a more sensitive, and hence a better endpoint for assessing the adverse effects of low 
concentrations of toxicants    
Thus, taken all together, the above studies that employed toxicogenomics to 
assess the toxicity of 2,4-D, illustrate that the herbicide induces alteration in gene 
expression at the transcriptional and translational levels.  Furthermore, the study 
conducted by Bharadwaj et al. (2005) illustrates that the alteration of gene expression 
pattern is a sensitive endpoint for determination of the toxic effects of low 
concentrations of toxicants (i.e. 2,4-D).  Additionally, all of the above studies illustrate 
that the alteration of gene expression patterns induced by chemical (i.e. 2,4-D) exposure 
may also serve to highlight cell and molecular pathways involved in toxicity.  For 
instance, the up-regulation of FTL, FTH1 and PCNA mRNA expression (expressions are 
suggested to be up-regulated in response to oxidative stress) in HepG2 cells observed by 
Bharadwaj and co-workers suggest that ROS mediated oxidative stress may be a 
mechanism of 2,4-D toxicity.  Therefore, in this thesis, studying the alteration in gene 
expression, serves as a useful tool for assessing the human toxicity that may be 
associated with low concentrations of 2,4-D and highlighting underlying mechanism(s) 
of its toxicity. 
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            2.1.8 Suggested mechanisms of 2,4-D toxicity 
 Within the last several years, toxicology researchers have been diverging away 
from simple cause and effect toxicity studies and have begun to investigate the 
mechanism(s) of chemical toxicity.  Several investigators have attempted to elucidate 
the mechanisms of 2,4-D toxicity.  However, to this date, the mechanisms of 2,4-D 
toxicity have not yet been completely elucidated.  Below is a review of some existing in 
vivo and in vitro studies that provides evidence that suggests that 2,4-D toxicity may be 
induced by various mechanisms (i.e. apoptosis, necrosis, uncoupling of oxidative 
phosphorylation, depression of transmembrane potential, formation of a reactive 
metabolite, ROS and associated oxidative stress).   
 
                     2.1.8.1 Role of apoptosis in 2,4-D toxicity 
 Programmed cell death, or apoptosis, may play a role in 2,4-D toxicity.  
Apoptosis is characterized by defined cellular events including; disruption of plasma 
membrane, DNA fragmentation, chromatin condensation, change in cell volume and 
formation of apoptotic bodies (De Moliner et al., 2002).   
Results from an in vivo study suggests that apoptosis may be a mechanism of 
2,4-D toxicity (Kaioumova et al., 2001a).  In this study, dose- and time-dependent 
apoptosis (assessed by DNA laddering pattern visualized by DNA gel electrophoresis) 
was evident in the thymocytes of rats exposed (via oral gavage) to single doses of 2.8, 
22.8, 228 mg/kg of commercial 2,4-D (containing 2,4-D DMA) for 4, 8, 12 and 24 hrs.   
The results from several in vitro studies that have utilized various cell models 
(human HepG2, blood lymphocytes, Jurkat T, cerebellar granule cells) also provide 
evidence to suggest that apoptosis may be a mechanism of 2,4-D toxicity.  Apoptotic 
activity was assessed using various assays (annexin-V, DNA gel electrophoresis, flow 
cytometry, nicoletti, and terminal transferase dUTP nick and labeling (TUNEL))   
Results from annexin-V assay revealed that exposure to 4, 8 and 16 mM of 2,4-D acid 
for 24 and 48 hrs induces HepG2 cell death by apoptosis (Tuschl and Schwab, 2003).  
Comparative results were also observed in later studies, when the authors exposed 
HepG2 cells to 4, 8 and 16 mM of 2,4-D acid for 24 hrs (Tuschl and Schwab, 2004) or 1 
to 28 days (Tuschl and Schwab, 2005), respectively.  In later studies that were 
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performed by the same researchers, results of apoptotic activity were supported by the 
results from another assay, flow cytometry (Tuschl and Schwab, 2004; 2005).    
In contrast to Tuschl and Schwab, Kaioumova and colleagues used human 
peripheral blood lymphocytes and Jurkat T cells to assess apoptotic activity following 
2,4-D exposure (Kaioumova et al., 2001b).  Concentration- and time-dependent 
apoptosis was observed in cells exposed to 0.1 to 5 mM of commercial 2,4-D 
(containing 2,4-D  DMA) for 2, 4, 6 and 24 hrs.  Similar to Tuschl and Schwab, 
apoptotic activity was determined by the annexin-V assay.  Furthermore, the authors 
also supported experimental results by performing additional assays (DNA gel 
electrophoresis and nicoletti assay) for assessing apoptotic activity.   
Finally, in vitro experimental evidence suggesting that apoptosis may be a 
mechanism of 2,4-D toxicity was presented by De Moliner et al. (2002).  In contrast to 
Tuschl and Schwab and Kaioumova and colleagues, the authors assessed 2,4-D – 
induced apoptotic activity in human cerebellar granule cell cultures.  Results obtained 
from the TUNEL assay revealed that there was a non concentration-dependent increase 
in apoptotic activity in cells exposed to 1 or 2 mM for 24 hrs.     
Thus, results from above studies that have used various experimental models (in 
vivo (rats) and in vitro (human HepG2, blood lymphocytes, Jurkat T, cerebellar granule 
cells)), assay (annexin-V, DNA gel electrophoresis, flow cytometry, nicoletti, and 
TUNEL), doses (2.8 to 228 mg/kg), concentrations (0.1 to 16 mM), durations of 
exposure (4 hrs to 28 days)  and 2,4-D forms (2,4-D acid or 2,4-D DMA) suggest that 
apoptosis may be a mechanism of 2,4-D toxicity. 
 
                     2.1.8.2 Role of necrosis in 2,4-D toxicity  
 Necrosis, or unprogrammed cell death is characterized by cellular swelling, 
organelle disruption, random and diffused DNA fragmentation and inflammation 
(Mitchell and Cotran, 1997) and has been suggested to be a mechanism of 2,4-D 
toxicity.   
Results from a TUNEL assay showed that exposure to 2 mM of 2,4-D acid for 24 
hrs induced necrotic activity in 72% of human cerebellar granule cells (De Moliner et 
al., 2002).  Necrotic activity induced by 2,4-D exposure was also documented in a later 
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study, where, via the annexin-V assay, it was revealed that exposure to 4, 8 and 16 mM 
of 2,4-D acid for 24 and 48 hrs induced necrosis in HepG2 cell (Tuschl and Schwab, 
2003).   
Thus, results from the above studies that have used various in vitro models 
(human HepG2 and cerebellar granule cells), assay (annexin-V and TUNEL), 
concentrations (2 to 16 mM), durations of exposure (24 and 48 hrs) and a similar 2,4-D 
form (2,4-D acid) suggest that necrosis may be a mechanism of 2,4-D toxicity. 
 
                     2.1.8.3 Alteration of cell physiology in 2,4-D toxicity 
 It is anticipated that 2,4-D toxicity will induce alterations in the physiological 
environment of the cell.  It has been suggested that 2,4-D may alter cell physiology by 
affecting mitochondrial oxidative phosphorylation and transmembrane potential.   
Two in vitro studies provide evidence that suggest that uncoupling of oxidative 
phosphorylation may play a role in 2,4-D toxicity.  Both studies used rat hepatocytes as 
their cell model and assessed mitochondrial oxidative phosphorylation via 
polarographically.  Mitochondria isolated from rat hepatocytes were exposed to 0.1 to 
4.0 mM of 2,4-D acid (Zychlinski and Zolnierowicz, 1990).  Exposure to 1.5 to 4 mM 
induced a concentration-dependent increase in the uncoupling of mitochondrial 
oxidative phosphorylation.  Evidence suggesting that uncoupling of oxidative 
phosphorylation may be a mechanism of 2,4-D toxicity was also provided Palmeira and 
co-workers (Palmeira et al., 1994).  Mitochondria that was isolated from rat hepatocytes 
was exposed to 0.1, 0.2, 0.3, 0.4, 0.5, 0.6 and 0.8 mM of 2,4-D acid.  Similar to 
Zychlinski and Zolnierowicz, Palmeira et al. (1994) reported a concentration-dependent 
increase in the uncoupling of mitochondrial oxidative phosphorylation following 2,4-D 
exposure.  
Thus, the above in vitro studies that used rat hepatocytes, 2,4-D acid, various 
concentrations of 2,4-D (0.1 to 4 mM) and assessed mitochondrial oxidative 
phosphorylation via polarographically, provide experimental evidence that suggest that 
the uncoupling of mitochondrial oxidative phosphorylation may be a mechanism of 2,4-
D toxicity. 
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Three in vitro studies have provided evidence that suggest that 2,4-D reduces 
transmembrane potential using primary rat hepatocytes (Palmeira et al., 1994), human 
HepG2 (Tuchl and Schwab, 2003) and Jurkat-T (Kaioumova et al., 2001b) cells as their 
cell models.  Transmembrane potential was assessed by calculation of membrane 
distribution of tetraphenylphosphonium and 5,5’,6’,6’-tetrachloro-1,1’,3,3-
tetraethybenimidazolycarbocyanine iodide (JC-1).  Results (obtained from calculation of 
membrane distribution of tetraphenylphosphonium) from one study revealed that 
mitochondrial membrane potential was reduced in primary rat hepatocytes exposed to 
0.1, 0.2, 0.3, 0.4, 0.5, 0.6 and 0.8 mM of 2,4-D acid (Palmeira et al., 1994).  A 
concentration-dependent effect was observed at concentrations greater than 0.1mM 2,4-
D acid.  Results obtained from the JC-1 fluorescent assays also provide evidence to 
support the hypothesis that 2,4-D represses mitochondrial membrane potential 
(Kaioumova et al., 2001b; Tuschl and Schwab, 2003).  A concentration-dependent 
depression of mitochondrial membrane potential in HepG2 cells exposed to 4, 8 and 16 
mM of 2,4-D acid for 6 hrs has been reported (Tuchl and Schwab, 2003).  A time-
dependent reduction in mitochondrial transmembrane potential has been observed 
following exposure of Jurkat-T cells to 1mM of a commercial formulation of 2,4-D 
(containing 2,4-D DMA) for 2, 4, 6 and 24 hrs (Kaioumova et al., 2001b). 
Thus, the above in vitro studies that used rat hepatocytes, human HepG2 and 
Jurkat-T cells, different 2,4-D forms (2,4-D acid or DMA), various concentrations (0.1 
to 1 mM) and assessed mitochondrial transmembrane potential via 
tetraphenylphosphonium or JC-1 probe detection, provide experimental evidence that 
suggest that reduction of mitochondrial transmembrane potential may be a mechanism of 
2,4-D toxicity.  Therefore, taken all together, results from the all of the above in vitro 
studies, suggest that uncoupling of mitochondrial oxidative phosphorylation and 
reduction of mitochondrial transmembrane potential may be mechanisms by which 2,4-
D alters cell physiology during toxicity. 
 
                     2.1.8.4 Formation of a reactive metabolite in 2,4-D toxicity 
The metabolism of 2,4-D in humans is an area of great controversy.  Some 
researchers have argued that in humans, 2,4-D is not metabolized to any reactive 
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metabolites and is essentially eliminated unchanged (Gregus et al., 1999; Sauerhauff et 
al., 1977; Van Ravenzwaay et al., 2003).  In contrast some researchers have illustrated 
that 2,4-D may form non-toxic conjugates in humans (Griffin et al., 1997; Sauerhauff et 
al., 1977).  This suggests that in humans, 2,4-D may be metabolized to toxic reactive 
metabolites and that conjugation with endogenous compounds, such as glutathione 
(GSH), facilitates detoxification of such metabolites in humans.  However, experimental 
evidence suggesting that 2,4-D may be metabolized in humans to toxic reactive 
metabolite(s) is scarce and limited to the results obtained an in vitro chemical synthesis 
study (Li et al., 2003).  Results from this study illustrate that 2,4-D may be metabolized 
to form an acyl-CoA thioester, 2,4-dichlorophenoxyacetyl-S-acyl-CoA (2,4-D-CoA).  In 
vitro chemical stability studies revealed that the reactive metabolite is stable at human 
physiologic pH (pH 7.4) and temperature (37°C).  In vitro reaction studies illustrated 
that 2,4-D-CoA  formed adducts with nucleophilic groups on human serum albumin 
(HSA).  Furthermore, it was illustrated in vitro, that 2,4-D-CoA binds covalently to  
hepatic proteins in freshly prepared rat hepatocytes.  Results from high performance 
liquid chromatography assays revealed that synthetic 2,4-D-CoA was also able to 
transacylate the cysteine sulfhydryl group of GSH to form 2,4-D-S-acyl-glutathione 
(2,4-D-SG).  The results suggest that the novel metabolite may be an electrophilic 
reactive metabolite that may be detoxified via transacylation with GSH or induce 
toxicity via covalent binding to nucleophilic groups on biomolecules, such as proteins, 
to result in possible toxic effects, in vivo.  Covalent binding to target molecule(s) is one 
mechanism of action of a toxicant (Gregus and Klaassen, 2001).  
 
                     2.1.8.5 Role of ROS and oxidative stress in 2,4-D toxicity 
Several investigators who have used both in vivo and in vitro experimental 
models have provided evidence that suggest that ROS mediated oxidative stress may 
play a role in 2,4-D toxicity.  The in vivo, followed by the in vitro studies will be 
reviewed.   
Using electron paramagnetic resonance spectroscopy, it was illustrated that 2,4-D 
induces ROS production in yeast cells (Teixeira et al., 2004).  A concentration-
dependent increase in the accumulation of the hydroxyl radical (OH.), a ROS, was 
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observed in yeast cells that were exposed to 0.45, 0.55 and 0.65 mM of 2,4-D acid for 15 
min.  Results suggest that 2,4-D may directly induce ROS production, in vivo.  The ROS 
subsequently induces toxicity by the mechanism of oxidative stress. 
Several in vitro studies (human erythrocytes, primary rat hepatocytes) have tried 
to determine if ROS mediated oxidative stress may be mechanisms of 2,4-D toxicity.  
However, these studies failed to directly measure ROS production, in vitro.  Instead 
ROS mediated oxidative stress was assessed by measuring the activity of antioxidant 
enzymes, levels of glutathione (GSH) and presence of lipid peroxidation.  Antioxidant 
enzymes (superoxide dismutase (SOD), glutathione peroxidase (GSH-Px)) and GSH are 
involved in the detoxification of ROS (Gregus and Klaassen, 2001; Kehrer, 1993; Kohen 
and Nyska, 2002).  Lipid peroxidation results from ROS – induced oxidative stress 
(Kohen and Nyska, 2002).   
    The effects of 2,4-D on the activity of several antioxidant enzymes and GSH  
have been investigated (Bukowska, 2003).  Human erythrocytes were exposed to 0.045, 
0.22, 0.45, 1.12 mM of 2,4-D acid for 1 hr.  Spectrophotometric analyses revealed that 
there was a significant concentration-dependent decrease in SOD activity in erythrocytes 
exposed to 0.22 to 1.12 mM of 2,4-D.  Analyses also revealed that there was a 
significant concentration-dependent increases or decreases in GSH-Px activity and GSH 
levels, respectively, in erythrocytes exposed to 0.45 and 1.12 mM of 2,4-D.    Similar 
effects of 2,4-D exposure on GSH levels were also observed in an earlier study 
(Palmeira et al., 1995).  Fluorescent measurements revealed concentration-and time-
dependent decreases in GSH levels in primary rat hepatocytes exposed to 1, 5 and 10 
mM of 2,4-D acid for 0 to 200 min.  Results suggest that 2,4-D exposure may induce 
ROS production in a concentration-dependent manner, and that increasing ROS 
concentration may exhaust GSH supplies, in vitro. 
Lipid peroxidation is also a valuable endpoint for determining if exposure to a 
chemical induces oxidative stress.  The effect of 2,4-D exposure on lipid peroxidation 
has been investigated (Duchnowicz and Koter, 2003). Human erythrocytes were exposed 
to 1 mM of 2,4-D acid for 1 hr.  Results from the thiobarbituric acid reactive substance 
(TBARS) assay revealed significant increases in malondialdehyde (MDA) levels.  MDA 
is an end product of lipid peroxidation (Palmeira et al., 1995).  Similar effects were also 
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observed in primary rat hepatocyte cell cultures (Palmeira et al., 1995).  A 
concentration- and time-dependent increase in MDA levels were observed in 
hepatocytes that were exposed to 1, 5 and 10 mM of 2,4-D acid for 0 to 200 min.    
Thus, results from both in vivo (yeast) and in vitro (human erythrocytes, primary 
rat hepatocytes) studies that have used the same 2,4-D acid form, various endpoints 
(ROS production, activity of antioxidant enzymes, levels of GSH and presence of lipid 
peroxidation), concentrations (0.045 to 10 mM) and durations of exposure (15 to 200 
min) suggest that ROS and associated oxidative stress may be mechanisms of 2,4-D 
toxicity.  However, with the exception of the study performed by Teixeira and 
colleagues, a flaw of all other studies is that the studies failed to illustrate that 2,4-D 
directly induces ROS production in in vitro experimental models.  Thus, to the best of 
our knowledge, this thesis is the first to examine if 2,4-D directly induces ROS 
production in human cell cultures (HepG2 and HEK293 cells), in vitro. 
 
Reviewed above, the results from several studies that used in vivo (yeast cells) or 
in vitro (human HepG2, erythrocytes, Jurkat-T cells, primary rat hepatocytes) 
experimental models suggest that apoptosis, necrosis, alterations of cell physiology, 
reactive metabolites, ROS and oxidative stress may be mechanisms of 2,4-D toxicity.  
However, as previously mentioned, the mechanism(s) of 2,4-D toxicity is a relatively 
novel research area that is still evolving.  Thus, one objective of the current study was to 
determine a possible mechanism of 2,4-D cytotoxicity, by investigating ROS production, 
in vitro.  The production of ROS was investigated in this thesis based on previous cDNA 
microarray analyses that illustrated increased expression of FTL, FTH1 and PCNA 
mRNA in response to 2,4-D exposure (Bharadwaj et al., 2005) and previous in vivo and 
in vitro studies that provides evidence that suggest that FTL, FTH1 and PCNA mRNA 
and protein expression is increased in response to ROS mediated oxidative stress 
(Balajee et al., 1999; Balla et al., 1992; Epsztejn et al., 1999; Holmes et al., 2002; Lin 
and Girotti, 1997; Orino et al., 2001; Regan et al., 2002; Savio et al., 1998).  A review 
of such studies is presented in the following sections.   
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      2.2 Ferritin 
            2.2.1 Ferritin: structure and function 
       Ferritin is a stable ubiquitous (Corsi et al., 2002; Ponka et al., 1998; Rogers and 
Munro, 1987; Rogers et al., 1990), multimeric (Cairo et al., 1995) iron-storage protein 
(Crichton et al., 2002; Hagen et al., 2002; Harrison and Arosio, 1996; Kwak et al., 1995; 
Ponka et al., 1998; Rogers and Munro, 1987; Rogers et al., 1990; Sánchez et al., 2005; 
Vidal et al., 2004).  The protein is found in a wide range of species that includes 
vertebrates, invertebrates, plants, fungi and bacteria (Leibold and Guo, 1992).  The 
maintenance of cellular iron homeostasis is a principal role of ferritin (Harrison and 
Arosio, 1996; Kwak et al., 1995).  Approximately 25% of the total body iron stores are 
contained in ferritin (Leibold and Guo, 1992) and its putative insoluble (Arosio and 
Levi, 2002) derivative product, hemosiderin (Arosio and Levi, 2002; Leibold and Guo, 
1992).  Hemosiderin is an aggregate of iron and protein found in lysosomes (Leibold and 
Guo, 1992).  Ferritin’s molecular structure is highly conserved in all organisms 
(Harrison and Arosio, 1996) and is mainly a cytosolic protein (Arosio and Levi, 2002; 
Corsi et al., 2002).  However, in vertebrates, a minor portion of ferritin is also present in 
serum and secretory fluids (Arosio and Levi, 2002).  Recently, a novel type of ferritin 
has been found in human mitochondria (Levi et al., 2001).  This novel ferritin is referred 
to as mitochondrial ferritin (MtF) (Drysdale et al., 2002; Levi et al., 2001; Levi and 
Arosio, 2004).  According to researchers, MtF is structurally similar to cytosolic 
ferritins, and also bears ferroxidase activity, suggesting that MtF may also be involved in 
iron detoxification in the mitochondria (Levi et al., 2001) (see below for review of 
ferritin ferroxidase activity and association between ferritin and iron detoxification).  
However, in contrast to cytosolic ferritins, MtF are homopolymers (Levi et al., 2001).   
Mammalian ferritin is a hollow sphere (Chaincone et al., 2004) which is made up 
of 24 subunits, consisting of FTL and FTH1 polypeptides (Cairo et al., 1995; Hagen et 
al., 2002; Harrison and Arosio, 1996; Kwak et al., 1995; Leibold and Guo, 1992; Lo and 
Hurta, 2000; Rogers and Munro, 1987; Rogers et al., 1990; Thompson et al., 2003; 
Vidal et al., 2004).  Among mammals, the FTL subunits are 82-88% identical, while the 
FTH1 subunits are 95% identical (reviewed by Leibold and Guo, 1992).  Ferritin is able 
to sequester 4500 iron atoms per ferritin molecule (Harrison and Arosio, 1996; Sánchez 
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et al., 2005), as insoluble (Harrison and Arosio, 1996) ferric oxy-hydroxide (Chiancone 
et al., 2004; Harrison and Arosio, 1996; Ponka et al., 1998).  However, under normal 
cellular conditions, ferritin is only 20% saturated with iron (Reif, 1992). 
There are approximately 25 iso-ferritins of varying FTL and FTH1 subunit ratios 
(i.e. H24L 0, H23 L1, H22L2, to H0L24) within the ferritin molecule (Harrison and Arosio, 
1996).  The ratio of the FTL (MW: 19kDa (Leibold and Guo, 1992; Rogers and Munro, 
1987; Rogers et al., 1990; Thompson et al., 2003;) and FTH1 (Molecular Weight (MW): 
21kDa (Leibold and Guo, 1992; Rogers and Munro, 1987; Rogers et al., 1990; 
Thompson et al., 2003) subunits within the ferritin molecule vary depending on the 
tissue in which it is expressed (Kwak et al., 1995; Thompson et al., 2003).  For example, 
the brain and heart consist of H-rich ferritins that have a lower FTL to FTH1 subunit 
ratio within ferritin molecules (Harrison and Arosio, 1996).  H-rich ferritins in these 
organs normally consist of less iron/molecule (i.e. 1000 iron atoms per ferritin molecule 
(Harrison and Arosio, 1996)).  In contrast, in iron-storing organs such as the liver and 
spleen there is a higher FTL to FTH1 subunit ratio within ferritin molecules (Harrison 
and Arosio, 1996).  For instance, liver ferritins (FTH1 to FTL subunit ratios of H2-3L22-
21) have a relatively high iron content of 1500 iron atoms per ferritin molecule (Harrison 
and Arosio, 1996).  The existence of variations of FTL and FTH1 subunit ratios allow 
for ferritins to have different and independent iron-storage and oxidizing capacity 
(Arosio and Levi, 2002).  For instance, the presence of a higher FTL to FTH1 subunit 
ratio allows for increased iron-storage capability of liver ferritins (Arosio and Levi, 
2002). 
The FTH1 subunit, which is largely responsible for the biological activity of 
mammalian ferritin (Corsi et al., 2002), bears the molecule’s ferroxidase enymatic 
activity (Corsi et al., 2002; Hagen et al., 2002; Kwak et al., 1995).  Ferroxidase allows 
for the catalytic oxidation of the soluble (Corsi et al., 2002) toxic form (Fe2+) of iron 
(Corsi et al., 2002; Hagen et al., 2002; Harrison and Arosio, 1996; Kwak et al., 1995; 
Thompson et al., 2003;) into the non-toxic ferric form (Fe3+) (Ponka et al., 1998).  The 
ferric form (Fe3+) of iron is subsequently stored as an insoluble (Harrison and Arosio, 
1996) ferric oxy-hydroxide molecule (Chiancone et al., 2004; Harrison and Arosio, 
1996; Ponka et al., 1998).  In contrast, the FTL subunit confers protein stability (Hagen 
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et al., 2002; Kwak et al., 1995) and nucleation of the iron core (Corsi et al.,2002; Ponka 
et al., 1998). 
 
            2.2.2 Regulation of ferritin gene expression 
 Gene expression of FTL and FTH1 is primarily and tightly regulated at the 
translational level (Arosio and Levi, 2002; Cairo et al., 1995; Corsi et al., 2002; 
Crichton et al., 2002; Leibold and Guo, 1992).  Gene expression is regulated in response 
to alterations in intracellular iron availability (Crichton et al., 2002) through specific 
interactions between the cytosolic iron regulatory proteins (IRPs) (Crichton et al., 2002) 
and the iron responsive element (IRE) (Arosio and Levi, 2002) situated in the 5’-
untranslated region (UTR) of the FTL and FTH1 mRNA (Cairo et al., 1995; Harrison 
and Arosio, 1996; Ponka et al., 1998).   
In mammals, two IRPs have been identified, IRP-1 and IRP-2 (Crichton et al., 
2002).  The proteins, IRP-1 and IRP-2 have been described to act as intracellular iron 
sensors (reviewed by Papanikolaou and Pantapoulos, 2005).  Similar homology exists 
between IRP-1 and the mitochondrial enzyme, aconitase (Ponka et al., 1998).  In 
mammals, aconitase is an enzyme that contains a [4Fe-4S] cluster and is involved in the 
citric acid cycle (Ponka et al., 1998).  A 61% amino acid sequence similarity exists 
between IRP-1 and IRP-2 (Ponka et al., 1998).  However, in contrast to IRP-1, IRP-2 
lacks aconitase activity, and therefore only possesses RNA-binding capabilities (Ponka 
et al., 1998).  The IRP-2 protein binds to IREs with similar affinity as IRP-1, but iron 
regulation by IRP-2 is mediated by specific proteolysis (Ponka et al., 1998).  The IREs 
are structural motifs that are located in the 5’-UTR of the FTL and FTH1 mRNA (Cairo 
et al., 1995; Harrison and Arosio, 1996; Papanikolaou and Pantapoulos, 2005; Ponka et 
al., 1998).  These responsive elements are approximately 30 nucleotides in length and 
fold and form a loop and a stem (reviewed by Papanikolaou and Pantapoulos, 2005).  
The IREs are able to recognize and hence provide a binding site for the IRPs (Leibold 
and Guo, 1992; Papanikolaou and Pantapoulos, 2005). 
In mammalian cells, iron homeostasis is maintained by balancing the uptake of 
iron with its intracellular storage and utilization (Crichton et al., 2002).  This balance is 
achieved primarily at the level of protein synthesis (Crichton et al., 2002). Ferritin and 
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transferrin are the major proteins involved in maintaining iron homeostasis (Leibold and 
Guo, 1992).  Transferrin functions to transport iron between its sites of absorption, 
storage and use (Ponka et al., 1998).  In the presence of increased intracellular iron 
concentration, IRP-1 possesses aconitase activity and binds the IRE with low affinity, 
resulting in increased translation of FTL and FTH1 mRNA (Crichton et al., 2002; Ponka 
et al., 1998).  The absence of the association between IRP-1 and the IRE (located in the 
3’-untranslated region) of the transferrin receptor mRNA results in degradation of 
transferrin receptor mRNA (reviewed by Ponka et al., 1998).  Following intracellular 
expansion of the labile iron pool, IRP-2 is degraded (reviewed by Crichton et al., 2002; 
Ponka et al., 1998).  In contrast, during periods of decreased intracellular iron 
concentration, IRP-1 does not possess aconitase activity (Crichton et al., 2002; Ponka et 
al., 1998).  Therefore, IRP-1 binds the IRE with high affinity, with subsequent decreased 
translation of FTL and FTH1 mRNA and increased translation of transferrin receptor 
mRNA (Ponka et al., 1998).    
The increased expression of FTL and FTH1 gene at the translational level 
effectively reduces the bioavailability of excess intracellular iron (Arosio and Levi, 
2002).  Transition metals, such as iron, are extremely important in the generation of 
ROS (Kehrer, 1993), due to its active participation in the Fenton and Haber-Weiss 
chemistry (Biemond et al., 1988; Chiancone et al., 2004; Harrison and Arosio, 1996; 
McCord, 1998; Papanikolaou and Pantopoulos, 2005).  The ROS are known mediators 
of oxidative stress (reviewed by Valko et al., 2007).  Thus, increased iron sequestration 
as a result of the up-regulation of iron-storage proteins, such as ferritin, may provide 
protection to cells and tissues from oxidative stress. 
It has now been suggested that during oxidative stress conditions, ferritin gene 
expression may in fact be regulated secondary to iron release by heme oxygenase-1 
(HO-1) protein (Gonzales et al., 2002; Vile and Tyrell, 1993; Vile et al., 1994).  The 
HO-1 protein is responsible for the catabolization of heme into carbon monoxide, 
biliverdin (rapidly converted to bilirubin) and free iron (Otterbein et al., 2003; Unno et 
al., 2007).  It has been illustrated in vitro, that oxidative stress conditions (ultraviolet A 
(UVA) rays or H2O2) induces the immediate release of heme from microsomal 
hemeproteins (i.e. cytochrome P450) in primary human skin fibroblasts (FEK4) (Kvam 
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et al., 1999).  In the presence of ROS, heme may be released from hemeproteins as a 
result of ROS – induced protein oxidation and degradation.  Proteins are biological 
targets for ROS – induced oxidation, damage and degradation (Davies, 1987; Davies et 
al., 1987a; 1987b; 1987c).  Therefore, during oxidative stress conditions, the chain of 
events responsible for induction of ferritin gene expression may be as follows; (1) 
increased release of heme from hemeproteins, (2) increased gene expression of HO-1, 
(3) increased catabolization of heme to carbon monoxide, biliverdin and free iron and 
(4) increased ferritin gene expression.  Thus, increased expression of the ferritin protein 
ultimately provides protection during oxidative stress conditions, by limiting the 
availability of free iron to the Fenton and Haber-Weiss reactions and thereby reducing 
further generation of ROS.  A review of some studies that presents evidence that suggest 
that the up-regulation of ferritin gene expression may be a cytoprotective mechanism 
against oxidative stress is presented below.  
 
            2.2.3 Ferritin and oxidative stress 
 The sequestration of free iron by ferritin, which subsequently reduces iron 
availability to the iron-catalyzed Fenton and Haber-Weiss reactions, is regarded as a 
protective mechanism against cellular oxidative stress (Balla et al., 1992).  Several 
studies conducted on various in vitro models (i.e. mouse cortical astrocytes, porcine 
aortic endothelial, murine erythroleukemia, immortalized human HeLa and HepG2 cells) 
provides evidence that suggest that the increased sequestration of labile iron as a result 
of the up-regulation of ferritin expression is a protective response to oxidative stress 
(Balla et al., 1992; Cairo et al., 1995; Epsztejn et al., 1999; Orino et al., 2001; Regan et 
al., 2002).   
In vitro studies conducted on mice cortical astrocytes illustrates that ferritin 
expression increases in response to oxidative stress (Regan et al., 2002).  Ferritin protein 
expression was increased following exposure to 5 µM of hemoglobin (Hb) or 3 µM of 
hemin.  Both Hb and hemin are direct sources of iron.  Western blot analyses revealed 
that exposure to 5 µM of hemoglobin for 2, 4 and 8 hrs induced a time-dependent 
increase in ferritin protein synthesis in astrocytes.  Results suggest that an up-regulation 
of ferritin protein expression may be a protective response to increased intracellular iron.  
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The sequestration of free iron by ferritin protects against oxidative stress by reducing 
iron availability to the Fenton and Haber-Weiss reactions and thus, further generation of 
ROS production.  In the same study, results from cytotoxicity assay (measurement of 
lactate dehydrogenase (LDH) activity) revealed that pre-treatment of astrocytes with 1, 2 
or 4 mg/L of apoferritin (ferritin that lacks iron (Harrison and Arosio, 1996)) provided 
concentration-dependent protection against cell death following exposure to a toxic 
concentration (30 µM) of hemin.  Furthermore, astrocytes pre-treated with 30 µM of Hb 
or 3 µM of hemin for 24 hrs were protected from hemin-induced oxidative injury in a 
concentration-dependent manner.  The results suggest that pre-treatment with 
apoferritin, Hb or hemin induced ferritin protein expression, which resulted in 
sequestration of free iron and reduced ROS production and associated oxidative stress 
upon hemin challenge.   
Enhanced ferritin protein synthesis in response to increased intracellular iron 
concentration and possible increased ROS production and potential oxidative stress has 
also been observed by Balla and co-workers.  Ferritin immunoassay illustrated that 
exposure to 1.0, 2.5, 5.0 and 10 µM of hemin induced a concentration-dependent 
increase in ferritin protein synthesis in porcine aortic endothelial cells.  Pre-treatment of 
cells with 5 µM of hemin or 100 µM of hydrogen peroxide (H2O2) resulted in a 
concentration-dependent reduction of ferritin synthesis in cells exposed to 1.0, 2.5, 5.0 
and 10 µM of hemin (Balla et al., 1992).  Results suggest that treatment or pre-treatment 
of cells with mediators (i.e. hemin or H2O2) of ROS production induces ferritin protein 
expression as a protective mechanism, since increased ferritin protein expression 
subsequently limits free iron availability of Fenton and Haber-Weiss chemistry and 
reduces further ROS production and oxidative damage. 
Further evidence to suggest that the increased expression of ferritin may be a 
protective response to increased ROS production and oxidative stress has also been 
presented by several other research groups (Cairo et al., 1995;  Epsztejn et al., 1999; 
Orino et al., 2001).   These studies showed that increased ferritin expression was 
associated with decreased ROS production.  For instance, Orino and colleagues exposed 
HeLa cells to 125 or 250 µM of H2O2 for 8 hrs (Orino et al., 2001).  Western blot 
analyses illustrated that exposure to H2O2 resulted in an increase in both FTL and FTH1 
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mRNA and protein expression.  Additionally in H2O2 challenged cells, over expression 
of FTL and FTH1 cDNA in transfected cells reduced the accumulation of intracellular 
ROS (assessed using 2,7’-DCFH-DA).  The results illustrates that the up-regulation of 
ferritin may be in fact a protective response to ROS – induced oxidative stress.  Similar 
increases in FTL and FTH1 mRNA and protein expression were also observed in the 
liver of mice exposed to the pro-oxidant, phorone for 3 or 6 hrs (Cairo et al., 1995).  
Decreased ROS production (assessed using 2’,7’-carboxy-dichlorofluorescein) following 
iron loads and oxidant challenges in murine erythroleukemia cell cultures transfected 
with FTH1 protein subunit have also been reported (Epsztejn et al., 1999). 
Thus, all of the above studies present evidence that suggest that increased ferritin 
mRNA or protein expression may be a protective response against iron-mediated 
increases in ROS production and associated oxidative stress.  Therefore, the up-
regulation of FTL and FTH1 mRNA expression that was observed in HepG2 cells 
exposed to 0.1 nM to 1 mM 2,4-D for 24 hrs (Bharadwaj et al., 2005) may have been a 
protective response to 2,4-D induced ROS production and associated oxidative stress.  
Thus, taken all together, the above studies presents evidence that provides the necessary 
rationale in this thesis for investigating ROS production in HepG2 and HEK293 cells 
exposed to 2,4-D and also allows for the suggestion that increased expression of FTL 
and FTH1 mRNA and protein expression highlights ROS mediated oxidative stress as a 
mechanism of 2,4-D toxicity.   
 
      2.3 Proliferating cell nuclear antigen 
            2.3.1 PCNA: structure and function 
Originally referred to as cyclin (Mathews et al., 1984; Moris and Mathews, 
1989), PCNA is a homotrimeric ring-shaped protein (Brand et al., 1994; Prosperi, 2006; 
Schurtenberger et al., 1998; Wyman and Botchan, 1995).  It is an acidic nuclear protein 
(Mathews et al., 1984) that plays an integral role in nucleic acid metabolism (Kelman, 
1997), including DNA replication, repair and cell cycle regulation (Kelman, 1997; 
Schurtenberger et al., 1998).   
The homotrimeric PNCA structure is composed of three identical monomers 
(Maga and Hübscher, 2003) with a molecular weight of 28.7kDa (Brand et al., 1994).  
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However, when the protein is resolved by SDS-PAGE, it migrates with an apparent 
molecular weight of 36kDa (Brand et al., 1994).  The proliferating antigen, which was 
first identified in the sera of some patients with systemic lupus erythematosus (SLE) is a 
member of the DNA sliding clamp family (Kelman and O’Donnell, 1995; Maga and 
Hübscher, 2003; Warbick, 2000; Wyman and Botchan, 1995).  The DNA sliding clamps 
are defined as ring-shaped proteins that indirectly bind to DNA by encircling and 
forming a topological link with the double helix molecule (Hingorani and O’Donnell, 
2000).  Additional members of the DNA sliding clamp family include; Escherichia Coli 
(E.coli) DNA polymerase III β subunit (Kelman and O’Donnell, 1995) and 
bacteriophage T4 gene45 protein (Wyman and Botchan, 1995).  The DNA sliding clamp 
members are highly evolutionary conserved (Warbick, 2000).  Thus, PCNA homologues 
are found in eukaryotes, archaea, bacteriophages and some viruses (Warbick, 2000), as 
well as in the cells of humans, mouse, hamster and bird  (Almendral et al., 1987).   
 
            2.3.2 Regulation of PCNA gene expression   
       The expression of this highly conserved protein is regulated at the transcriptional 
level (Almendral et al., 1987).  The expression level of PCNA protein is greatly 
increased in the S phase of the cell cycle (Bravo and Celis, 1980; Celis and Celis, 1985) 
and is synthesized during the proliferation of normal cells, transformed cells and tumors 
(Almendral et al., 1987; Bravo and Macdonald-Bravo, 1985).  In contrast, the expression 
level of the proliferating antigen is reduced in non-dividing cells (Almendral et al., 
1987; Bravo and Macdonald-Bravo, 1985). 
             
            2.3.3 PCNA and oxidative stress 
       Due to its key role in DNA replication, PCNA has become a novel tool, as a cell 
proliferation marker in toxicology studies aimed at determining the cell and molecular 
mechanisms of toxicity and/or carcinogenicity of compounds of interest (Dietrich, 
1993).  However, some in vivo (rats) and in vitro (human fibroblast cells) experimental 
studies have utilized PCNA protein expression as a potential marker of oxidative DNA 
damage (Balajee et al., 1999; Holmes et al., 2002; Savio et al., 1998).   
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An in vivo study was conducted that was aimed at determining if oxidative stress 
plays a role in peroxisome proliferation-induced carcinogenicity in isolated rat 
hepatocytes (Holmes et al., 2002).  The authors used three proteins as markers of 
oxidative stress; DNA polymerase beta (Polβ), apurinic/apyrimidinic endonuclease (Ref-
1) and PCNA.  The proteins; Polβ, Ref-1 and PCNA are all involved in the repair of 
oxidative DNA damage (reviewed by Holmes et al., 2002).    Rats were exposed to WY 
14,643, a peroxisome proliferator.  Peroxisome proliferators (i.e 2,4-D) are a structurally 
diverse group of compounds (Ge et al., 2002) that may induce hypertrophy of tissue 
peroxisomes and pronounced increases in the tissue levels of many peroxisomal 
enzymes (reviewed by Holmes et al., 2002).  A concentration-dependent increase in 
Polβ and Ref-1 expression was observed in the liver of rats exposed to 5,000 or 50,000 
µg/L of WY 14,634 for 6 days.  Western blot analyses illustrated that PCNA protein 
expression was up-regulated 5 fold in rats exposed to 500,000 µg/L of WY 14,634 for 
34 days.  The results suggest that in addition to increased cell proliferation, increased 
PCNA protein expression may have been a protective response against oxidative DNA 
damage, since PCNA is known to be involved in DNA repair.    
Results from two in vitro studies that were conducted a few years earlier also 
suggest that increased PCNA protein expression indicate chemical insult via the 
mechanism of oxidative stress.  Immunofluorescent and western blot studies analyses 
provide experimental evidence that suggest that increased PCNA protein expression may 
be a response to oxidative DNA-damage (Balajee et al., 1999).  Human fibroblast cell 
cultures were exposed to ultraviolet C (UVC) or H2O2.  Both UV and H2O2 are known to 
induce a variety of oxidative DNA lesions (Balajee et al., 1999).  Exposure to 2.5 mM of 
H2O2 for 15 min induced a 4- to 5-fold increase in PCNA-DNA complex, while 
exposure to 10 J/m2 UV for 30 min induced a 9-fold increase in PCNA-DNA complex 
formation in the nucleus.  Results suggest that up-regulation of PCNA protein 
expression may be a protective response to oxidative DNA damage, where, PCNA 
protein may play a role in one or more repair pathways of induced oxidative DNA 
lesions.   
An additional immunofluorescent study also produced results that suggest that 
PCNA protein expression is up-regulated in response to oxidative DNA damage (Savio 
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et al., 1998).  Compared to Balajee and co-workers, in the study, human fibroblasts cells 
were exposed to 10 fold or less H2O2 (0 to 200 µM) for a longer duration of time (1 hr).  
Exposure induced a rapid concentration-dependent increase in the nuclear binding of 
PCNA in cells.  Results suggest that up-regulation of PCNA may be in response to 
oxidative DNA damage induced by the known DNA oxidizing agent, H2O2.   
The results from the above studies suggest that increased PCNA protein 
expression may be a protective response against ROS – induced oxidative DNA damage.  
Therefore, the up-regulation of PCNA mRNA expression that was observed in HepG2 
cells exposed to 0.1 nM to 1 mM of 2,4-D for 24 hrs (Bharadwaj et al., 2005) may have 
been a protective response to 2,4-D – induced intracellular ROS production and 
associated oxidative DNA damage in cells.  Thus, taken all together, the above studies 
present evidence that provides the necessary rationale in this thesis for investigating 
ROS production in HepG2 and HEK293 cells exposed to 2,4-D and also allows for the 
suggestion that increased expression of PCNA mRNA and protein expression indicates 
ROS mediated oxidative stress as a mechanism of 2,4-D toxicity.   
 
      2.4 Reactive oxygen species  
            2.4.1 Introduction to ROS 
  Reactive oxygen species, commonly referred to as ROS and oxygen free radicals 
(OFR) are chemically unstable, independent (Kehrer, 1993) species that contain one or 
more unpaired electrons (Halliwell, 1987; Kehrer, 1993) in their outer orbital (Gregus 
and Klaassen, 2001).  Some examples of ROS include the superoxide anion (O2.-) and 
the noxious hydroxyl radical (OH.) (Gregus and Klaassen, 2001).  These reactive species 
are produced from both endogenous and exogenous sources (reviewed by Kohen and 
Nyska, 2002).  In humans, endogenous sources of ROS may include white blood cells 
(neutrophils, eosinophils, basophils), enzymes directly producing ROS (nitric oxide 
synthase), enzymes indirectly producing ROS (xanthine oxidase), mitochondrial 
metabolism and diseases (i.e. ischemic processes) (reviewed by Kohen and Nyska, 
2002).  Food, UV radiation, pollutants, xenobiotics and toxins are some examples of 
exogenous sources of ROS (reviewed Kohen and Nyska, 2002).   
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            2.4.2 Relationship between iron, ROS and oxidative stress 
            The production of ROS may be mediated by various metals including iron, 
copper and chromium (reviewed by Valko et al., 2006).  For the purposes of this thesis, 
in order to allow for a better understanding of the relationship between ferritin, iron, 
ROS and oxidative stress; only the association between iron and ROS will be reviewed.  
Intracellularly, an increase in iron levels may lead to an increase in ROS production via 
Haber-Weiss chemistry (Biemond et al., 1988; Chiancone et al., 2004; Harrison and 
Arosio, 1996; McCord, 1998; Papanikolaou and Pantopoulos, 2005).  In the Haber-
Weiss reaction, the reaction between O2.- and H2O2, described as a ‘lethal mixture’ 
(Harrison and Arosio, 1996),  results in the formation of the very reactive OH. species 
(Halliwell, 1987; Thomas et al., 1985).   
 
        Fe2+ + H2O2 → Fe3+ + OH- + OH.        (Fenton Reaction)               (2.1) 
                             Fe3++ O2.- → Fe2+ + O2                                                                                            (2.2) 
     
                   H2O2 + O2.- → OH- + OH. + O2            (Haber-Weiss Reaction)      (2.3)   
  
Once produced, in order to achieve a more stable electron status, ROS readily 
combine with the unpaired electrons of other molecules (Kehrer, 1993), such as 
biological molecules (i.e. DNA, lipids and proteins) (reviewed Kohen and Nyska, 2002) 
leading to tissue damage (Kehrer, 1993).  The damage of biological molecules by ROS 
results in a condition referred to as oxidative stress (reviewed by Valko et al., 2007).  
Oxidative stress is defined as a disturbance in the balance between prooxidants and 
antioxidants, in which there is the increased presence of prooxidants, in contrast to 
antioxidants (reviewed by Kehrer, 1993).   
Cells have developed a tremendous antioxidant defense system against ROS 
damage, which include Vitamin C, E, superoxide dismutase, catalase, GSH conjugation 
system and several others that aid in the detoxification of ROS (reviewed by Kehrer, 
1993; Kohen and Nyska, 2002).  Recently, the increase in transcription of cytoprotective 
genes (ferritin) in response to oxidative stress has also been described as an antioxidant 
response (Tsuji et al., 2000).  Previously reviewed, the up-regulation of ferritin mRNA 
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and subsequent protein expression limits the availability of free iron to the Fenton 
reaction, thus protecting the cells and tissues from the damaging effects of further 
generation of noxious ROS production and associated oxidative stress.  Thus, in this 
present study, increases in ferritin mRNA or protein expression in HepG2 and HEK293 
cells may be an antioxidant response to 2,4-D induced ROS production and associated 
oxidative stress.  
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3. METHODS 
      3.1 Experimental design 
  In vitro studies were conducted using human cell cultures exposed once to 
increasing concentrations of a technical grade or commercial formulation of 2,4-D.  All 
exposure experiments consisted of untreated control and treated 2,4-D cell cultures.  Cell 
viability was determined following 6, 24, 48 and 72 hrs of incubation with 0 to 10 mM 
of technical or commercial 2,4-D.  An oxidant (H2O2) (Halliwell, 1987 and Zhou et al., 
2004) was used as a positive control in ROS studies.  The measurement of ROS 
production was performed following 1.3 hrs of incubation with 0 to 400 µM of H2O2, or 
2 to 6 hrs of incubation with 0 to 1 mM of commercial 2,4-D.  Following 24 hrs of 
exposure to 0 to 1 mM of commercial 2,4-D,  RNA and protein were extracted for RT-
PCR and western blot assays, respectively. 
  
      3.2 Culturing, subculturing and counting of cells 
 Two human cell lines (American Type Culture Collection (ATCC)) were used in 
this study; human hepatocellular carcinoma (HepG2) and human embryonic kidney 
(HEK293) cells.  The HepG2 cells are epithelial carcinoma cells derived from the liver 
(ATCC, 2004).  The HEK293 are epithelial cells derived from the kidney and 
transformed with human adenovirus 5 DNA (ATCC, 2004; Thomas and Smart, 2005).   
 Cell cultures were maintained according to ATCC recommendations.  Frozen 
stocks of HepG2 and HEK293 cells were stored at a density of 1 x 107 cells/mL in a 
solution of fetal bovine serum (FBS) (Sigma-Aldrich Canada Ltd) (90% (v/v)) and 
dimethylsulfoxide (DMSO) (EM Science) (10% (v/v)).  One mL cell suspensions were 
stored in 2 mL cryovials (VWR Scientific) in a cryo biological storage tank 
(Thermolyne) containing liquid nitrogen.  Frozen cells were thawed as needed for 
conducting experimental procedures.  Cells were thawed by placing the sealed cryovial 
in a styrofoam container containing warm water for approximately 1 min.  Thawed cells 
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were placed in a sterile 50 mL centrifuge tube (VWR Scientific) with approximately 10 
mL of complete growth media (Dulbecco’s minimum essential medium (DMEM) 
containing 2 mM L-Glutamine, 4 mM nonessential amino acids and 126 mM Earle’s 
salts (Invitrogen Corporation) supplemented with 1.5 g/L sodium bicarbonate, 1 mM 
sodium pyruvate, 10,000 U/mL penicillin – 10,000 µg/mL streptomycin (Invitrogen 
Corporation) and 10% (v/v) FBS.  Cell suspensions were then centrifuged at 1000 x g 
for 10 min at room temperature using a Fisher Scientific IEC PR-6000 centrifuge to 
ensure removal of all DMSO from cells.  Following centrifugation, media was removed 
by gentle aspiration using a pipette and discarded.  Cells were then re-suspended by 
gentle pipetting in 15mL of complete growth media and placed in 75 cm2 Falcon culture 
flasks (VWR Scientific).  Total volume in 75 cm2 Falcon culture flasks was 15 mL.  
Unless otherwise stated, cell cultures were always maintained in a sterile air 
environment, at 37ºC, 95% O2, 5% CO2.  Media on HepG2 and HEK293 cell cultures 
was renewed 2-3 times per week.  In order to maintain similar culturing conditions for 
HepG2 and HEK293 cells, in contrast to ATCC recommendations to culture HEK293 
cells in media supplemented with 10% (v/v) Heat-inactivated horse serum, in this 
present study HEK293 cells were grown in media supplemented with 10% (v/v) FBS.   
 Cells were subcultured when they reached approximately 80-85% cell 
confluency (attained approximately 3-4 days for HepG2 and HEK293), as determined by 
microscopic examination using an Olympus compound microscope at 4X magnification, 
cell cultures were subcultivated.   Cells were subcultured in 75 cm2 Falcon culture 
flasks.  Media was removed by gentle aspiration and discarded.  5 mL of 0.25% (w/v) 
trypsin-EDTA solution (Invitrogen Corporation) was added to the flasks and cell 
cultures were incubated for 5-10 min, followed by the addition of 10 mL of complete 
growth media to the flask.  Cell suspensions were placed in 50 mL centrifuge tubes and 
centrifuged at 1000 x g for 10 min at room temperature to ensure removal of all trypsin-
EDTA solution from cells.  After centrifugation, supernatants were discarded and the 
cells were re-suspended in complete growth media by gentle pipetting.  In order to 
ensure that cells were passaged into the culture flasks at equal cell density; cells were 
counted (described below), before being plated in the culture flasks.  
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 Cells were dispersed from culture flasks using trypsin-EDTA as described above.  
Following the removal of trypsin-EDTA solution, cells were re-suspended in complete 
growth media by gentle pipeting.  For cell counting, 1:1 mixtures of cell suspension (40 
µL) and 0.4% (w/v) trypan blue stain (40 µL) (Invitrogen Corporation) were made.  Cell 
mixtures were pipetted to ensure complete suspension of cells.  20 µL aliquots of cell 
mixtures were added to a Bright Line® hemacytometer.  Cells were counted using an 
Ernest Leitz Wetzlar compound microscope at 10X magnification.  The Bright Line® 
hemacytometer consists of a total of 9 grids.  Cell numbers were calculated using an 
average of the cell numbers counted in 5 out of 9 grids on the hemacytometer.  HepG2 
and HEK293 cells were subcultured at a ratio of 1:2 and 1:4, respectively.  HepG2 and 
HEK293 cells were used at passage numbers 15 and 6, respectively for cell viability, 
ROS (positive control only), RNA and protein studies.  HepG2 and HEK293 cells were 
used at passages 19 and 9, respectively for ROS assay following treatment with 2,4-D.   
 
      3.3 Preparation of chemical solutions for cell treatments 
            3.3.1 2,4-D 
 Two forms of 2,4-D were used in this study; (1) a technical grade of 2,4-D; 2,4-
D dimethylamine (2,4-D DMA) concentrate; purity 67.1% (a gift from Nufarm 
Agriculture Inc.) and (2) a commercial formulation of 2,4-D; C.I.L. Dandelion Killer 
(containing 2,4-D DMA)(Nu-Gro Corporation).  The 2,4-D treatment concentrations 
used in the study were; 0.1 nM (2,4-D DMA: 0.026 µg/L; 2,4-D acid: 0.022 µg/L), 1 
nM (2,4-D DMA: 0.26 µg/L; 2,4-D acid: 0.22 µg/L),  10 nM (2,4-D DMA: 2.60 µg/L; 
2,4-D acid: 2.20 µg/L), 100 nM (2,4-D DMA: 26 µg/L; 2,4-D acid: 22 µg/L), 1 µM 
(2,4-D DMA: 260 µg/L; 2,4-D acid: 220 µg/L), 10 µM (2,4-D DMA: 2.6 x 103 µg/L; 
2,4-D acid: 2.2 x 103 µg/L), 100 µM (2,4-D DMA: 2.6 x 104 µg/L; 2,4-D acid: 2.2 x 104 
µg/L) and 1 mM (2,4-D DMA: 2.6 x 105 µg/L; 2,4-D acid: 2.2 x 105 µg/L).  Additional 
2,4-D treatment concentrations of  5 mM (2,4-D DMA: 1.3 x 106 µg/L; 2,4-D acid: 1.1 x 
106 µg/L) and 10 mM (2,4-D DMA: 2.6 x 106 µg/L; 2,4-D acid: 2.2 x 106 µg/L) were 
used only in cell viability studies.  Using initial stock (1M) solutions of either technical 
or commercial 2,4-D, serial dilutions were performed to obtain solutions of 2,4-D that 
contained 10X desired 2,4-D treatment concentrations.  The 2,4-D solutions were 
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prepared in complete growth media for cell viability, mRNA and protein studies.  The 
2,4-D solutions were prepared in sterile water for the ROS assay.  The solutions of 2,4-D 
were prepared less than 24 hrs before use, sterile filtered using Acrodisc® 0.2 µM 
syringe filters (Pall German Laboratory) and stored at 4ºC, protected from light.  
 
            3.3.2 H2O2  
 The H2O2 treatment concentrations used in this study were 100 µM, 200 µM, 
300 µM and 400 µM.  Stock solutions of H2O2 were made in sterile water to contain 
10X desired H2O2 treatment concentrations.  The H2O2 treatments were prepared less 
than 30 min before use and stored at 4ºC, protected from light. 
  
      3.4 Plating and treatment of cells prior to performing assays  
            3.4.1 Plating and treatment of cells prior to performing cell viability assay
 The HepG2 and HEK293 cells were passaged and counted as previously 
described (see section 3.2) and plated into NUNC™ black 96-multiwell plates (VWR 
Scientific).  The HepG2 cells were plated at a density of 30,000 cells/well.  In contrast, 
since HEK293 cells were larger, these cells were plated at a density of either 30,000 or 
15,000cells/well for 6 and 24 hrs or 48 and 72 hrs cell viability studies, respectively.  
Cells were incubated.  Cell cultures were treated with 2,4-D following 48 hrs after the 
initial plating to allow cultures to attain at least 55-60% cell confluency.  Media was 
removed from cells and 200 µL (untreated control cell cultures) or 180 µL (treated cell 
cultures) aliquots of fresh complete growth media was  added, followed by the addition 
of 20 µL media containing either technical or commercial 2,4-D.  Total well volume was 
200 µL for untreated control and treated cell cultures.  Gentle pipetting using a 
multichannel pipette was used to ensure the thorough mixing of 2,4-D treatments with 
complete growth media, without displacing cells.   
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            3.4.2 Plating and treatment of cells prior to performing ROS assay 
                     3.4.2.1 Plating and treatment of cells with H2O2 prior to performing    
                       ROS assay 
 Cells were passaged and counted as described above (see section 3.2) and plated 
into NUNC™ black 96-multiwell plates at a density of 30,000 cells/well; a density 
similar to that previously used by Wu et al (1997).  Cells were incubated.  At 
approximately, 55-60% cell confluency, media was removed and discarded from cells 
using a multichannel pipette and cells were washed twice with 200 µL aliquots of 1X 
Dulbecco’s phosphate buffered saline (DPBS) (Ca2+, Mg2+ and phenol red-free) 
(Invitrogen Corporation).  Two hundred µL (untreated control cell cultures) or 180 µL 
(treated cultures) aliquots of D-PBS was added to cells, followed by the addition of 20 
µL of H2O2 stock treatments.  Total well volume was 200 µL for untreated control and 
treated cell cultures.  Gentle pipetting using a multichannel pipette was used to ensure 
the thorough mixing of H2O2 treatments with D-PBS, without displacing cells.  Cells 
were incubated.   
    
                     3.4.2.2 Plating and treatment of cells with 2,4-D prior to performing    
                                 ROS assay 
 HepG2 and HEK293 cell cultures were passaged, counted and maintained as 
described above (see section 3.2) prior to 2,4-D treatments.  Two hundred µL (untreated 
control cell cultures) or 180 µL (treated cultures) aliquots of D-PBS was added to cells 
in each well, followed by the addition of 20 µL of commercial 2,4-D stock treatments.    
Total well volume was 200 µL for untreated control and treated cell cultures.  Gentle 
pipetting using a multichannel pipette was used to ensure the thorough mixing of 2,4-D 
treatments with D-PBS, without displacing cells.  Cells were incubated.   
 
                     3.4.2.3 Plating of cells and treatment with 2,4-D prior to RNA and          
         protein extraction for RT-PCR and western blot assays 
 HepG2 and HEK293 cells were passaged and counted as described above (see 
section 3.2) and plated into 9 individual NUNC™ 100 x 20 mm culture dishes (VWR 
Scientific) at a density of 1 x 107 cells/culture dish for either RNA or protein studies.  At 
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approximately 80-85% cell confluency (attained approximately 4-5 days for HepG2 and 
3 days for HEK293 cells), media from cells were removed and discarded and cells were 
replenished with 10 mL (untreated control cell cultures) or 9 mL (all cell cultures, 
excluding untreated control cell cultures) of fresh complete growth media, followed by 1 
mL of 2,4-D treatment stock solutions.  Final volume in cell culture dishes was 10 mL 
for untreated control and treated cell cultures.  Culture dishes were then gently swirled 
clockwise for 30 sec to ensure thorough mixture of 2,4-D treatments with complete 
growth media, without displacing cell cultures.  Plated cells were incubated for 24 hrs 
prior to RNA and protein extraction.  
 
      3.5 Assays 
            3.5.1 Cell viability 
 Cell viability was determined fluorometrically using an in vitro toxicology assay 
kit, containing the dye, Resazurin (Sigma-Aldrich Canada Ltd).  The basis of the assay is 
the reduction of Resazurin.  Cell viability is determined as a function of metabolic 
activity.  Viable cells have the ability to reduce the oxidized (blue) form of Resazurin to 
a fluorescent (red) intermediate, therefore indicating the magnitude of the toxic effect of 
test compounds (Sigma-Aldrich Canada Ltd.)  
 Cell viability assays were performed as outlined by the manufacturer’s protocol 
(Sigma-Aldrich Canada Ltd protocol references: Dutka et al., 1983; King, 1984; Liu, 
1981; Strotmann et al., 1993) with minor modifications.  Cell cultures were incubated 
with 20 µL of the Resazurin dye (final concentration 10% (v/v)) in the last 2.5 hrs prior 
to the end of the respective incubation period (6, 24, 48, and 72 hrs).  Total well volume 
was 220 µL for untreated control and treated cell cultures.  Following incubation, 
fluorescence was measured using a Dynex Technologies Fluorolite 1000 fluorometer 
reader, at excitation and emission wavelengths of 546 nm and 590 nm, respectively.  
Cell viability assays were performed in replicates of 6 for untreated control and treated 
cell cultures. 
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            3.5.2 ROS  
 The production of ROS was determined according to Seth et al. (2004), Wan et 
al. (2003) and Wu et al. (1997) with minor modifications.  The production of ROS in 
cells was determined fluorometrically using 2’,7’-DCFH-DA (Sigma-Aldrich Canada 
Ltd).  The compound, 2’,7’-DCFH-DA is a non-ionic, non-polar molecule that is 
permeable to the cell membrane (Bass et al., 1983).  Subsequent to its entry into the cell, 
the molecule is enzymatically hydrolyzed by intracellular esterases to the non-permeable 
molecule, 2’,7’-dichlorofluorescin (DCFH), where in the presence ROS, DCFH is 
rapidly oxidized to the highly fluorescent molecule, 2’,7’-dichlorofluorescein (DCF) 
(Bass et al., 1983).  The fluorescent signal is directly proportional to ROS production 
(Osseni et al., 1999, 2000).  
 
                     3.5.2.1 Determination of ROS production in cells exposed to H2O2 
 In order to avoid photo-oxidation of 2’7’-DCFH-DA, all procedures of this assay 
were performed in the dark.  All 2’7’-DCFH-DA solutions were prepared immediately 
before use and any unused portions were discarded.  Initially, a 5 mM stock solution of 
2’,7’-DCFH-DA was prepared in 95% ethanol (Wu et al., 1997)  and  stored at 4ºC (Seth 
et al., 2004), protected from light, until needed.  The 5 mM 2’,7’-DCFH-DA stock 
solution was diluted to 1 mM in D-PBS, immediately before use.  At the end of the H2O2 
incubation period (20 min), cell cultures were incubated with 50 µL of 1 mM 2’,7’-
DCFH-DA  (final concentration 2’,7’-DCFH-DA  200 µM; final concentration ethanol 
3.8% (v/v)) (Wu et al., 1997) for an additional 1 hr (Seth et al., 2004).  Total well 
volume was 250 µL for untreated control and treated cell cultures.  Fluorescence was 
subsequently measured using a Fluorolite 1000 fluorometer reader (Dynex 
Technologies), at excitation and emission wavelengths of 485 nm and 535 nm, 
respectively.  ROS assays were performed in replicates of 6 for untreated control and 
treated cell cultures.   
 
                     3.5.2.2 Determination of ROS production in cells exposed to 2,4-D 
 Following 1 hr incubation with 2,4-D, HepG2 and HEK293 cells were incubated 
with 50 µL of 1mM 2’,7’-DCFH-DA as described above and fluorescence measured 
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(see section 3.4.2a).   Fluorescence was measured every hour for a total of 5 hrs.  Cell 
cultures were incubated in the intervals between fluorescent measurements.  ROS assays 
were performed in replicates of 8 for untreated control and treated cell cultures.  
 
            3.5.3 mRNA analysis 
                     3.5.3.1 RNA extraction and purification  
  Following 2,4-D incubation, media was removed and discarded, and cells were 
gently washed twice with sterile 1X phosphate buffered saline (PBS) (pH 7.4) (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) (Sambrook and Russell, 2001).  
Trizol reagent (Invitrogen Corporation) was used to extract RNA from HepG2 and 
HEK293 cells.  RNA extraction was performed as outlined by the manufacturer’s 
protocol (Invitrogen Corporation protocol reference: Chomczymski and Sacchi, 1987) 
with minor modifications.  To avoid RNA degradation by Ribonuclease (RNase) 
enzymes (Ambion, 2007), all reagents that were used in RNA extraction process were 
prepared using RNase-free water supplemented with autoclaved 0.1% (v/v) diethyl 
pyrocarbonate (DEPC) (Sigma-Aldrich Canada Ltd), an RNase enzyme inhibitor 
(Leonard et al., 1970; Solymosy et al., 1968).  Cells were directly lysed by addition of 1 
mL Trizol reagent to each culture dish.  Samples were incubated for 5 min at room 
temperature.  Samples from each plate were transferred to individual sterile 15 mL 
centrifuge tubes, mixed with 200 µL of chloroform, shaken vigorously 15 sec and 
incubated for 3 min at room temperature.  Samples were then centrifuged using a 
Beckman Coulter™ centrifuge at 11,500 x g for 15 min at 2 to 8ºC.  Following 
centrifugation, the aqueous phases containing RNA were transferred to new sterile 15 
mL centrifuge tubes, mixed with 500 µL of isopropyl alcohol and incubated for 10 min 
at room temperature to allow RNA precipitation.  Samples were centrifuged at 11,500 x 
g for 10 min at 4ºC.  The RNA pellets were washed with 1 mL of 75% ethanol (v/v) 
(prepared in RNase-free water) by gently mixing, followed by centrifugation at 7,500 x 
g for 5 min at 2 to 8ºC.  The ethanol was removed and the RNA pellets were allowed to 
air dry for 10 min.  The RNA pellets were dissolved in 3 mL of a solution containing 
tris-ethylene diamine tetraacetic Acid (TE) (pH 8.0) (10 mM Tris-HCL), 1 mM EDTA 
(Sambrook and Russell, 2001)) 300 µL 3 M NaAc (pH 5.2) and 7.5 mL 100% ethanol), 
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equally aliquotted into sterile 1.5 mL microcentrifuge tubes and stored at -80ºC.  The 
RNA was quantified by measuring the absorbance at 260 nm using a Bio-Rad 
SmartSpec™ Plus Spectrophotometer. 
 Contaminating genomic DNA was removed from quantified RNA samples to 
eliminate false positive results in RT-PCR (Ambion, Inc., 2006) by DNase I enzymatic 
digestion using DNase I (Fermentas Canada Inc.) as outlined in the manufacturer’s 
protocol (Fermentas Canada Inc. protocol references: Anderson, 1981; Kienzl et al., 
1996; Kunitz, 1950; Sambrook and Russell, 2001; Wiame et al., 2000).  Five µg pellets 
of RNA were obtained by centrifugation of stored RNA precipitates in sterile, RNase-
free 1.5 mL microcentrifuge tubes using a Fisher Scientific accuSpin™ Micro R at 
16,060 x g for 15 min at 4ºC were air dried for 10 min and dissolved in 45 µL of RNase-
free water.  Samples were mixed with 5 µL of 10X reaction buffer (100 mM Tris-HCL 
(pH 7.5 at 25ºC), 25 mM MgCl2, 1 mM CaCl2) (Fermentas Canada Inc.) and 5 µL of 
DNase I (1 U/µL) (Fermentas Canada Inc.) and incubated for 30 min at 37ºC.  Total 
reaction volume was 55 µL.  Reactions were mixed with 5 µL of 25 mM EDTA and 
incubated for 10 min at 65ºC.   
 Samples were subsequently purified using an RNeasy® Mini Kit (Qiagen Inc.) 
according to the manufacturer’s protocol.  The kit was supplied with RNeasy® lysis RLT 
(containing guanidine thiocyanate) and wash RPE (supplied as a concentrate) buffer, 
mini spin columns (containing silica-gel membrane) and 2 mL collection tubes.  The 
RNA sample volumes were adjusted to 100 µL with RNase-free water.  350 µL of buffer 
RLT was added to the samples and mixed thoroughly by pipetting.  Two hundred and 
fifty µL of 100% ethanol was added to the samples and mixed thoroughly by pipetting.  
Samples (total volume 700 µL) were applied to mini spin columns, placed in 2 mL 
collection tubes and centrifuged for 16,060 x g for 1 min at 4ºC.  Mini spin columns 
were transferred to new 2 mL collection tubes and spun twice with 500 µL of buffer 
RPE at 16,060 x g for 15 sec.  Fifty µL of RNase-free water was then added to columns, 
and purified RNA was eluted by centrifugation at 16,060 x g for 1 min.  Purified RNA 
samples were used for cDNA synthesis. 
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                     3.5.3.2 cDNA synthesis 
 First strand cDNA synthesis was performed using RevertAid™ M-MuLV 
Reverse Transcriptase (M-MuLV RT, Fermentas Canada Inc.) as outlined in the 
manufacturer’s protocol (Fermentas Canada Inc. protocol references: Gerard and 
D’Alessio, 1993; Sambrook and Russell, 2001; Verma, 1981).  A negative (–) Reverse 
Transcriptase control (-RT control, consisting of all cDNA synthesis reagents with the 
exception of M-MuLV RT) was included in the cDNA synthesis procedure.  First strand 
cDNA synthesis was performed according to the following stepwise reactions; (1) 0.5 
µL (0.5 µg) of oligonucloetide (dT)18 (GE Healthcare) was added to 5 µg of purified 
RNA samples (dissolved in 50 µL of RNase-free water) and reaction mixtures (total 
reaction volume of each sample  55.5 µL) were incubated at 70ºC for 5 min and placed  
on ice for 5 min, (2) 20 µL of 5X reaction buffer (250 mM Tris-HCL(pH 8.3 at 25ºC), 
250 mM KCL, 20 mM MgCl2, 50 mM DL-Dithiothreitol (DTT)) (Fermentas Canada 
Inc.), 20 µL of 5 mM 4 deoxyribonucleoside triphosphate (dNTP) mix (5 mM dATP, 5 
mM dCTP, 5 mM dGTP, 5 mM dTTP) (Fermentas Canada Inc.), 0.5 µL (20 U) of 
RiboLock™ ribonuclease inhibitor (Fermentas Canada Inc.), 9 µL (–RT control) or 8 µL 
(all samples, excluding –RT control) of RNase-free water was added to the reaction 
mixtures (total reaction volumes were 100 µL (-RT control) or 99 µL (all samples, 
excluding –RT control).  Reaction mixtures were incubated at 37ºC for 5 min, (3) 0 µL 
(–RT control) or 1 µL (all samples, excluding –RT control) of M-MuLV RT (200 U/µL) 
was added and the reaction mixtures (total reaction volume of all samples, including –
RT control was 100 µL) were incubated at 42ºC for 60 min and (4) cDNA synthesis 
reactions were stopped by incubation of the mixtures at 70ºC for 10 min and chilled on 
ice for 10 min.   
  To remove any contaminating RNA from Single-Stranded (SS) cDNA samples, 
samples were treated with an RNase A/T1 enzyme mix (Fermentas Canada Inc.) as 
outlined by the manufacturer’s protocol (Fermentas Canada Inc. protocol reference: 
Ausbel, 1994).  Two µL of RNase A/T1 enzyme mix (2 mg/mL RNase A, 5000 U/mL 
RNase T1) was added to cDNA samples and incubated at 37ºC for 30 min (total reaction 
volume was 102 µL).  
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  cDNA samples were subsequently purified by phenol/chloroform extraction 
(Sambrook and Russell, 2001) with minor modifications.  One hundred µL of phenol 
(pH 8.0) /chloroform (1:1) was added to cDNA samples (total reaction volume of each 
samples was 202 µL) and mixed thoroughly by vortexing.  cDNA samples were 
centrifuged at 16,060 x g for 5 min at 4ºC.  Aqueous phases were transferred to sterile, 
1.5 mL centrifuge tubes, and samples were extracted again with phenol/chloroform (1:1) 
as described above.  Samples were next extracted with 100 µL of chloroform/isoamyl 
alcohol mixture (19:1) and centrifuged as above.  Aqueous phases were transferred to 
sterile, 1.5 mL centrifuge tubes and mixed with one-third volume of 7.5 M NH4Ac and 
2.5 volumes of 100% ethanol (total volume of each sample was 385 µL).  Samples were 
then allowed to precipitate at -20ºC for 1 hr, and then centrifuged at 16,060 x g for 15 
min at 4ºC.  The cDNA pellets were air dried at room temperature for 10 min, dissolved 
in 100 µL of sterile water, and stored at -20ºC.  The cDNA was quantified by measuring 
the absorbance at 260nm using a Bio-Rad SmartSpec™ Plus Spectrophotometer. 
       
                     3.5.3.3 Design of primers for use in RT-PCR 
 Primers used for RT-PCR were designed empirically according to Bio-Rad 
Laboratories Real-Time PCR application guide in order to optimize RT-PCR conditions 
(Bio-Rad Laboratories, 2005).  Primers were designed to; (1) avoid GC (Guanidine and 
Cytosine) repeats in excess of 3 consecutive base pairs (bp), (2) contain an overall GC 
content of 50-60%, (3) have a melting temperature (Tm) between 50ºC-65ºC and (4) 
contain terminal G or C nucleotides.  Additionally, primers were designed to result in 
amplification of cDNA sequences (amplicons) between 75-200bp. 
 Designed primers were synthesized by Invitrogen Corporation.  One mM stock 
solutions of all primers were made in TE (pH 8.0) (10 mM Tris-HCL, 1 mM EDTA) 
(Sambrook and Russell, 2001) and stored at -20ºC.  Ten µM forward or reverse primer 
working solutions were made immediately before use by dilution in sterile water. 
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Ferritin light polypeptide (FTL): 
Ferritin light polypeptide forward primer (FTL-F) and ferritin light polypeptide reverse 
primer (FTL-R) were designed using a human ferritin light polypeptide cDNA sequence 
(National Center for Biotechnology Information (NCBI) accession number: BC018990). 
FTL-F primer: 5’cga tga tgt ggc tct gga ag3’ 
FTL-R primer: 5’gga cat caa gaa gcc agc tg3’   
% GC in FTL-F: 55% 
% GC in FTL-R: 55% 
Tm of FTL-F: 62ºC 
Tm of FTL-R: 62ºC 
Amplicon length: 140 bp 
 
Ferritin heavy polypeptide 1 (FTH1): 
Ferritin heavy polypeptide forward primer (FTH1-F) and ferritin heavy polypeptide 1 
reverse primer (FTH1-R) were designed using a human ferritin heavy polypeptide 1 
cDNA sequence (NCBI accession number: BC000857). 
FTH1-F primer: 5’cta cgc ctc cta cgt ttc cc3’ 
FTH1-R primer: 5’ggt tct gca gct tca tca g3’   
% GC in FTH1-F: 55% 
% GC in FTH1-R: 53% 
Tm of FTH1-F: 62ºC 
Tm of FTH1-R: 58ºC 
Amplicon length: 140 bp 
 
Proliferating cell nuclear antigen (PCNA): 
Proliferating cell nuclear antigen forward primer (PCNA-F) and proliferating cell 
nuclear antigen reverse primer (PCNA-R) were designed using a human proliferating 
cell nuclear antigen cDNA sequence (NCBI accession number: BC062439). 
PCNA-F primer: 5’gcc tgc tgg gat att agc tc3’ 
PCNA-R primer: 5’ca tac tgg tga ggt tca cgc3’   
% GC in PCNA-F: 55% 
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% GC in PCNA-R: 53% 
Tm of PCNA-F: 62ºC 
Tm of PCNA-R: 62ºC 
Amplicon length: 150 bp 
 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH): 
GAPDH gene (reference gene) was used as the internal control in RT-PCR assays. 
Glyceraldehyde-3-phosphate dehydrogenase forward primer (GAPDH-F) and 
glyceraldehyde-3-phosphate dehydrogenase reverse primer (GAPDH-R) were designed 
using a human glyceraldehyde-3-phosphate dehydrogenase cDNA sequence (NCBI 
accession number:NM_002046). 
GAPDH-F primer: 5’cca ggg ctg ctt tta act ctg3’ 
GAPDH-R primer: 5’cg ttc tca gcc ttg acg gtg3’   
% GC in GAPDH-F: 52% 
% GC in GAPDH-R: 60% 
Tm of GAPDH-F: 64ºC 
Tm of GAPDH-R: 64ºC 
Amplicon length: 138 bp 
  
                     3.5.3.4 RT-PCR assays 
 The RT-PCR assays were performed using a 2X iQTM SYBR® Green Supermix 
solution (Bio-Rad Laboratories) according to the manufacturer’s protocol.  The RT-PCR 
assays were performed in white 48-multiwell PCR plates (Bio-Rad Laboratories).  
Assays for the target genes (FTL, FTH1, PCNA) and reference gene (GAPDH) included 
reaction mixtures for (1) –RT control, (2) untreated control samples, (3) 2,4-D treated 
samples, (4) cDNA blank (containing all RT-PCR components, excluding primers), (5) 
SYBR Green I blank (containing all RT-PCR components, excluding cDNA template 
and primers) and (6) primer blank (containing all RT-PCR components, excluding 
cDNA template).    
  Master mixtures for RT-PCR assays (containing all reaction components, 
excluding cDNA templates) of target genes were obtained by the addition 775 µL of iQ® 
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SYBR Green Supermix (final concentrations of all components indicated below), 542.5 
µL of sterile water, 38.75 µL (final concentration indicated below) of forward primer 
and 38.75 µL (final concentration indicated below) of reverse primer followed by the 
thorough vortexing of mixtures.  Forty five µL of the master mixture was added to the 
respective wells (each well contained 25 µL (1X) iQTM SYBR® Green Supermix (50 
mM KCl, 20 mM Tris-HCl (pH 8.4), 0.2 mM dNTP, iTaq DNA polymerase (1.25 U), 3 
mM MgCl2, SYBR Green I, 10 nM fluoroscein, and stabilizers, 125 nM forward primer, 
125 nM reverse primer, 17.5 µL of sterile water).  Five µL (25 ng) of cDNA template 
was added to the wells (final reaction volume in each well was 50 µL) and mixed using 
a multichannel pipette.  Master mixtures for RT-PCR assays of the reference gene were 
prepared as described above for the target genes.     
 Reaction mixtures for cDNA blank, SYBR Green I blank, and primer blank were 
prepared individually.  The cDNA blank (total reaction volume 50 µL) consisted of 25 
µL (1X) of iQ® SYBR Green Supermix, 5 µL (25 ng) of control cDNA template and 20 
µL of sterile water.  The SYBR Green I blank (total reaction volume 50 µL) consisted of 
25 µL (1X) of iQ® SYBR Green Supermix and 25 µL of sterile water.  Primer blank 
(total reaction volume 50 µL) consisted of 25 µL (1X) of iQ® SYBR Green Supermix, 
1.25 µL (125 nM) of forward primer, 1.25 µL (125 nM) of reverse primer and 22.5 µL 
of sterile water.  
 The RT-PCR assays were performed using a Bio-Rad MiniOpticon™ System.  
The PCR cycle protocol used in each reaction was: hot start at 95ºC for 3 min, 
denaturation at 95ºC for 45 sec, annealing at 56ºC for 45 sec, and extension at 72ºC for 2 
min, plate read (reading of fluorescence), for 30 cycles, followed by production of a 
melting curve between 55-90ºC, where fluorescence was read at every 0.2ºC temperature 
increments held for 2 sec.   
 Target mRNA expression levels in each sample was calculated relative to the 
expression level in control cell cultures, normalized to the expression level of the 
reference gene, GAPDH, using the Pfaffl method (Pfaffl, (2001)).  The Pfaffl method is 
a formula that is used to calculate relative gene expression when the efficiencies of 
reactions being compared are not the same (Bio-Rad Laboratories).  
The Pfaffl method: 
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Ratio = [(Etarget)∆CT, target (calibrator-test)] / [(Eref)∆CT, ref (calibrator-test)] 
Etarget:  Efficiency of the reaction in amplification of the target cDNA sequence 
Eref:  Efficiency of the reaction in amplification of the internal control cDNA 
 sequence 
CT:  the cycle at which a sample’s fluorescence trace crosses the threshold line 
∆ CT:  difference between 2 CT values 
Calibrator:  control sample 
Test:  test sample 
 RT-PCR assays were performed in replicates of 3 for one set of exposure 
experiments for untreated control and treated cell cultures. 
             
            3.5.4 Protein analysis 
                     3.5.4.1 Protein extraction 
 Following 2,4-D incubation, cells were harvested as outlined by Sambrook and 
Russell. (2001) with minor modifications.  Media was removed and discarded and cells 
were gently washed twice with sterile PBS solution.  Cell culture dishes were placed on 
ice, and cells were directly lyzed by addition of 1mL of lysis buffer (10 mM Hepes (pH 
7.9), 400 mM NaCl, 1.5 mM MgCl2, 5% glycerol, 0.1 mM EDTA, 2 mM DTT, 10 
µg/mL Aprotinin, 10 µg/mL Leupeptin and 0.5 mM phenylmethanesulfonyl fluoride 
(PMSF)).  Cells from each culture dish were collected using rubber policemen and cell 
homogenates were transferred to individual sterile 1.5 mL microcentrifuge tubes.  
Samples were sonicated on ice for approximately 30 sec at a power level of 7 
(amplitude: 247 microns) using a Sonifier® Cell Disruptor.  Following sonication, 
samples were then centrifuged at 16,060 x g for 15 min at 4ºC and supernatants were 
transferred to sterile 1.5 mL microcentrifuge tubes and stored at -80ºC.  Protein was 
quantified using the Bradford assay (Bradford, 1976).  Absorbance was measured at 
595nm using a Bio-Rad SmartSpec™ Plus Spectrophotometer. 
   
                     3.5.4.2 Western blot analysis 
 Denaturing SDS-PAGE and subsequent protein transfer to nitrocellulose 
membrane was performed using Bio-Rad’s Mini-Protean 3 cells and Trans-Blot® SD 
 65
Semi-Dry Transfer cell apparatus according to Sambrook and Russell, 2001 with minor 
modifications.  Protein aliquots (10-30 µg as indicated in figure legends) were mixed 
with one-fifth volume of 5X Laemmli buffer (0.0625 M Tris (pH 6.8), 2% (w/v) SDS, 
10% (v/v) glycerol, 5% (v/v) β-mercaptoethanol and 0.001% (w/v) Bromophenol Blue) 
(Laemmli, 1970) and denatured at 95 to 100ºC for 10 min, then chilled on ice for 1 min.  
Samples were centrifuged at 16,060 x g for 1 min at 4ºC and chilled on ice, then loaded 
onto SDS-polyacrylamide gels (15% (w/v) acrylamide for ferritin and 12% (w/v) 
acrylamide for PCNA detection).  Detection of GAPDH and Hsp72 were performed 
after ferritin or PCNA antibodies were stripped off transferred blots as described below.  
5 uL of PageRuler™ prestained protein ladder (Fermentas Canada Inc.) was included in 
the outer left lane of all gels.  Gels for ferritin or PCNA were initially electrophoresed at 
90V for 30 min, in order to allow proteins to stack, followed by electrophoresis at 120V 
for 3 hrs and 2 hrs, in order to allow for ferritin and PCNA protein resolution, 
respectively.    
 In preparation for the transfer of proteins to 0.45 µM nitrocellulose membranes 
(Bio-Rad Laboratories), pieces of blotting paper (Ahlstrom) and nitrocellulose 
membrane (cut to gel area, approximately 55 cm2) were soaked for 30 min in transfer 
buffer (25 mM Tris, 192 mM glycine, 20% (v/v) methanol) (Towbin et al., 1979).  
Following the electrophoresis of proteins, the gels were assembled for transfer as 
follows; gels were stacked on 2 layers of blotting paper, 1 layer of 0.45 µM pure 
nitrocellulose membrane and covered with 2 additional layers of blotting paper.  A glass 
rod was gently, but firmly rolled over the gel stacks to ensure complete removal of 
trapped air bubbles.  Proteins were transferred using a Bio-Rad Trans-Blot® SD Semi-
Dry Transfer Cell at 20V for 1 hr. 
 Following transfer to nitrocellulose membranes, membranes were blocked with 
10-15 mL of blocking solution.  The blocking solution was prepared according to 
Towbin et al. (1979) with minor modifications; 5% (w/v) Nestle Carnation skim milk in 
TBST (20 mM Tris-HCL (pH 7.5), 500 mM NaCl, 0.1% (v/v) Tween 20) at 4ºC 
overnight.  All primary and secondary antibody incubations were performed in 5% milk 
as described above. 
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 For detection of FTL and FTH1, membranes were incubated with primary anti-
ferritin antibody (rabbit polyclonal to Ferritin, catalog number: ab7332; Novus 
Biologicals) (1:10,000) at 4ºC overnight.  For the detection of PCNA, membranes were 
incubated with primary anti-PCNA antibody (mouse monoclonal to PCNA, catalog 
number: SC-56, Santa Cruz Biotechnologies, Inc.) (1:1,000) at 4ºC overnight.  For the 
detection of Hsp72, the membranes were incubated with a primary anti-Hsp70 (Hsp72) 
antibody (rabbit polyclonal to Hsp70 (Hsp72), catalog number: SPA-812, Stessgen 
Bioreagents) (1:10,000) at 4ºC overnight.  For the detection of GAPDH, membranes 
were incubated with primary anti-GAPDH antibody (mouse monoclonal to GAPDH, 
catalog number: MAB374, Chemicon International Inc.) (1:5,000) at 4ºC overnight.  
Primary antibodies were removed and membranes were washed 3 times (1 x 5min; 1 x 
15min; 1 x 5min) in 5% milk and incubated with the respective secondary antibodies.  
 Ferritin and Hsp72 were detected using goat anti-rabbit-secondary antibody-
Horseradish Peroxidase Conjugate (catalog number: 170-6516, Bio-Rad Laboratories 
Ltd.) (1:4,000) and (1:5000) at room temperature for 1.5 hrs, respectively.  PCNA and 
GAPDH were detected using donkey anti-mouse-secondary antibody-Horse Radish 
Peroxidase (catalog number: SA1-100, Affinity Bioreagents) (1:5000) at room 
temperature for 1.5 hrs.  Secondary antibodies were removed and membranes were 
washed 3 times (1 x 5 min; 1 x 15 min; 1 x 5 min) in 5% skim milk, followed by 2 
washes (2 x 5 min) in TBST and 1 wash (1 x 5 min) in TBS (20 mM Tris-HCL (pH 7.5), 
500 mM NaCl).  
 The washed membranes were incubated with Western Lightning™  
Chemiluminescence Reagent PLUS (Perkin Elmer LAS, Inc.) according to the 
manufacturer’s protocol.  Reagent was prepared immediately prior to 
chemiluminescence in sterile 15 mL centrifuge tubes by mixing 5 mL of enhanced 
luminol and 5 mL oxidizing reagent followed by gentle shaking.  The mixture was 
applied onto membranes, incubated in the mixture for 1 min, then blotting paper was 
used to remove excess chemiluminescence reagent from membranes.  All blots were 
exposed to KODAK BioMax MS Film and developed using a Summit Quality Control 
Processor X-ray film developer.   
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 For re-blotting, (performed before detection of GAPDH and Hsp72) membranes 
were washed at room temperature for 5 min in TBS and stripped using Re-Blot Plus 
strong antibody stripping solution (supplied as a 10X stripping solution, Chemicon 
International Inc.) according to the manufacturer’s protocol.  The membranes were 
incubated by gentle agitation at room temperature for 20 to 25 min with 10 mL of 1X 
Re-Blot Plus Strong Antibody Stripping solution (1:10 dilution in sterile water).   
Membranes were incubated with 10-15 mL of 5% skim milk blocking solution at 4ºC 
overnight.  The blocked membranes were then used for detection of GAPDH and Hsp72.   
 Western analyses were performed in replicates of 3 for one set of exposure 
experiments for untreated control and 2,4-D treated cell cultures. 
 
                     3.5.4.3 Densitometry 
 Protein expression was quantified using densitometry.  Briefly, exposed films 
were scanned using an Epson perfection 4990 photo scanner.  Scanned images were 
cropped using Adobe® Photoshop® CS2.  Densitometry was performed using National 
Institute of Health (NIH) Image J.  Protein expression was quantified by measuring the 
mean density of the entire target and GAPDH protein expression band for untreated 
control and treated samples.  Mean background density value was subtracted from all 
untreated control and treated sample protein mean density values.  Target protein 
expression level in each sample was calculated relative to the expression level in control 
cell cultures, normalized to the expression level of the reference gene, GAPDH. 
 
      3.6 Statistical analysis 
 Statistical analyses were performed using SPSS® 14.0 for windows. 
 To determine if treatments induced statistically significant effects, compared to 
untreated control cell cultures, analyses were performed using one-way analysis of 
variance (ANOVA), followed by a two-sided Dunnett’s post-hoc test.  Results were 
considered significant if P<0.05.  To determine if treatments induced statistically 
significant effects between exposure time points or between treatment groups within the 
same cell line, analyses were performed using one-way ANOVA, followed by a Tukey 
honestly significant difference (Tukey HSD) post-hoc test.  Results were considered 
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significant if P<0.05.  To determine if there were statistically significant differences in 
the treatment effects between (1) different 2,4-D forms within the same cell line, or (2) 2 
cell lines, analyses were performed using unpaired student t-tests.  Results were 
considered significant if P<0.05. 
 
      3.7 Figure production 
 All figures were produced using Microsoft Office® Excel and Power Point 
software. 
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4. RESULTS 
      4.1 Introduction 
 In the present study, two human cell lines; HepG2 and HEK293 cells were used 
to evaluate the toxicity of 2,4-D.  HepG2 cells were chosen for use in this study because 
they have been employed in a vast array of in vitro toxicology studies and retain both 
Phase I and II hepatic biotransformation enzymes (Merch-Sundermann et al., 2004), 
allowing for a more realistic metabolism of 2,4-D in vitro.  The use of HepG2 cells also 
helped to verify results of cDNA microarray analyses performed on HepG2 cells by 
Bharadwaj et al. (2005).   
 In humans, 82.3% of 2,4-D is excreted in the kidney mainly unchanged 
(Sauerhoff et al., 1977).  The HEK293 cells (renal cells), were chosen as an additional in 
vitro cell model to assess the cell specificity of 2,4-D – induced cytotoxicity.   
 Cell cultures were exposed to either a technical grade or a commercial 
formulation of 2,4-D to determine if cytotoxic effects are enhanced by the presence of 
‘inert ingredients’ in the 2,4-D commercial formulation or are a result of the active 
ingredient; 2,4-D.  Cells were exposed for 6 to 72 hrs depending on the assay used to 
evaluate toxicity.  A commercial formulation containing 2,4-D DMA was used because 
2,4-D amine and ester commercial formulations make up approximately 90-95% of 
global 2,4-D use (reviewed by Charles et al., 2001) and amine formulations are more 
hydrophilic (Charles et al., 2001; PMRA, 2005) and less volatile (WHO, 1984) than 
ester formulations.     
 The HepG2 and HEK293 cell cultures were exposed to concentrations of 2,4-D 
ranging from 0.1 nM to 10 mM.  This particular range of 2,4-D concentrations was 
chosen because, it included; (1) environmentally realistic concentrations of 2,4-D that 
have been found in Canadian groundwater [i.e. 0.07 µg/L, 2.67 µg/L (Grover et al., 
1997) and 29 µg/L (reviewed by Environment Canada, 1991; WHO, 2003)], (2) 
Canada’s established IMAC guideline for 2,4-D in drinking water [100 µg/L 
(Environment Canada, 1991)] and (3) toxic concentrations of 2,4-D (1 to 10 mM). 
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4.2 The effects of 2,4-D on cell viability 
 Cell viability assays were performed to determine if exposure to 2,4-D at 
environmental concentrations would induce toxic effects in human cell cultures.  Cell 
viability was determined fluorometrically using an in vitro toxicology assay kit, 
containing the dye, Resazurin.  The present cell viability assay provides a rapid and 
efficient method for determination of the magnitude of cytotoxicity induced by test 
compounds/chemicals.   
 Cells were exposed to 2,4-D for 6 to 72 hrs to determine if toxicity was more 
pronounced with longer durations of exposure.  The concentrations; 5 and 10mM were 
expected to induce more pronounced cytotoxicity, compared to low concentrations (0.1 
nM to 1 mM), and thus was used as a positive control to determine the efficacy of the 
Resazurin assay for assessing 2,4-D – induced cytotoxicity.  Cell viability was 
calculated as a percent (%) of the fluorescence of untreated control cell cultures, using 
the formula: 
 
% cell viability =  (mean treated sample fluorescence)     x    100% 
                              (mean control fluorescence)                                                           (4.1) 
 
 Cell viability results were presented as the mean % cell viability ± standard error 
of the mean (SEM). 
 
 
            4.2.1 The effects of 2,4-D on HepG2 cell viability 
 As seen in figures 1 (A) to (D), exposure to technical 2,4-D decreased viability in 
exposed cells.  A decrease in cell viability was observed at all durations of exposure (6 
to 72 hrs).  However, effects appeared to be limited (mean decreases in viability < 20%) 
at lower environmental concentrations (0.1 to 100 nM) and more pronounced (mean 
decreases in viability > 40%) at higher concentrations (5 and 10 mM).  A statistical 
significant (P<0.0.5) decrease (6%) in viability was initially manifested at 0.1 nM 
following 48 hrs of exposure.    Exposure to concentrations of 1 nM to 100 µM induced 
significant decreases in viability following 6, 24 and 48 hrs of exposure.  Increasing  
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Figure 1: The effects of technical 2,4-D on viability of exposed HepG2 cells.    Cells 
were exposed to 0 to 10mM of 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in 
complete growth media.  Cell viability was determined using the fluorometric Resazurin 
assay.  Fluorescence from a blank sample (complete growth media and Resazurin) was 
subtracted from all samples (untreated control and treated cell cultures).  Cell viability is 
expressed as a percent (%) of the fluorescence of untreated control cell cultures.  Results 
are presented as the mean ± standard error of the mean (SEM) from 6 independent 
experiments.  Statistical analysis was performed using one-way analysis of variance 
(ANOVA), followed by two-sided Dunnett’s post-hoc test.  Statistically significant 
(P<0.05) differences from fluorescence of untreated control cell cultures are denoted by 
the symbol *.  Significant differences from fluorescence of untreated control cell 
cultures were observed in HepG2 cells exposed to the following concentrations and 
respective durations of exposure: (A) 1nM: P = 0.006; 100nM: P = 0.016; 1µM: P = 
0.041; 10mM: P = 0.0001.  (B) 1µM: P = 0.015; 10mM: P = 0.0001.  (C) 0.1nM: P = 
0.032; 1nM: P = 0.0001; 10nM: P = 0.002; 100nM: P = 0.0001; 1µM: P = 0.0001; 
10µM: P = 0.001; 100µM: P = 0.009, 5mM: P = 0.0001; 10mM: P = 0.0001.  (D)  1µM: 
P = 0.031; 10µM: P = 0.035; 1mM: P = 0.001; 5mM: P = 0.0001; 10mM: P = 0.0001. 
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concentrations (over the range of concentrations of 0.1 nM to 100 µM) and durations of 
exposure did not alter the magnitude of observed decreases in cell viability.  A 
statistically significant (P<0.05) increase (14%) in cell viability was observed following 
exposure to 1 mM for 72 hrs.  Exposure to 5 or 10 mM induced statistically significant 
(P<0.05) decreases in cell viability at all durations of exposure (6 to 72 hrs).  Exposure 
to 5 mM induced significant decreases of 27 and 78% in cell viability following 48 and 
72 hrs of exposure, respectively.  Significant decreases (57, 46, 92 and 100%) in 
viability were observed following exposure to 10 mM for 6 to 72 hrs of exposure, 
respectively.   
 The results of figure 1 were compiled into one graph for comparison of the 
effects of exposure to 0.1 nM to 1 mM of technical grade 2,4-D for 6 to 72 hrs.  As seen 
in figure 2, in contrast to 5 and 10 mM, exposure to 0.1 nM to 100 µM for 6, 24, 48 and 
72 hrs induced limited cytotoxic effects, reflected by small decreases in cell viability.  
Similar effects in cell viability were observed over the concentration range of 0.1 nM to 
100 µM.  More pronounced decreases in cell viability were not observed with longer 
durations of exposure.  Exposure to 1 mM for similar durations of treatments increased 
cell viability.   
 Figure 3 illustrates the effect on viability of HepG2 cell cultures exposed to 
increasing concentrations of commercial 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs.  
Decreases in cell viability were observed at all durations of exposure.  Effects appeared 
to be small (mean decreases in viability < 20%) at lower environmental concentrations 
(0.1 to 100 nM) and increased (mean decreases in viability > 40%) at higher 
concentrations (5 and 10 mM).  A statistical significant (P<0.0.5) decrease (11%) in 
viability was initially manifested at 0.1 nM of 2,4-D following 6 hrs of exposure.  
Exposure to 1 nM to 100 µM induced significant decreases in viability following 6, 24 
and 48 hrs of exposure.  Declines in cell viability were not exacerbated with exposure to 
increasing concentrations over this range of concentrations or with increasing times of 
exposure.  Increases (7, 6 and 20%) in cell viability were observed following exposure 
to 1 mM for 24 to 72 hrs, respectively. The effects were statistically significant 
(P<0.05). 
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Figure 2: Comparison of the effects of technical 2,4-D on viability of HepG2 cells 
exposed for 6, 24, 48 and 72 hrs.  Cells were exposed to 0 to 10mM of 2,4-D for 6, 24, 
48 and 72 hrs in complete growth media.  Cell viability was determined using the 
fluorometric Resazurin assay.  Fluorescence from a blank sample (complete growth 
media and Resazurin) was subtracted from all samples (untreated control and treated cell 
cultures).  Cell viability is expressed as a percent (%) of the fluorescence of untreated 
control cell cultures.  Results are presented as the mean from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by a Tukey’s honestly significant difference (HSD) test.  Statistically 
significant (P<0.05) differences between exposure periods are denoted by the symbols a, 
b and c for the following comparisons: a 6 hrs vs. 24 hrs; b24 hrs vs. 48 hrs; c 48 hrs vs. 
72 hrs.  Significant differences between exposure periods were observed in HepG2 cells 
exposed to the following concentrations: 0.1nM: a P = 0.0001; c P = 0.001.  1nM: a P = 
0.0001.  10nM: a P = 0.0001. 100M: a P = 0.0001.  1µM: a P = 0.0001.  10µM: a P = 
0.0001.  100µM: a P = 0.0001.  1mM: a P = 0.0001; c P = 0.001.  5mM: a P = 0.0001; b P 
= 0.001; c P = 0.0001.  10mM: b P = 0.0001. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 75
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a
a
a
a
a
a
a,c
a,c
a,b
2040608010
0
12
0
Cell viability (% of control)
,c
b
0
Control
1.00E-04
1.00E-03
1.00E-02
1.00E-02
1.00E+00
1.00E+01
1.00E+02
1.00E+03
5.00E+03
1.00E+04
[2
,4
-D
]/u
M
6 h
rs
24
 hr
s
48
 hr
s
72
 hr
s
 76
Figure 3: The effects of commercial 2,4-D on viability of exposed HepG2 cells.    
Cells were exposed to 0 to 10mM of 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in 
complete growth media.  Cell viability was determined using the fluorometric Resazurin 
assay.  Fluorescence from a blank sample (complete growth media and Resazurin) was 
subtracted from all samples (untreated control and treated cell cultures).  Cell viability is 
expressed as a percent (%) of the fluorescence of untreated control cell cultures.  Results 
are presented as the mean ± standard error of the mean (SEM) from 6 independent 
experiments.  Statistical analysis was performed using one-way analysis of variance 
(ANOVA), followed by two-sided Dunnett’s post-hoc test.  Statistically significant 
(P<0.05) differences from fluorescence of untreated control cell cultures are denoted by 
the symbol *.  Significant differences from fluorescence of untreated control cell 
cultures were observed in HepG2 cells exposed to the following concentrations and 
respective durations of exposure: (A) 0.1nM: P = 0.037; 1nM: P = 0.003; 10nM: P = 
0.017; 100nM: P = 0.031; 1µM: P = 0.0001; 10µM: P = 0.021; 100µM: P = 0.043; 
5mM: P = 0.0001; 10mM: P = 0.0001.   (B) 1nM: P = 0.003; 10nM: P = 0.033; 100nM: 
P = 0.050; 10µM: P = 0.0001; 100µM: P = 0.047; 1mM: P = 0.0001; 5mM: P = 0.0001; 
10mM: P = 0.0001.  (C) 1nM: P = 0.006; 10nM: P = 0.0001; 100nM: P = 0.0001; 1mM: 
P = 0.028; 5mM: P = 0.0001; 10mM: P = 0.0001.  (D) 1mM: P = 0.0001; 5mM: P = 
0.0001; 10mM: P = 0.0001. 
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Statistically significant (P<0.05) decreases in cell viability were observed following 
exposure to 5 or 10 mM.  Exposure to 5 mM induced significant decreases of 18, 24, 65 
and 96% in cell viability following 6 to 72 hrs of exposure, respectively.  Exposure to 10 
mM for 48 and 72 hrs was lethal to all cells; inducing a 100% decrease in cell viability.   
 The results of figure 3 were compiled into one graph for comparison of the 
effects of exposure to 0.1 nM to 1 mM of commercial 2,4-D for 6 to 72 hrs.  As seen in 
figure 4, in contrast to 5 and 10 mM, exposure to 0.1 nM to 100 µM for all durations of 
exposure induced limited cytotoxic effects, reflected by small decreases in cell viability.  
A similar decline in cell viability was observed in cells treated over the concentrations 
range of 0.1 nM to 100 µM.  More pronounced decreases in cell viability were not 
observed with longer durations of exposure.  Exposure to 1 mM for 24, 48 and 72 hrs 
increased cell viability.   
 
            4.2.2 Comparison of the effects of technical or commercial 2,4-D on HepG2
           cell viability 
 Figure 5 illustrates that exposure to either form of 2,4-D appears to elicit similar 
effects on HepG2 cell viability for all durations of exposure (6 to 72 hrs).  Decreases in 
viability were observed following exposure to 0.1 nM to 100 µM of either technical or 
commercial 2,4-D for 6 to 72 hrs.  More pronounced decreases in viability were not 
observed with increasing concentrations or times to either forms of 2,4-D.  Mean 
decreases in viability were observed following exposure to 0.1 nM to 100 µM for 6 
(technical: 9%, commercial formulation: 12%); 24 (technical: 8%, commercial 
formulation: 5%); 48 (technical: 9% and commercial formulation: 7%) and 72 hrs 
(technical: 7%, commercial formulation: 2%), respectively.  In contrast to technical 2,4-
D, exposure to commercial 2,4-D induced a statistically significant (P<0.05) decrease in 
viability at the lowest concentration (0.1 nM) at an earlier time point (technical grade: 48 
hrs; commercial formulation: 6hrs).   Increases in cell viability were observed upon 
exposure to 1 mM of either technical or commercial 2,4-D for 24 to 72 hrs.  However, 
statistically significant (P<0.05) differences between the effects were only observed 
following exposure to 1 mM at 24 and 48 hrs.   
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Figure 4: Comparison of the effects of commercial 2,4-D on viability of HepG2 cells 
exposed for 6, 24, 48 and 72 hrs.  Cells were exposed to 0 to 10mM of 2,4-D for 6, 24, 
48 and 72 hrs in complete growth media.  Cell viability was determined using the 
fluorometric Resazurin assay.  Fluorescence from a blank sample (complete growth 
media and Resazurin) was subtracted from all samples (untreated control and treated cell 
cultures).  Cell viability is expressed as a percent (%) of the fluorescence of untreated 
control cell cultures.  Results are presented as the mean from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by a Tukey’s honestly significant difference (HSD) test.  Statistically 
significant (P<0.05) differences between exposure periods are denoted by the symbols a, 
b and c for the following comparisons: a 6 hrs vs. 24 hrs;  b24 hrs vs. 48 hrs; c 48 hrs vs. 
72 hrs.  Significant differences between exposure periods were observed in HepG2 cells 
exposed to the following concentrations: 0.1nM: a P = 0.0001; b P = 0.0001; c P = 0.005.  
1nM: a P = 0.0001; b P = 0.0001; c P = 0.0001.  10nM: a P = 0.0001; b P = 0.0001; c P = 
0.0001.  100nM: a P = 0.0001; b P = 0.0001; c P = 0.0001.  1µM: a P = 0.0001; b P = 
0.0001.  10µM: a P = 0.0001; b P = 0.0001; c P = 0.0001.  100µM: a P = 0.0001; b P = 
0.0001; c P = 0.0001.  1mM: a P = 0.0001; b P = 0.0001; c P = 0.027.  5mM: a P = 
0.0001; b P = 0.0001; c P = 0.0001.  10mM: a P = 0.0001. 
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Figure 5: Comparison of the effects of technical or commercial 2,4-D on viability of 
exposed HepG2 cells.  Cells were exposed to 0 to 10mM of technical grade or 
commercial 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in complete growth media.  
Cell viability was determined using the fluorometric Resazurin assay.  Fluorescence 
from a blank sample (complete growth media and Resazurin) was subtracted from all 
samples (untreated control and treated cell cultures).  Cell viability is expressed as a 
percent (%) of the fluorescence of untreated control cell cultures.  Results are presented 
as the mean from 6 independent experiments.  Statistical analysis was performed using 
unpaired student t-tests.  Statistically significant (P<0.05) differences between 2,4-D 
forms are denoted by the symbol *.  Significant differences between 2,4-D forms were 
observed in HepG2 cells exposed to the following concentrations: (A) 1nM: P = 0.002; 
10nM: P = 0.005; 100nM: P = 0.0001; 10µM:  P = 0.011; 100µM: P = 0.023; 5mM: P = 
0.0001.  (B) 0.1nM: P = 0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 
0.0001; 1µM: P = 0.013; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.001; 
5mM: P = 0.0001; 10mM: P = 0.0001.  (C)  0.1nM: P = 0.0001; 1nM: P = 0.0001; 
10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: 
P = 0.0001; 1mM: P = 0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (D) 5mM: P = 
0.003. 
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As seen from figures 5 (A) to (D) exposure to 5 and 10 mM of either technical or 
commercial 2,4-D for durations of 6 to 72 hrs induced similar viability effects.  A 
pronounced decline in viability was observed with increasing concentrations and 
durations of exposure to 5 and 10 mM of either forms of 2,4-D.      
 Thus, the similar pattern of cell viability effects induced by either forms of 2,4-D 
suggests that toxicity was directly induced by 2,4-D and that the presence of ‘inert 
ingredients’ in the commercial formulation did not enhance the toxicity of 2,4-D to a 
great degree. 
 
            4.2.3 The effects of 2,4-D on HEK293 cell viability                                       
 As seen in figures 6 (A) to (D), a 6 to 72 hr exposure to technical 2,4-D 
decreased cell viability.  The effects appeared to be limited (mean decreases in viability 
< 20%) at lower environmental concentrations (0.1 to 100 nM) and exacerbated (mean 
decreases in viability > 40%) at higher concentrations.  A mean decrease of 
approximately 30% in cell viability was observed over the concentration range of 0.1 to 
100 nM following 6 hrs of exposure.  A significant decrease (16%) in viability was 
initially manifested at 0.1 nM following 48 hrs of exposure.  Similar reductions in cell 
viability were observed over the concentration range of 0.1 nM to 1 mM and durations 
of exposure.     
 Statistically significant (P<0.05) decreases in viability were observed following 
exposure to 5 or 10 mM for 6 to 72 hrs.  Decreases in cell viability were more 
pronounced upon exposure to 10 mM (55, 93 and 100%), compared to 5 mM (37, 71 and 
97%) for 24, 48 and 72 hrs, respectively.    
  The results of figure 6 were compiled into one graph for comparison of the 
effects of exposure to 0.1 nM to 1 mM of technical grade 2,4-D for 6 to 72 hrs.  As seen 
in figure 7, in contrast to 24, 48 and 72 hrs (mean decreases in cell viability: 5, 16 and 
19%, respectively), more pronounced decreases in viability were observed in cells 
exposed to 0.1 nM to 1 mM for 6 hrs (mean decrease in viability: 32%).  More 
pronounced decreases in cell viability were not observed with longer durations of 
exposure to concentrations of 0.1 nM to 1 mM.   
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Figure 6: The effects of technical 2,4-D on viability of exposed HEK293 cells.    
Cells were exposed to 0 to 10mM of 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in 
complete growth media.  Cell viability was determined using the fluorometric Resazurin 
assay.  Fluorescence from a blank sample (complete growth media and Resazurin) was 
subtracted from all samples (untreated control and treated cell cultures).  Cell viability is 
expressed as a percent (%) of the fluorescence of untreated control cell cultures.  Results 
are presented as the mean ± standard error of the mean (SEM) from 6 independent 
experiments.  Statistical analysis was performed using one-way analysis of variance 
(ANOVA), followed by two-sided Dunnett’s post-hoc test.  Statistically significant 
(P<0.05) differences from fluorescence of untreated cell cultures are denoted by the 
symbol *.  Significant differences from fluorescence of untreated control cell cultures 
were observed in HEK293 cells exposed to the following concentrations and respective 
durations of exposure: (A) 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 0.0001; 
1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 5mM: P = 
0.0001; 10mM: P = 0.0001.  (B) 5mM: P = 0.0001; 10mM: P = 0.0001.  (C) 0.1nM: P = 
0.004; 1nM: P = 0.041; 10nM: P = 0.017; 100nM: P = 0.001; 10µM: P = 0.001; 100µM: 
P = 0.019; 1mM: P = 0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (D) 1mM: P = 
0.010; 5mM: P = 0.0001; 10mM: P = 0.0001. 
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Figure 7: Comparison of the effects of technical 2,4-D on viability of HEK293 cells 
exposed for 6, 24, 48 and 72 hrs.  Cells were exposed to 0 to 10mM of 2,4-D for 6, 24, 
48 and 72 hrs in complete growth media.  Cell viability was determined using the 
fluorometric Resazurin assay.  Fluorescence from a blank sample (complete growth 
media and Resazurin) was subtracted from all samples (untreated control and treated cell 
cultures).  Cell viability is expressed as a percent (%) of the fluorescence of untreated 
control cell cultures.  Results are presented as the mean from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by a Tukey’s honestly significant difference (HSD) test.  Statistically 
significant (P<0.05) differences between exposure periods are denoted by the symbols a, 
b and c for the following comparisons: a 6 hrs vs. 24 hrs; b24 hrs vs. 48 hrs; c 48 hrs vs. 
72 hrs.  Significant differences between exposure periods were observed in HEK293 
cells exposed to the following concentrations: 1nM: a P = 0.002.  10nM: a P = 0.018.  
100nM: a P = 0.014; c P = 0.006.  1µM: a P = 0.0001.  10µM: a P = 0.0001.  100µM: a P 
= 0.0001.  1mM: a P = 0.0001; c P = 0.020.  5mM: a P = 0.002; b P = 0.0001; c P = 
0.0001.  10mM: b P = 0.0001. 
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Figure 8 illustrates the effect on viability of HEK293 cell cultures exposed to increasing 
concentrations of commercial 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs.  As seen in 
the figure, exposure to 2,4-D at all durations of exposure decreased cell viability.  The 
viability effects appeared to be limited (mean decreases in viability < 20%) at lower 
environmental concentrations (0.1 to 100 nM) and exacerbated (mean decreases in 
viability > 40%) at higher concentrations (5 and 10 mM).  A statistically significant 
(P<0.05) decrease (8%) in cell viability was initially manifested following exposure to 1 
nM for 24 hrs.  Similar decreases in cell viability were observed over the concentration 
range of 0.1 nM to 1 mM and at all durations of exposure. Statistically significant 
(P<0.05) decreases in viability were observed following exposure to 5 and 10 mM for 6 
to 72 hrs.  Decreases in cell viability were more pronounced upon exposure to 10 mM 
(70, 99, 100 and 100%), compared to 5 mM (26, 48, 74 and 97%), respectively.    
 The results of figure 8 were compiled into one graph for comparison of the 
effects of exposure to 0.1 nM to 1 mM of commercial 2,4-D for 6 to 72 hrs.  As seen in 
figure 9, in contrast to 24, 48 and 72 hrs (mean decreases in cell viability: 11, 10 and 
10%, respectively), more pronounced decreases in viability were observed in cells 
exposed to 0.1 nM to 1 mM for 6 hrs (mean decrease in viability: 18%).  More 
pronounced decreases in cell viability were not observed with longer durations of 
exposure to concentrations of commercial 2,4-D within the range of 0.1 nM to 1 mM.   
  
            4.2.4 Comparison of the effects of technical or commercial 2,4-D on HEK293
           cell viability 
 Figure 10 illustrates that exposure to either technical grade or commercial 2,4-D 
elicited similar effects on HEK293 cell viability for all durations of exposure tested.  
However, in contrast to technical grade 2,4-D, exposure to commercial 2,4-D induced a 
statistically significant (P<0.05) decrease in viability at the lowest concentration and at 
the earliest time point (technical grade: 0.1 nM at 48 hrs; commercial formulation: 1 nM 
at 24 hrs).  More pronounced decreases in cell viability were not observed with 
increasing concentrations or times to either forms of 2,4-D.  For example, mean 
decreases in viability observed upon exposure to either 0.1 nM to 1mM of technical or 
commercial 2,4-D for 6, 24, 48 and 72 hrs were:  technical grade: 33%, commercial  
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Figure 8: The effects of commercial 2,4-D on viability of exposed HEK293  cells.    
Cells were exposed to 0 to 10mM of 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in 
complete growth media.  Cell viability was determined using the fluorometric Resazurin 
assay.  Fluorescence from a blank sample (complete growth media and Resazurin) was 
subtracted from all samples (untreated control and treated cell cultures).  Cell viability is 
expressed as a percent (%) of the fluorescence of untreated control cell cultures.  Results 
are presented as the mean ± standard error of the mean (SEM) from 6 independent 
experiments.  Statistical analysis was performed using one-way analysis of variance 
(ANOVA), followed by two-sided Dunnett’s post-hoc test.  Statistically significant 
(P<0.05) differences from fluorescence of untreated control cell cultures are denoted by 
the symbol *.  Significant differences from fluorescence of untreated control cell 
cultures were observed in HEK293 cells exposed to the following concentrations and 
respective durations of exposure: (A) 100nM: P = 0.0001; 1µM: P = 0.0001; 10µM: P = 
0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (B) 1nM: P = 0.017; 10nM: P = 0.010; 
100nM: P = 0.0001; 1µM:  P = 0.0001; 10µM: P = 0.038; 100µM: P = 0.028; 1mM: P = 
0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (C) 100µM: P = 0.014; 1mM: P = 
0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (D) 5mM: P = 0.0001; 10mM: P = 
0.0001. 
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Figure 9: Comparison of the effects of commercial 2,4-D on viability of HEK293 
cells exposed for 6, 24, 48 and 72 hrs.  Cells were exposed to 0 to 10mM of 2,4-D for 
6, 24, 48 and 72 hrs in complete growth media.  Cell viability was determined using the 
fluorometric Resazurin assay.  Fluorescence from a blank sample (complete growth 
media and Resazurin) was subtracted from all samples (untreated control and treated cell 
cultures).  Cell viability is expressed as a percent (%) of the fluorescence of untreated 
control cell cultures.  Results are presented as the mean from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by a Tukey’s honestly significant difference (HSD) test.  Statistically 
significant (P<0.05) differences between exposure periods are denoted by the symbols a, 
b and c for the following comparisons: a 6 hrs vs. 24 hrs; b24 hrs vs. 48 hrs; c 48 hrs vs. 
72 hrs.  Significant differences between exposure periods were observed in HEK293 
cells exposed to the following concentrations: 1nM: a P = 0.0001; b P = 0.001.  10nM: a 
P = 0.001; b P = 0.0001.  100nM: a P = 0.021; c P = 0.019.  1µM: a P = 0.006.  10µM: a P 
= 0.0001; b P = 0.003; c P = 0.0001.  100µM: a P = 0.006; c P = 0.0001.  1mM: c P = 
0.001.  5mM: b P = 0.0001; c P = 0.0001.  10mM: a P = 0.0001. 
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Figure 10: Comparison of the effects of technical grade or commercial 2,4-D on 
viability of exposed HEK293 cells.  Cells were exposed to 0 to 10mM of technical 
grade or commercial 2,4-D for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in complete growth 
media.  Cell viability was determined using the fluorometric Resazurin assay.  
Fluorescence from a blank sample (complete growth media and Resazurin) was 
subtracted from all samples (untreated control and treated cell cultures).  Cell viability is 
expressed as a percent (%) of the fluorescence of untreated control cell cultures.  Results 
are presented as the mean from 6 independent experiments.  Statistical analysis was 
performed using unpaired student t-tests.  Statistically significant (P<0.05) differences 
between 2,4-D forms are denoted by the symbol *.  Significant differences between 2,4-
D forms were observed in HEK293 cells exposed to the following concentrations: (A) 
0.1nM: P = 0.007; 10nM: P = 0.0001; 1mM: P = 0.011; 5mM: P = 0.016; 10mM: P = 
0.0001.  (B) 0.1nM: P = 0.002; 100nM: P = 0.049; 1mM: P = 0.001; 10mM: P = 0.001.  
(C) 0.1nM: P = 0.009; 1nM: P = 0.017; 10nM: P = 0.0001; 100nM: P = 0.0001; 10µM: 
P = 0.001; 5mM: P = 0.001; 10mM: P = 0.018.  (D) 10µM: P = 0.004; 100µM: P = 
0.002; 1mM: P = 0.043. 
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formulation: 18% (6hrs); technical grade: 5%, commercial formulation: 11% (24hrs); 
technical grade:16%, commercial formulation: 10% (48hrs) and technical grade: 19%, 
commercial formulation: 10% (72hrs), respectively.   Thus, in contrast to 24, 48 and 72  
hrs, exposure to either technical grade or commercial 2,4-D for 6 hrs appeared to induce 
greater magnitudes of cytotoxic effects, reflected by more pronounced decreases in 
viability.   
    A more pronounced decrease in cell viability was observed following exposure 
to 10 mM (mean decrease in cell viability; technical: 72%, commercial: 93%), compared 
to 5 mM (mean decrease in cell viability; technical: 64%, commercial: 63%) of either 
forms of 2,4-D for 6 to 72 hrs.  Statistically significant (P<0.05) differences between the 
viability effects were observed following exposure to 5 and 10 mM for 6 and 48 hrs; 10 
mM for 24 hrs and 5 mM for 72 hrs.   
 The effects on cell viability induced by either form of 2,4-D, suggests that 
toxicity was directly induced by 2,4-D and that the presence of ‘inert ingredients’ in the 
commercial formulation did not enhance the toxicity of 2,4-D to a great degree. 
 
            4.2.5 Comparison of the effects of technical 2,4-D on HepG2 and HEK293 
           cell viability 
 As seen from figure 11 (A) to (D), 2,4-D elicited similar effects on viability in 
both HepG2 and HEK293 cells at all durations of exposure (6 to 72 hrs).  Significant 
decreases in both HepG2 and HEK293 cell viability were observed at the lowest 
concentrations (0.1 nM) following 48 hrs of exposure.  However, in contrast to HepG2 
cells, HEK293 cells appeared to be more susceptible to exposures of 0.1 nM to 100 µM 
for 6, 48 and 72 hrs, reflected by the more pronounced decreases in cell viability.  For 
example exposure to 0.1 nM to 100 µM for 6 to 72 hrs induced greater magnitudes of 
decreases in HEK293 (33, 16 and 19%), compared to HepG2 (9, 9 and 7%) cell 
viability, respectively.  An additional difference observed between the two cell types 
was the increase in cell viability observed in HepG2 cells exposed to 1 mM for 6 to 72 
hrs.  This was not observed in HEK293 cells similarly exposed to the same 
concentration and duration.  
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Figure 11: Comparison of the effects of technical 2,4-D on viability of exposed 
HepG2 and HEK293 cells.  Cells were exposed to 0 to 10mM of technical grade 2,4-D 
for (A) 6, (B) 24, (C) 48 and (D) 72 hrs in complete growth media.  The HepG2 and 
HEK293 cells were not simultaneously exposed to 2,4-D.  Cell viability was determined 
using the fluorometric Resazurin assay.  Fluorescence from a blank sample (complete 
growth media and Resazurin) was subtracted from all samples (untreated control and 
treated cell cultures).  Cell viability is expressed as a percent (%) of the fluorescence of 
untreated control cell cultures.  Results are presented as the mean from 6 independent 
experiments.   Statistical analysis was performed using unpaired student t-tests.  
Statistically significant (P<0.05) differences between HepG2 and HEK293 cells are 
denoted by the symbol *.  Significant differences between HepG2 and HEK293 cells 
were observed upon exposure to 0.1nM to 10mM at all durations of exposure, as 
follows: (A) 0.1nM: P = 0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 
0.0001; 1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 
5mM: P = 0.0001; 10mM: P = 0.0001.  (B) 0.1nM: P = 0.0001; 1nM: P = 0.0001; 
10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: 
P = 0.0001; 1mM: P = 0.0001; 5mM: P = 0.0001; 10mM: P = 0.002.  (C) 0.1nM: P = 
0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P = 0.0001; 
10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 5mM: P = 0.0001; 10mM: P 
= 0.009.  (D) 0.1nM: P = 0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 
0.006; 1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 
5mM: P = 0.001; 10mM: P = 0.001.  
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In both HepG2 and HEK293 cells, decreases in viability were more exacerbated 
following 24 to 72 hrs of exposure to 10 mM (HepG2: 46, 92 and 100%; HEK293: 55, 
93 and 100%), compared to 5 mM (HepG2: 2, 27 and 78%; HEK293: 37, 71 and 97%).   
            
            4.2.6 Comparison of the effects of commercial 2,4-D on HepG2 and HEK293 
           cell viability 
 As seen from figure 12 (A) to (D), similar effects on viability were observed in 
HepG2 and HEK293 cells following exposure to commercial 2,4-D for 6 to 72 hrs.  
However, in contrast to HEK293, a significant decrease in HepG2 cell viability was 
initially observed at the lowest concentration and the earliest duration of exposure 
(HepG2: 0.1 nM at 6 hrs; HEK293: 1 nM at 24 hrs).  More pronounced decreases in cell 
viability were observed in HEK293 (11, 10 and 10%) exposed to 0.1 nM to 100 µM for 
24 to 72 hrs of exposure compared to HepG2 (5, 7 and 2%) cells, respectively.    
 In both HepG2 and HEK293 cells, decreases in viability were more exacerbated 
following 6 to 72 hrs of exposure to 10mM (HepG2: 54, 99, 100 and 100%; HEK293: 
70, 99, 97 and 100%), compared to 5mM (HepG2: 18, 24, 65 and 96%; HEK293: 26, 48, 
74 and 97%).   
 
 Therefore, in summary, cell viability results illustrated that: (1) exposure to 0.1 
nM to 1 mM of either technical or commercial 2,4-D induced similar effects on cell 
viability in exposed HepG2 and HEK293 cells; suggesting that 2,4-D – induced 
cytotoxicity may be induced directly by 2,4-D, and the presence of ‘inert ingredients’ in 
the commercial formulation has limited ability to act synergistically with 2,4-D and 
enhance the magnitude of toxicity to a great degree, (2) similar magnitudes of decreases 
in HepG2 and HEK293 cell viability were observed over the concentration range of 0.1 
nM to 100 µM of either forms of 2,4-D, (3) more pronounced decreases in HepG2 and 
HEK293 cell viability were not observed with longer durations of exposure  to either 
forms of 2,4-D and (4) compared to HepG2, HEK293 cells appeared to be more 
susceptible to the toxic effects induced by exposure to 0.1 nM to 1 mM of either forms 
of 2,4-D; reflected by more pronounced  decreases in viability.  Thus, based on the  
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Figure 12: Comparison of the effects of commercial 2,4-D on viability of exposed 
HepG2 and HEK293 cells.  Cells were exposed to 0 to 10mM of commercial 2,4-D for 
(A) 6, (B) 24, (C) 48 and (D) 72 hrs in complete growth media.  The HepG2 and 
HEK293 cells were not simultaneously exposed to 2,4-D.  Cell viability was determined 
using the fluorometric Resazurin assay.  Fluorescence from a blank sample (complete 
growth media and Resazurin) was subtracted from all samples (untreated control and 
treated).  Cell viability is expressed as a percent (%) of the fluorescence of untreated 
control cell cultures.  Results are presented as the mean from 6 independent experiments.    
Statistical analysis was performed using unpaired student t-tests.  Statistically significant 
(P<0.05) differences between HepG2 and HEK293 cells are denoted by the symbol *.  
Significant differences between HepG2 and HEK293 cells were observed upon exposure 
to 0.1nM to 10mM at all durations of exposure, as follows: (A) 0.1nM: P = 0.0001; 
1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P = 0.0001; 10µM: P = 
0.0001; 100µM: 1mM: P =0.0001; 5mM: P = 0.0001; 10mM: P = 0.0001.  (B) 0.1nM: P 
= 0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P = 0.0001; 
10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 5mM: P = 0.0001.  (C) 
0.1nM: P = 0.0001; 1nM: P = 0.0001; 10nM: P = 0.0001; 100nM: P = 0.0001; 1µM: P 
= 0.0001; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P = 0.0001; 5mM: P = 0.0001; 
10mM: P = 0.005.  (D)  0.1nM: P = 0.001; 1nM: P = 0.0001; 10nM: P = 0.0001; 
100nM: P = 0.004; 1µM: P = 0.0001; 10µM: P = 0.0001; 100µM: P = 0.0001; 1mM: P 
= 0.0001; 5mM: P = 0.009; 10mM: P = 0.017. 
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results obtained from cell viability assays, all subsequent studies were performed using 
HepG2 and HEK293 cell cultures exposed to commercial 2,4-D for 24 hrs. 
 
      4.3 ROS production in cells 
 The ROS assays were performed using 2’,7’-DCFH-DA to determine if 
environmental concentrations of 2,4-D induce ROS production in exposed human cell 
cultures.  The HepG2 and HEK293 cells were exposed to H2O2 to assess the efficacy of 
the ROS assay.  The compound, 2’,7’-DCFH-DA, is considered to be superior for 
detection of intracellular ROS production (Hempel et al., 1999).  Additionally, 2’,7’-
DCFH-DA provides a rapid and efficient in vitro method for determination of 
intracellular ROS production, in contrast to other conventional assays (i.e. thiobarbituric 
acid assay, which measures the accumulation of the lipid peroxidation end product, 
malondialdehyde (MDA) (reviewed by Cathcart et al., 1983)).  It is also considered to be 
highly sensitive, as it is able to detect picomoles (pM) of hydroperoxides (Cathcart et al., 
1983).   
 The fluorescent signal was directly proportional to ROS production.  Therefore, 
results were presented as the mean fluorescent signal unit (FSU) ± standard error of the 
mean (SEM).  Fluorescence was measured every hour for a total of 5 hrs to determine if 
more pronounced ROS production would be observed with longer durations of exposure 
to 2,4-D.   
 
            4.3.1 The effects of H2O2 on ROS production in HepG2 and HEK293 cells 
 As illustrated in figures 13 and 14, ROS production is increased in HepG2 and 
HEK293 cells following exposure to H2O2.  Statistically significant (P<0.05) increases 
in ROS production were observed at concentrations equal to and greater than 200 µM in 
HepG2 cells.  Concentration-dependent increases in ROS production were observed in 
HepG2 cells. The observed increases in ROS production between successive 
concentrations (100 to 400 µM) of H2O2 were statistically significant (P<0.05) in 
HepG2 cells.  Statistically significant (P<0.05) increases in ROS production were 
observed in HEK293 cells exposed to concentrations greater and equal to 100 µM.   
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Figure 13:  Reactive oxygen species (ROS) production in HepG2 cells exposed to 
hydrogen peroxide (H2O2).  Cells were exposed to 0 to 400µM of H2O2 for 20 min in 
phosphate buffered saline (PBS) solution.  The production of ROS was determined using 
2’,7’-dichlorofluorescin diacetate (2’,7’-DCFH-DA).  Fluorescence from a blank sample 
(PBS and 2’,7’-DCFH-DA) was subtracted from all samples (untreated control and 
treated cell cultures).  Results are expressed as the mean 2’,7’-dichlorofluorescein (DCF) 
fluorescence ± standard error of the mean (SEM) from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by two-sided Dunnett’s post-hoc test.  Statistically significant (P<0.05) 
differences from fluorescence of untreated control cell cultures are denoted by the 
symbol *.  Significant differences from from fluorescence of untreated control cell 
cultures were observed in HepG2 cells exposed to the following concentrations: 200µM: 
P = 0.0001.  300µM: P = 0.0001.  400µM: P = 0.0001.  Statistical analysis was 
performed using one-way ANOVA, followed by a Tukey’s honestly significant 
difference (HSD) test.  Statistically significant (P<0.05) differences in the increases in 
ROS production between successive increasing exposure concentrations are denoted by 
the symbols a, b and c for the following comparisons: a 100µM vs. 200µM; b 200µM vs. 
300µM; c 300µM vs. 400µM.  Significant differences in the increases in ROS 
production between successive increasing concentrations were observed in HepG2 cells 
as follows: 200µM: a P = 0.009.  300µM: b P = 0.0001.  400µM: c P = 0.0001. 
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Figure 14:  Reactive oxygen species (ROS) production in HEK293 cells exposed to 
hydrogen peroxide (H2O2).  Cells were exposed to 0 to 400µM of H2O2 for 20 min in 
phosphate buffered saline (PBS) solution.  The production of ROS was determined using 
2’,7’-dichlorofluorescin diacetate (2’,7’-DCFH-DA).  Fluorescence from a blank sample 
(PBS and 2’,7’-DCFH-DA) was subtracted from all samples (untreated control and 
treated cell cultures).  Results are expressed as the mean 2’,7’-dichlorofluorescein (DCF) 
fluorescence ± standard error of the mean (SEM) from 6 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by two-sided Dunnett’s post-hoc test.  Statistically significant (P<0.05) 
differences from fluorescence of untreated control cell cultures are denoted by the 
symbol *.  Significant differences from fluorescence of untreated control cell cultures 
were observed in HEK293 cells exposed to the following concentrations: 100µM: P = 
0.0001. 200µM: P = 0.0001.  300µM: P = 0.0001.  400µM: P = 0.0001.  Statistical 
analysis was performed using one-way ANOVA, followed by a Tukey’s honestly 
significant difference (HSD) test.  There were statistically insignificant (P < 0.05) 
differences in the increases in ROS production between successive increasing exposure 
concentrations in HEK293 cells.   
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Increases in ROS production in HEK293 cells observed at concentrations equal to and 
greater than 200 µM were similar in magnitude to that observed at 100 µM.  
 
            4.3.2 The effects of increasing exposure time to PBS solution on                       
             ROS production in untreated HepG2 and HEK293 control cells 
 The ROS assays were performed in PBS solution.  Figure 15 illustrates that in 
both HepG2 and HEK293 cells; ROS production increased with longer durations of 
exposure to PBS solution.  The ROS production observed between 2 and 3 hrs, 3 and 4 
hrs, 4 and 5 hrs, and 5 and 6 hrs in both HepG2 and HEK293 cells were statistically 
significant (P<0.05).  At all exposure time points (2 to 6 hrs), ROS production in 
HEK293 cells was 50 to 70% statistically significant (P<0.05) less than that produced in 
HepG2 cells at all durations of exposure.   
 
            4.3.3 The effects of commercial 2,4-D on ROS production in cells 
                     4.3.3.1 The effects of commercial 2,4-D on ROS production in HepG2     
                                  cells 
 Figure 16 illustrates that exposure to high concentrations of 2,4-D (100 µM and 
1 mM) induce ROS production in HepG2 cells.  Statistically significant (P<0.05) 
increases in ROS production were observed following exposure to 100µM and 1mM at 
all durations of exposure.  Approximately twice the amount of ROS was produced in 
cells exposed to 1 mM, compared to 100 µM.  The differences in ROS produced 
between 100 µM and 1 mM at all duration of exposure were statistically significant 
(P<0.05).  The ROS production increased significantly (P<0.05) in cells exposed to 100 
µM or 1 mM with successive exposure times (100 µM (2 to 3 hrs, 3 to 4hrs, 4 to 5hrs) 
and 1 mM (2 to 3 hrs, 3 to 4 hrs, 4 to 5 hrs, 5 to 6 hrs).   
 
                     4.3.3.2 The effects of commercial 2,4-D on ROS production in HEK293 
                                  cells 
Figure 17 illustrates that exposure to 2,4-D induces ROS production in exposed 
HEK293 cells.  Statistically significant (P<0.05) increases in ROS production were only 
observed following exposure to concentrations equal to and greater than 1 µM for all  
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Figure 15:  The effects of phosphate buffered saline (PBS) solution on reactive 
oxygen species (ROS) production in untreated HepG2 and HEK293 control cells.   
Cells were exposed to PBS for 1 hr.  The HepG2 and HEK293 cells were not 
simultaneously exposed to PBS.  The production of ROS was determined using 2’,7’-
dichlorofluorescin diacetate (2’,7’-DCFH-DA).  Fluorescence from a blank sample (PBS 
and 2’,7’-DCFH-DA) was subtracted from all samples (untreated control and treated cell 
cultures).  Results are expressed as the mean 2’,7’-dichlorofluorescein (DCF) 
fluorescence ± standard error of the mean (SEM) from 8 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by a Tukey’s honestly significant difference (HSD) test.  Statistically 
significant (P<0.05) differences between exposure periods are denoted by the symbols a, 
b, c and d for the following comparisons: a 2 hrs vs. 3 hrs;  b 3 hrs vs. 4 hrs; c 4 hrs vs. 5 
hrs; d 5 hrs vs. 6 hrs.  Significant differences between exposure periods were observed in 
HepG2 and HEK293 cells, as follows: HepG2 cell cultures: a P = 0.0001; b P = 0.0001; c 
P = 0.0001; d P = 0.0001.  HEK293 cell cultures:  a P = 0.0001; b P = 0.0001; c P = 
0.0001; d P = 0.0001.  Statistical analysis was performed using unpaired student t-tests.  
Statistically significant (P<0.05) differences between HepG2 and HEK293 cells are 
denoted by the symbol **.  Significant differences between HepG2 and HEK293 cells 
were observed at all durations of exposure, as follows: 2 hrs: ** P = 0.0001; 3 hrs: ** P 
= 0.0001; 4 hrs: ** P = 0.0001; 5 hrs: ** P = 0.0001; 6 hrs: ** P = 0.0001. 
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Figure 16:  Reactive oxygen species (ROS) production in HepG2 cells exposed to 
commercial 2,4-D.  Cell were exposed to 0 to 1mM of 2,4-D in phosphate buffered 
saline (PBS) solution for 1 hr.  The production of ROS was determined using 2’,7’-
dichlorofluorescin diacetate (2’,7’-DCFH-DA).  Fluorescence from a blank sample (PBS 
and 2’,7’-DCFH-DA) was subtracted from all samples (untreated control and treated cell 
cultures).  Results are expressed as the mean 2’,7’-dichlorofluorescein (DCF) 
fluorescence ± standard error of the mean (SEM) from 8 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by two-sided Dunnett’s post-hoc test.  Statistically significant (P<0.05) 
differences from fluorescence of untreated control cell cultures are denoted by the 
symbol *.  Significant differences from fluorescence of untreated control cell cultures 
were observed in HepG2 cells exposed to the following concentrations: 100µM: 2 hrs: P 
= 0.002; 3 hrs: P = 0.0001; 4 hrs: P = 0.002; 5 hrs: P = 0.0001.  1mM: 2 hrs: P = 0.0001; 
3 hrs: P = 0.0001; 4 hrs: P = 0.002; 5 hrs: P = 0.0001; 6 hrs: P = 0.0001.  Statistically 
significant (P<0.05) differences in the increases in ROS production between successive 
increasing exposure concentrations (10µM to 1mM) are denoted by the symbols ^ and 
** for the following comparisons: ^ 10µM vs. 100µM; ** 100µM vs. 1mM.  Statistical 
analysis was performed using one-way ANOVA, followed by a Tukey’s honestly 
significant difference (HSD) test.  Significant differences in ROS production between 
successive increasing concentrations were observed in HepG2 cells, as follows: 2 hrs: ^ 
P = 0.014, ** P = 0.0001; 3 hrs: ^ P = 0.0001. ** P = 0.0001; ^ P = 0.002, ** P = 
0.0001; ^ P = 0.0001, ** P = 0.0001; 6 hrs: ** P = 0.0001.  Statistically significant 
(P<0.05) differences in the increases in ROS production between successive increasing 
exposure periods following exposure to 100µM and 1mM are denoted by the symbols a, 
b, c and d for the following comparisons: a 2 hrs vs. 3 hrs; b 3 hrs vs. 4 hrs; c 4 hrs vs. 5 
hrs; d 5 hrs vs. 6 hrs.  Statistical analysis was performed using one-way ANOVA, 
followed by a Tukey’s HSD test.  Significant differences in ROS production between 
successive increasing exposure periods were observed in HepG2 cells exposed to 
100µM and 1mM as follows: 100µM: a P = 0.0001;   b P = 0.0001; c P = 0.0001.  1mM: a 
P = 0.0001; b P = 0.0001; c P = 0.0001; d P = 0.0001. 
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Figure 17:  Reactive oxygen species (ROS) production in HEK293 cells exposed to 
commercial 2,4-D.  Cell were exposed to 0 to 1mM of 2,4-D in phosphate buffered 
saline (PBS) solution for 1 hr.  The production of ROS was determined using 2’,7’-
dichlorofluorescin diacetate (2’,7’-DCFH-DA).  Fluorescence from a blank sample (PBS 
and 2’,7’-DCFH-DA) was subtracted from all samples (untreated control and treated cell 
cultures).  Results are expressed as the mean 2’,7’-dichlorofluorescein (DCF) 
fluorescence ± standard error of the mean (SEM) from 8 independent experiments.  
Statistical analysis was performed using one-way analysis of variance (ANOVA), 
followed by two-sided Dunnett’s post-hoc test.  Statistically significant (P<0.05) 
differences from fluorescence of untreated control cell cultures are denoted by the 
symbol *.  Significant differences from fluorescence of untreated control cell cultures 
were observed in HEK293 cells exposed to the following concentrations: 1µM: 2 hrs: P 
= 0.005; 3 hrs: P = 0.0001; 4 hrs: P = 0.0001; 5 hrs: P = 0.002; 6 hrs: P = 0.007.  10µM: 
2 hrs: P = 0.0001; 3 hrs: P = 0.0001; 4 hrs: P = 0.0001; 5 hrs: P = 0.0001; 6 hrs: P = 
0.0001.  100µM: 2 hrs: P = 0.0001; 3 hrs: P = 0.0001; 4 hrs: P = 0.0001; 5 hrs; P = 
0.0001; 6 hrs: P = 0.0001.  1mM: 2 hrs: P = 0.0001; 3 hrs: P = 0.0001; 4 hrs: P = 
0.0001; 5 hrs: P = 0.0001; 6 hrs: P = 0.0001.  Statistically significant (P<0.05) 
differences in the increases in ROS production between successive increasing exposure 
concentrations (1µM to 1mM) are denoted by the symbols ^ and ** for the following 
comparisons: ^ 10µM vs. 100µM; ** 100µM vs. 1mM.  Statistical analysis was 
performed using one-way ANOVA, followed by a Tukey’s honestly significant 
difference (HSD) test.  Significant differences in ROS production between successive 
increasing concentrations were observed in HEK293 cells as follows: 2 hrs: ^ P = 0.026, 
** P = 0.0001; 3 hrs: ^ P = 0.005, ** P = 0.0001; 4 hrs: ^ P = 0.001, ** P = 0.0001; 5 
hrs: ^ P = 0.005, ** P = 0.0001; 6 hrs: ^ P = 0.007, ** P = 0.0001.  Statistically 
significant (P<0.05) differences in the increases in ROS production between successive 
increasing exposure periods following exposure to 1µM to 1mM are denoted by the 
symbols a, b, c and d for the following comparisons.  a 2 hrs vs. 3 hrs;  b 3 hrs vs. 4 hrs; c 
4 hrs vs. 5 hrs; d 5 hrs vs. 6 hrs.  Statistical analysis was performed using one-way 
ANOVA, followed by a Tukey’s HSD test.  Significant differences in  ROS production 
between successive increasing exposure periods were observed in HEK293 cells 
exposed to 1µM to 1mM, as follows: 1µM: a P = 0.012, b P = 0.005, c P = 0.001, d P = 
0.022;  10µM: a P = 0.0001, b P = 0.0001, c P = 0.0001; d P = 0.0001;   100µM: a P = 
0.0001, b P = 0.0001, c P = 0.0001, d P = 0.0001; 1mM: a P = 0.0001, b P = 0.0001, c P = 
0.006 hrs: d P = 0.0001.   
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durations of exposure.  Furthermore, although ROS production appeared to increase with 
increasing concentrations of 2,4-D (1 µM to 1 mM); significant (P<0.05) differences in  
ROS production were only observed between 10 and 100 µM, and 100 µM and 1 mM.  
Exposure to 1 µM to 1 mM induced more pronounced increases in ROS production with 
longer durations of exposure.  The effects were statistically significant (P<0.05).   
                      
                     4.3.3.3 Comparison of the effects of commercial 2,4-D on ROS       
                                  production in HepG2 and HEK293 cells 
 Figure 18 illustrates that at all concentrations (0 to 1 mM) and times (2 to 6 hrs), 
50 to 70% statistically significant (P<0.05) less ROS was produced in HEK293, 
compared to HepG2 cells.   
 
      4.4 The effects of commercial 2,4-D on mRNA expression in cells 
 The RT-PCR assays were performed to determine if exposure to environmental 
concentrations of 2,4-D would induce up-regulation of FTL, FTH1 and PCNA gene 
expression at the level of mRNA accumulation.  In contrast to conventional Northern 
Blot assays, RT-PCR assays provide a rapid, efficient and sensitive method for 
determination of mRNA accumulation levels.   
 Target mRNA expression levels in each sample was calculated relative to the 
expression in control cell cultures, normalized to the expression of the reference gene, 
GAPDH. 
 
            4.4.1 The effects of commercial 2,4-D on FTL mRNA expression in cells        
                     4.4.1.1 The effects of commercial 2,4-D on FTL mRNA expression 
                        in HepG2 cells 
Figure 19 illustrates that exposure to 2,4-D induces alterations (< 2 fold) in FTL 
mRNA expression.  A consistent pattern in mRNA expression was not observed over the 
concentrations tested.  The FTL mRNA expression was repressed in cells exposed to 
concentrations less than 10 µM.  The greatest degree of repression (0.19 fold) of mRNA 
expression was observed in cells exposed to 100 nM.  Induction of FTL mRNA 
expression was observed in cells exposed to concentrations equal to and greater than  
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Figure 18:  Comparison of reactive oxygen species (ROS) production in HepG2 and 
HEK293 cells exposed to commercial 2,4-D.  Cells were exposed to 0 to 1mM of 2,4-
D in phosphate buffered saline (PBS) solution for 1 hr.  The HepG2 and HEK293 cells 
were not simultaneously exposed to 2,4-D.  The production of ROS in HepG2 and 
HEK293 cells was determined using 2’,7’-dichlorofluorescin diacetate (2’,7’-DCFH-
DA).  Fluorescence from a blank sample (PBS and 2’,7’-DCFH-DA) was subtracted 
from all samples (untreated control and treated cell cultures).  Results are expressed as 
the mean 2’,7’-dichlorofluorescein (DCF) fluorescence ± standard error of the mean 
(SEM) from 8 independent experiments.  Statistically significant (P<0.05) differences 
between HepG2 and HEK293 cells are denoted by the symbol *.  Significant differences 
between HepG2 and HEK293 cells were observed upon exposure to 0 to 1mM at all 
durations of exposure, as follows: control: 2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 4 hrs: P 
= 0.0001, 5 hrs: P = 0.0001, 6 hrs: P = 0.0001; 0.1nM: 2 hrs: P = 0.0001, 3 hrs: P = 
0.0001, 4 hrs: P = 0.0001, 5 hrs: P = 0.0001, 6 hrs: P = 0.0001; 1nM: 2hrs: P = 0.0001, 
3hrs: P = 0.0001, 4hrs: P = 0.0001, 5hrs; P = 0.0001, 6hrs: P = 0.0001; 10nM: 2hrs: P = 
0.0001, 3hrs: P = 0.0001, 4hrs: P = 0.0001, 5hrs: P = 0.0001, 6hrs: P = 0.0001; 100nM: 
2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 4 hrs: P = 0.0001, 5 hrs: P = 0.0001, 6 hrs: P = 
0.0001; 1µM: 2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 4 hrs: P = 0.0001, 5 hrs: P = 0.0001, 
6 hrs: P = 0.0001; 10µM: 2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 4 hrs: P = 0.0001, 5 hrs; 
P = 0.0001, 6 hrs: P = 0.0001; 100µM: 2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 4 hrs: P = 
0.0001, 5 hrs: P = 0.0001, 6 hrs: P = 0.0001; 1mM: 2 hrs: P = 0.0001, 3 hrs: P = 0.0001, 
4 hrs: P = 0.0001, 5 hrs: P = 0.0001, 6 hrs: P = 0.0001. 
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Figure 19: The effects of commercial 2,4-D on ferritin light polypeptide (FTL) 
mRNA expression in exposed HepG2 cells.  Cells were exposed to 0 to 1mM of 2,4-D 
in complete growth media for 24 hrs.  Cells were harvested and RNA extracted.  Single-
stranded (SS) cDNA was produced using first strand synthesis; subsequently real time 
polymerase chain reaction assay was performed.  Target mRNA expression levels are 
presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, glyceraldehyde-6-phosphate dehydrogenase 
(GAPDH). 
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10 µM.  The highest magnitude of induction (1.06 fold) of FTL mRNA expression was 
observed in cells exposed to 100 µM or 1 mM.       
 
                     4.4.1.2 The effects of commercial 2,4-D on FTL mRNA expression 
                        in HEK293 cells 
Figure 20 illustrates that exposure to 2,4-D induces alterations in FTL mRNA 
expression.  A consistent pattern in mRNA expression was not observed over the 
concentrations tested.  The FTL mRNA expression was repressed in cells exposed to 1 
nM, 100 nM and 10 µM.  The highest degree of repression (0.22 fold) of mRNA 
expression was observed in cells exposed to 1 nM.  Induction of FTL mRNA expression 
was observed in cells exposed to 0.1 nM, 10 nM, 1 µM, 100 µM and 1 mM.  The highest 
degree of induction (4.33 fold) of mRNA expression was observed in cells exposed to 1 
mM.     
 
                     4.4.1.3 Comparison of the effects of commercial 2,4-D on FTL mRNA  
                                  expression in HepG2 and HEK293 cells 
Figure 21 illustrates that 2,4-D induces different effects on FTL mRNA 
expression in HepG2 and HEK293 cells.  A consistent pattern in mRNA expression in 
HepG2 or HEK293 cells was not observed over the concentrations tested.  With the 
exception of HEK293 cells exposed to 1 mM, 2,4-D induced less than 2 fold alterations 
in FTL mRNA expression in both HepG2 and HEK293 cells.   
 
            4.4.2 The effects of commercial 2,4-D on FTH1 mRNA expression in cells      
                     4.4.2.1 The effects of commercial 2,4-D on FTH1 mRNA expression 
             in HepG2 cells 
Figure 22 illustrates that 2,4-D induces less than 2 fold alterations (increases and 
decreases) in FTH1 mRNA expression at concentrations above 0.1 nM.  FTH1 mRNA 
expression was repressed (0.11 fold) in cells exposed to 1 nM.  FTH1 mRNA expression 
was induced by 1.28 fold (average) in cells exposed to concentrations equal to and 
greater than 10 nM.  A 1.58 fold increase induction of mRNA expression was observed 
in cells exposed to 100 µM.     
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Figure 20: The effects of commercial 2,4-D on ferritin light polypeptide (FTL) 
mRNA expression in exposed HEK293 cells.  Cells were exposed to 0 to 1mM of 2,4-
D in complete growth media for 24 hrs.  Cells were harvested and RNA extracted.  
Single-stranded (SS) cDNA was produced using first strand synthesis; subsequently real 
time polymerase chain reaction assay was performed.  Target mRNA expression levels 
are presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, glyceraldehyde-6-phosphate dehydrogenase 
(GAPDH). 
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Figure 21: Comparison of the effects of commercial 2,4-D on ferritin light 
polypeptide (FTL) mRNA expression in exposed HepG2 and HEK293 cells.  Cells 
were exposed to 0 to 1mM of 2,4-D in complete growth media for 24 hrs.  The HepG2 
and HEK293 cells were not simultaneously exposed to 2,4-D.  Cells were harvested and 
RNA extracted.  Single-stranded (SS) cDNA was produced using first strand synthesis; 
subsequently real time polymerase chain reaction assay was performed.  Target mRNA 
expression levels are presented as the mean of triplicate assays from one independent 
experiment; and are expressed relative to the expression level in control cell cultures, 
normalized to the expression level of the reference gene, glyceraldehyde-6-phosphate 
dehydrogenase (GAPDH). 
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Figure 22: The effects of commercial 2,4-D on ferritin heavy  polypeptide (FTH1) 
mRNA expression in exposed HepG2 cells.  Cells were exposed to 0 to 1mM of 2,4-D 
in complete growth media for 24 hrs.  Cells were harvested and RNA extracted.  Single-
stranded (SS) cDNA was produced using first strand synthesis; subsequently real time 
polymerase chain reaction assay was performed.  Target mRNA expression levels are 
presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, glyceraldehyde-6-phosphate dehydrogenase 
(GAPDH). 
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                     4.4.2.2 The effects of commercial 2,4-D on FTH1 mRNA expression 
                        in HEK293 cells 
 Figure 23 illustrates that exposure to 2,4-D induces alterations (< 2 fold) FTH1 
mRNA expression.  A consistent pattern in mRNA expression was not observed over the 
concentrations tested.  The FTH1 mRNA expression was repressed in cells exposed to 
concentrations less than 1 mM.  The greatest degree of repression (0.55 fold) of mRNA 
expression was observed in cells exposed to 10 µM.  Exposure to 1 mM induced (1.89 
fold) FTH1 mRNA expression.     
 
                     4.4.2.3 Comparison of the effects of commercial 2,4-D on FTH1 mRNA
            expression in HepG2 and HEK293 cells 
 Figure 24 illustrates that 2,4-D induces different effects on FTH1 mRNA 
expression in HepG2 and HEK293 cells.  The magnitudes of alterations in mRNA 
expression in HepG2 and HEK293 cells were less than 2 fold.  A consistent pattern in 
changes in mRNA expression in HepG2 or HEK293 cells was not observed over the 
concentrations tested.   
   
            4.4.3 The effects of commercial 2,4-D on PCNA mRNA expression in cells 
                     4.4.3.1 The effects of commercial 2,4-D on PCNA mRNA expression
             in HepG2 cells 
 Figure 25 illustrates that exposure to 2,4-D alters (< 2 fold) PCNA mRNA 
expression.  A consistent pattern in mRNA expression was not observed over the 
concentrations tested.  The PCNA mRNA expression was induced in cells exposed to 
0.1 nM to 100 µM.  The highest degree of induction (1.79 fold) in mRNA expression 
was observed in cells exposed to 100 µM.  Exposure to 1 mM repressed (0.47 fold) 
PCNA mRNA expression.      
 
                     4.4.3.2 The effects of commercial 2,4-D on PCNA mRNA expression 
                    in HEK293 cells 
 Figure 26 illustrates that exposure to 2,4-D induces changes (< 2 fold) in PCNA 
mRNA expression.  A consistent pattern in mRNA expression was not observed over the  
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Figure 23: The effects of commercial 2,4-D on ferritin heavy  polypeptide (FTH1) 
mRNA expression in exposed HEK293 cells.  Cells were exposed to 0 to 1mM of 2,4-
D in complete growth media for 24 hrs.  Cells were harvested and RNA extracted.  
Single-stranded (SS) cDNA was produced using first strand synthesis; subsequently real 
time polymerase chain reaction assay was performed.  Target mRNA expression levels 
are presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, glyceraldehyde-6-phosphate dehydrogenase 
(GAPDH). 
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Figure 24: Comparison of the effects of commercial 2,4-D on ferritin heavy 
polypeptide (FTH1) mRNA expression in exposed HepG2 and HEK293 cells.    
Cells were exposed to 0 to 1mM of 2,4-D in complete growth media for 24 hrs.  The 
HepG2 and HEK293 cells were not simultaneously exposed to 2,4-D.  Cells were 
harvested and RNA extracted.  Single-stranded (SS) cDNA was produced using first 
strand synthesis; subsequently real time polymerase chain reaction assay was performed.  
Target mRNA expression levels are presented as the mean of triplicate assays from one 
independent experiment; and are expressed relative to the expression level in control cell 
cultures, normalized to the expression level of the reference gene, glyceraldehyde-6-
phosphate dehydrogenase (GAPDH). 
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Figure 25: The effects of commercial 2,4-D on proliferating cell nuclear antigen 
(PCNA) mRNA expression in exposed HepG2 cells.  Cells were exposed to 0 to 1mM 
of 2,4-D in complete growth media for 24 hrs.  Cells were harvested and RNA extracted.  
Single-stranded (SS) cDNA was produced using first strand synthesis; subsequently real 
time polymerase chain reaction assay was performed.  Target mRNA expression levels 
are presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, glyceraldehyde-6-phosphate dehydrogenase 
(GAPDH). 
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Figure 26: The effects of commercial 2,4-D on proliferating cell nuclear antigen 
(PCNA) mRNA expression in exposed HEK293 cells.  Cells were exposed to 0 to 
1mM of 2,4-D in complete growth media for 24 hrs.  Cells were harvested and RNA 
extracted.  Single-stranded (SS) cDNA was produced using first strand synthesis; 
subsequently real time polymerase chain reaction assay was performed.  Target mRNA 
expression levels are presented as the mean of triplicate assays from one independent 
experiment; and are expressed relative to the expression level in control cell cultures, 
normalized to the expression level of the reference gene, glyceraldehyde-6-phosphate 
dehydrogenase (GAPDH). 
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concentrations tested.  The PCNA mRNA expression was induced (1.04 fold) in cells 
exposed to 0.1 nM.  Repression of PCNA mRNA expression was observed in cells 
exposed to 1 nM to 1 mM.  The highest degree of repression (0.40 fold decrease) of 
PCNA mRNA expression was observed in cells exposed to 10 µM. 
  
                     4.4.3.3 Comparison of the effects of commercial 2,4-D on PCNA mRNA
            expression in HepG2 and HEK293 cells 
 Figure 27 illustrates that 2,4-D induces different effects on PCNA mRNA 
expression in HepG2 and HEK293 cells.  The magnitudes of alterations in mRNA 
expression in HepG2 and HEK293 cells were less than 2 fold.  A consistent pattern in 
mRNA expression in HepG2 or HEK293 cells was not observed over the concentrations 
tested.   
  
      4.5 The effects of commercial 2,4-D on protein expression in cells 
 Western blot assays were performed to determine if exposure to environmental 
concentrations of 2,4-D would induce up-regulation of FTL, FTH1 and PCNA gene 
expression at the level of protein accumulation.  The expression of Hsp72, which is 
involved in cellular stress response (reviewed by Aufricht, 2005), was used as an 
additional marker of the potential induction of intracellular oxidative stress following 
2,4-D exposure.  Western blot assays are the conventional method used for detection of 
protein expression levels in cell and molecular research.   
 Horse spleen ferritin was used as a positive control in western blot assays to 
assess the efficacy of the anti-ferritin antibody.  The anti-ferritin antibody used in this 
study was anticipated to recognize both FTL and FTH1 polypeptide subunits.  However, 
only one subunit band was detected; either the FTL or FTH1 subunit.  Thus, the protein 
band that was detected was referred to as ferritin.   
 Target protein expression level in each sample was calculated relative to the 
expression level in control cell cultures, normalized to the expression level of the 
reference gene, GAPDH. 
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Figure 27: Comparison of the effects of commercial 2,4-D on proliferating cell 
nuclear antigen (PCNA) mRNA expression in exposed HepG2 and HEK293 cells.   
Cells were exposed to 0 to 1mM of 2,4-D in complete growth media for 24 hrs.  The 
HepG2 and HEK293 cells were not simultaneously exposed to 2,4-D.  Cells were 
harvested and RNA extracted.  Single-stranded (SS) cDNA was produced using first 
strand synthesis; subsequently real time polymerase chain reaction assay was performed.  
Target mRNA expression levels are presented as the mean of triplicate assays from one 
independent experiment; and are expressed relative to the expression level in control cell 
cultures, normalized to the expression level of the reference gene, glyceraldehyde-6-
phosphate dehydrogenase (GAPDH).   
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            4.5.1 The effects of commercial 2,4-D on ferritin protein expression in cells  
                     4.5.1.1 The effects of commercial 2,4-D on ferritin protein expression 
                  in HepG2 cells 
Figure 28 (A) and (B) illustrates that exposure to 2,4-D induces ferritin protein 
expression in HepG2 cell cultures.  The effect was not concentration-dependent.  The 
highest degree of induction (2.09 fold) of ferritin protein expression was observed in 
cells exposed to 10 µM.    
 
                     4.5.1.2 The effects of commercial 2,4-D on ferritin protein expression   
             in HEK293 cells 
Figure 29 (A) and (B) illustrates that exposure to 2,4-D alters (< 2 fold) ferritin 
protein expression.  A consistent pattern in protein expression was not observed.  
Ferritin protein expression was repressed in cells exposed to 0.1 to 10 nM, 1 µM to 1 
mM.  The greatest degree of repression (0.86 fold) of protein expression was observed in 
cells exposed to 1 mM.  Exposure to 100 nM induced a 1.13 fold increase in ferritin 
protein expression. 
 
                     4.5.1.3 Comparison of the effects of commercial 2,4-D on ferritin  
            protein expression in HepG2 and HEK293 cells 
 Figure 30 illustrates that 2,4-D elicits different effects on ferritin protein 
expression in HepG2 and HEK293 cell cultures.  Induction of ferritin protein expression 
was observed in HepG2 cells over the concentrations tested.  In contrast, inconsistent 
changes in protein expression were observed in HEK293 cells exposed to 0.1 nM to 1 
mM.  Exposure to 2,4-D induced less than 2 fold alterations in protein expression in 
HEK293, compared to HepG2 cells.   
 
            4.5.2 The effects of commercial 2,4-D on PCNA protein expression in cells 
                     4.5.2.1 The effects of commercial 2,4-D on PCNA protein expression                        
             in HepG2 cells 
Figure 31 (A) and (B) illustrates that exposure to 2,4-D alters (< 2 fold) PCNA 
protein expression.  A consistent pattern in protein expression was not observed over the  
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Figure 28: The effects of commercial 2,4-D on ferritin protein expression in 
exposed HepG2 cells.  Cells were exposed to 0 to 1mM of 2,4-D for 24 hrs.  Cells were 
harvested and protein lysates obtained.  Thirty µg of total proteins was separated by 
sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE).  Ferritin 
protein expression was detected using anti-ferritin antibody (rabbit polyclonal to ferritin, 
catalog number: ab7332; Novus Biologicals).  The ferritin protein band detected may 
have been either FTL (19kDa) or FTH1 (21kDa).  Equal loading was ensured through 
detection of glyceraldehyde-6-phosphate dehydrogenase (GAPDH) protein expression 
using anti-GAPDH antibody (mouse monoclonal to GAPDH, catalog number: MAB374, 
Chemicon International Inc.).  A representative western blot (A) of 3 replicates from one 
independent experiment is shown.  Results of densitometric analysis (B) are presented as 
the mean of triplicate assays from one independent experiment.  Target protein 
expression levels are presented as the mean of triplicate assays from one independent 
experiment; and are expressed relative to the expression level in control cell cultures, 
normalized to the expression level of the reference gene, GAPDH.   
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Figure 29: The effects of commercial 2,4-D on ferritin protein expression in 
exposed HEK293 cells.  Cells were exposed to 0 to 1mM of 2,4-D for 24 hrs.  Cells 
were harvested and protein lysates obtained.  Thirty µg of total proteins was separated 
by sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-PAGE).  Ferritin 
protein expression was detected using anti-ferritin antibody (rabbit polyclonal to ferritin, 
catalog number: ab7332; Novus Biologicals).  The ferritin protein band detected may 
have been either FTL (19kDa) or FTH1 (21kDa).  Equal loading was ensured through 
detection of glyceraldehyde-6-phosphate dehydrogenase (GAPDH) protein expression 
using anti-GAPDH antibody (mouse monoclonal to GAPDH, catalog number: MAB374, 
Chemicon International Inc.).  A representative western blot (A) of 3 replicates from one 
independent experiment is shown.  Results of densitometric analysis (B) are presented as 
the mean of triplicate assays from one independent experiment.  Target protein 
expression levels are presented as the mean of triplicate assays from one independent 
experiment; and are expressed relative to the expression level in control cell cultures, 
normalized to the expression level of the reference gene, GAPDH. 
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Figure 30: Comparison of the effects of commercial 2,4-D on ferritin protein 
expression in exposed HepG2 and HEK293 cells.  Cells were exposed to 0 to 1mM of 
2,4-D for 24 hrs.  The HepG2 and HEK293 cells were not simultaneously exposed to 
2,4-D.  Cells were harvested and protein lysates obtained.  Thirty µg of total proteins 
was separated by sodium dodecyl sulfate – polyacrylamide gel electrophoresis (SDS-
PAGE).  Ferritin protein expression was detected using anti-ferritin antibody (rabbit 
polyclonal to ferritin, catalog number: ab7332; Novus Biologicals).  The ferritin protein 
band detected may have been either FTL (19kDa) or FTH1 (21kDa).  Equal loading was 
ensured through detection of glyceraldehyde-6-phosphate dehydrogenase (GAPDH) 
protein expression using anti-GAPDH antibody (mouse monoclonal to GAPDH, catalog 
number: MAB374, Chemicon International Inc.).  Results of densitometric analysis are 
presented as the mean of triplicate assays from one independent experiment.  Target 
protein expression levels are presented as the mean of triplicate assays from one 
independent experiment; and are expressed relative to the expression level in control cell 
cultures, normalized to the expression level of the reference gene, GAPDH. 
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Figure 31: The effects of commercial 2,4-D on proliferating cell nuclear antigen 
(PCNA) protein expression in exposed HepG2 cells.  Cells were exposed to 0 to 1mM 
of 2,4-D for 24 hrs.  Cells were harvested and protein lysates obtained.  Ten µg of total 
proteins was separated by sodium dodecyl sulfate – polyacrylamide gel electrophoresis 
(SDS-PAGE).  The protein expression of PCNA was detected using anti-PCNA 
antibody (mouse monoclonal to PCNA, catalog number: SC-56, Santa Cruz 
Biotechnologies, Inc.).  Equal loading was ensured through detection of glyceraldehyde-
6-phosphate dehydrogenase (GAPDH) protein expression using anti-GAPDH antibody 
(mouse monoclonal to GAPDH, catalog number: MAB374, Chemicon International 
Inc.).  A representative western blot (A) of 3 replicates from one independent 
experiment is shown.  Results of densitometric analysis (B) are presented as the mean of 
triplicate assays from one independent experiment.  Target protein expression levels are 
presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, GAPDH. 
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concentrations tested.  The PCNA protein expression was repressed in cells exposed to 
0.1 to 100 nM, 1 µM, 100 µM and 1 mM.  Exposure to 1mM induced the greatest degree 
of repression (0.35 fold) of PCNA protein expression.  Exposure to 10 µM induced (1.05 
fold) protein expression. 
 
                     4.5.2.2 The effects of commercial 2,4-D on PCNA protein expression in  
            HEK293 cells 
Figure 32 (A) and (B) illustrates that exposure to 2,4-D induces (< 2 fold) PCNA 
protein expression.  Exposure to 1 mM induced the greatest degree of induction (1.90 
fold) of PCNA protein expression. 
 
                     4.5.2.3 Comparison of the effects of commercial 2,4-D on PCNA 
                       protein expression in HepG2 and HEK293 cells 
Figure 33 illustrates that exposure to 2,4-D elicits different effects on PCNA 
protein expression in HepG2 and HEK293 cell cultures.  The magnitudes of alterations 
in protein expression were less than 2 fold in HepG2 and HEK293 cells.  Induction of 
PCNA protein expression was observed in HEK293 cells over the concentrations tested.  
In contrast, inconsistent changes in protein expression were observed in HepG2 cells 
exposed to 0.1 nM to 1 mM.   
 
            4.5.3 The effects of commercial 2,4-D on Hsp72 protein expression in cells              
                     4.5.3.1 The effects of commercial 2,4-D on Hsp72 protein expression 
             in HepG2 cells 
Figure 34 (A) and (B) illustrates exposure to 2,4-D induces (< 2 fold) Hsp72 
protein expression.  Exposure to 1 mM induced the greatest degree of induction (1.45 
fold) of Hsp72 protein expression. 
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Figure 32: The effects of commercial 2,4-D on proliferating cell nuclear antigen 
(PCNA) protein expression in exposed HEK293 cells.  Cells were exposed to 0 to 
1mM of 2,4-D for 24 hrs.  Cells were harvested and protein lysates obtained.  Ten µg of 
total proteins was separated by sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis (SDS-PAGE).  The protein expression of PCNA was detected using anti-
PCNA antibody (mouse monoclonal to PCNA, catalog number: SC-56, Santa Cruz 
Biotechnologies, Inc.).  Equal loading was ensured through detection of glyceraldehyde-
6-phosphate dehydrogenase (GAPDH) protein expression using anti-GAPDH antibody 
(mouse monoclonal to GAPDH, catalog number: MAB374, Chemicon International 
Inc.).  A representative western blot (A) of 3 replicates from one independent 
experiment is shown.  Results of densitometric analysis (B) are presented as the mean of 
triplicate assays from one independent experiment.  Target protein expression levels are 
presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, GAPDH. 
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Figure 33: Comparison of the effects of commercial 2,4-D on proliferating cell 
nuclear antigen (PCNA) protein expression in exposed HepG2 and HEK293 cells.  
Cells were exposed to 0 to 1mM of 2,4-D for 24 hrs.  The HepG2 and HEK293 cells 
were not simultaneously exposed to 2,4-D.  Cells were harvested and protein lysates 
obtained.  Ten µg of total proteins was separated by sodium dodecyl sulfate – 
polyacrylamide gel electrophoresis (SDS-PAGE).  The protein expression of PCNA was 
detected using anti-PCNA antibody (mouse monoclonal to PCNA, catalog number: SC-
56, Santa Cruz Biotechnologies, Inc.).  Equal loading was ensured through detection of 
glyceraldehyde-6-phosphate dehydrogenase (GAPDH) protein expression using anti-
GAPDH antibody (mouse monoclonal to GAPDH, catalog number: MAB374, 
Chemicon International Inc.).  Results of densitometric analysis are presented as the 
mean of triplicate assays from one independent experiment.  Target protein expression 
levels are presented as the mean of triplicate assays from one independent experiment; 
and are expressed relative to the expression level in control cell cultures, normalized to 
the expression level of the reference gene, GAPDH. 
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Figure 34: The effects of commercial 2,4-D on the inducible form of heat shock 
protein (Hsp72) protein expression in exposed HepG2 cells.  Cells were exposed to 0 
to 1mM of 2,4-D for 24 hrs.  Cells were harvested and protein lysates obtained.  Thirty 
µg of total proteins was separated by sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis (SDS-PAGE).  The protein expression of Hsp72 was detected using anti-
Hsp72 antibody (rabbit polyclonal to Hsp70 (Hsp72), catalog number: SPA-812, 
Stressgen Bioreagents).  Equal loading was ensured through detection of 
glyceraldehyde-6-phosphate dehydrogenase (GAPDH) protein expression using anti-
GAPDH antibody (mouse monoclonal to GAPDH, catalog number: MAB374, 
Chemicon International Inc.).  A representative western blot (A) of 3 replicates from one 
independent experiment is shown.  Results of densitometric analysis (B) are presented as 
the mean of triplicate assays from one independent experiment.  Target protein 
expression levels are presented as the mean of triplicate assays from one independent 
experiment; and are expressed relative to the expression level in control cell cultures, 
normalized to the expression level of the reference gene, GAPDH. 
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                     4.5.3.2 The effects of commercial 2,4-D on Hsp72 protein expression
             in HEK293 cells 
Figure 35 (A) and (B) illustrates that 2,4-D alters (< 2 fold) Hsp72 protein 
expression.  A consistent pattern in protein expression was not observed over the 
concentrations tested.  The protein expression of Hsp72 was repressed in cells exposed 
to 0.1, 10 and 100 nM.  The greatest magnitude of repression (0.06 fold) of protein 
expression was observed in cells exposed to 0.1 nM.  Induction of Hsp72 protein 
expression was observed in cells exposed to 1 nM, 1 µM to 1 mM.  The greatest 
magnitude of induction (1.09 fold) of protein expression was observed in cells exposed 
to 1 mM.         
   
                     4.5.3.3 Comparison of the effects of commercial 2,4-D on Hsp72     
                       protein expression in HepG2 and HEK293 cells 
Figure 36 illustrates that 2,4-D elicits different effects on Hsp72 protein 
expression in HepG2 and HEK293 cell cultures.  The magnitudes of alterations in 
protein expression were less than 2 fold in HepG2 and HEK293 cells.  Induction of 
Hsp72 protein expression was observed in HepG2 cells over the concentrations tested.  
In contrast, inconsistent changes in protein expression were observed in HEK293 cells 
exposed to 0.1 nM to 1 mM.   
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Figure 35: The effects of commercial 2,4-D on the inducible form of heat shock 
protein (Hsp72) protein expression in exposed HEK293 cells.  Cells were exposed to 
0 to 1mM of 2,4-D for 24 hrs.  Cells were harvested and protein lysates obtained.  Thirty 
µg of total proteins was separated by sodium dodecyl sulfate – polyacrylamide gel 
electrophoresis (SDS-PAGE).  The protein expression of Hsp72 was detected using anti-
Hsp72 antibody (rabbit polyclonal to Hsp70 (Hsp72), catalog number: SPA-812, 
Stessgen Bioreagents).  Equal loading was ensured through detection of glyceraldehyde-
6-phosphate dehydrogenase (GAPDH) protein expression using anti-GAPDH antibody 
(mouse monoclonal to GAPDH, catalog number: MAB374, Chemicon International 
Inc.).  A representative western blot (A) of 3 replicates from one independent 
experiment is shown.  Results of densitometric analysis (B) are presented as the mean of 
triplicate assays from one independent experiment.  Target protein expression levels are 
presented as the mean of triplicate assays from one independent experiment; and are 
expressed relative to the expression level in control cell cultures, normalized to the 
expression level of the reference gene, GAPDH. 
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Figure 36: Comparison of the effects of commercial 2,4-D on the inducible form of 
heat shock protein (Hsp72) protein expression in exposed HepG2 and HEK293 
cells.  Cells were exposed to 0 to 1mM of 2,4-D for 24 hrs.  The HepG2 and HEK293 
cells were not simultaneously exposed to 2,4-D.  Cells were harvested and protein 
lysates obtained.  Thirty µg of total proteins was separated by sodium dodecyl sulfate – 
polyacrylamide gel electrophoresis (SDS-PAGE).  The protein expression of Hsp72 was 
detected using anti-Hsp72 antibody (rabbit polyclonal to Hsp70 (Hsp72), catalog 
number: SPA-812, Stressgen Bioreagents).  Equal loading was ensured through 
detection of glyceraldehyde-6-phosphate dehydrogenase (GAPDH) protein expression 
using anti-GAPDH antibody (mouse monoclonal to GAPDH, catalog number: MAB374, 
Chemicon International Inc.).  Results of densitometric analysis are presented as the 
mean of triplicate assays from one independent experiment.  Target protein expression 
levels are presented as the mean of triplicate assays from one independent experiment; 
and are expressed relative to the expression level in control cell cultures, normalized to 
the expression level of the reference gene, GAPDH. 
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5. DISCUSSION 
 The cytotoxic effects of low environmental concentrations (0.1 to 100 nM) of 
2,4-D were investigated in the present study.  The major findings from the present 
investigation were low environmental concentrations of 2,4-D (1) induce limited 
cytotoxic effects, reflected by small decreases in HepG2 and HEK293 cell viability that 
are independent of the duration of exposure, (2) induce cell specific viability effects (3) 
do not induce significant ROS production in exposed cells and (4) induce inconsistent 
patterns of alterations (< 2 fold increases and decreases) in FTL, FTH1 and PCNA gene 
expression, at the levels of mRNA and protein accumulation.   
 Cell viability studies revealed that low environmental concentrations (0.1 to 100 
nM) induce limited, but statistically significant (P<0.05) cytotoxic effects in HepG2 
(Figs. 1 and 3 (A to C)) and HEK293 cells (Figs. 6 and 8 (A to C)), as reflected by small 
decreases (mean decreases in cell viability < 20%) in cell viability.  Cytotoxic effects 
were exacerbated (mean decreases in viability > 40%) at higher concentrations (5 and 10 
mM).  Decreases in viability were not concentration-dependent and did not change 
significantly when durations of exposure were increased in cells exposed to the 
concentration range of 0.1 to 100 nM.  Statistically significant (P<0.05) increases in cell 
viability were observed in HepG2 cells exposed to 1mM of technical 2,4-D for 72 hrs 
(Fig. 1(D)) and commercial 2,4-D for 24 to 72 hrs (Fig. 3 (B) to (C)).  Both forms of 
2,4-D (i.e. technical or commercial) induced similar cell viability effects within 
individual cell types (i.e HepG2 or HEK293 cells) suggesting that toxicity was induced 
directly by 2,4-D and ‘inert ingredients’ in the commercial formulation had limited 
ability to act synergistically with 2,4-D and enhance toxic effects in exposed cells.  An 
inert ingredient is a substance other than an active ingredient that is added to a herbicide 
formulation and plays a role in its effectiveness (i.e. better absorption, longer shelf-life) 
(US EPA, 2006).    
 Compared to HepG2, HEK293 cells appeared to be more susceptible to the toxic 
effects of either form of 2,4-D, reflected by a more pronounced reduction in cell 
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viability (Figs. 11 and 12 (A to D)).  At all exposure times, mean decreases in HEK293 
cell viability were 4 to 26% greater in magnitude, as compared to HepG2 cell viability 
over the range of 2,4-D concentrations used (0.1 nM to 10 mM).  The differences 
between HepG2 and HEK293 cell viability effects at all concentrations and durations of 
treatment were statistically significant (P<0.05).    
 Results from ROS studies revealed that low environmental concentrations of 2,4-
D do not induce significant ROS production in exposed cells.  Statistically significant 
(P<0.05) ROS production was observed at concentrations greater than 10 µM and 100 
nM in HepG2 (Fig. 16) and HEK293 (Fig. 17) cells, respectively.  ROS production was 
concentration-dependent in HepG2 and HEK293 cells.  ROS production increased with 
longer durations of exposure.  Figure 18 illustrates that ROS production was consistently 
50 to 70% less in HEK293, compared to HepG2 cells, at all concentrations and times.   
 Preliminary results from the present study reveal that exposure to low 
environmental concentrations of 2,4-D induce alterations (> 2 fold increases and 
decreases) in FTL (Figs. 19 and 20), FTH1 (Figs. 22 and 23) and PCNA (Figs. 25 and 
26) mRNA expression in exposed HepG2 and HEK293 cells.  A concentration-
dependent increase or decrease in mRNA accumulation was not observed in cells 
exposed to the range of environmentally realistic concentrations of 2,4-D.   
 Preliminary studies of ferritin and PCNA protein expression reveal that exposure 
to low environmental concentrations of 2,4-D induce alterations (< 2 fold increases and 
decreases) in ferritin (Figs. 28 and 29) and PCNA (Figs. 31 and 32) protein expression in 
HepG2 and HEK293 cells.  A concentration-dependent increase or decrease in protein 
accumulation was not observed in cells exposed to the range of environmentally realistic 
concentrations of 2,4-D.   
  The present study is the first to report that low environmental concentrations of 
2,4-D decrease HepG2 and HEK293 cell viability.  Previous in vivo and in vitro 2,4-D 
toxicological studies have utilized high concentrations of 2,4-D (see section 2.1.6.1 to 
2.1.6.9) and have not directly tested concentrations found in the environment.  
Bharadwaj et al. (2005) assessed the cytotoxic effects of 2,4-D in HepG2 cells using the 
same low concentrations and commercial form of 2,4-D that was used in the present 
study.  However it was illustrated that exposure to low concentrations of 2,4-D for 24 
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hrs did not induce statistically significant decreases in HepG2 cell viability.  Compared 
to the present study, the decreases in cell viability that were observed by Bharadwaj et 
al. (2005) were approximately 20% greater in magnitude.  The differences in the 
reported significance of results in the studies performed by Bharadwaj et al. (2005) and 
the present investigation may have been due to the different statistical multiple 
comparison tests that were used to determine significant differences in treatment effects 
between control and treated groups in the two studies.  Bharadwaj et al. (2005) used 
ANOVA followed by a student Neuman-Keul’s post-hoc test and the present study used 
ANOVA followed by a two-sided Dunnett’s t-test.  In contrast to a student Neuman-
Keul’s post-hoc test, Dunnett’s t-test is a t-statistic test that is considered to be less 
conservative indicator for the detection of differences between control and treated 
groups (Lane, 1997).  The power of a statistical test is the probability that the test will 
reject the null hypothesis (High, 2000).   
 Decreases in HepG2 and HEK293 cell viability were not dependent on duration 
of exposure to 0.1 to 100 nM.  In humans, 2,4-D has an average t½ of 17.7 hrs (Sauerhoff 
et al., 1977).  Sauerhoff et al. (1977) reported that following oral exposure, 
approximately 82.3% of 2,4-D was eliminated unchanged and 12.8% was  excreted as an 
unidentified conjugate in urine.  Therefore, it is possible that in the present study, more 
pronounced decreases in HepG2 and HEK293 cell viability were not observed following 
longer durations of exposure due to the rapid intracellular metabolism of 2,4-D to non-
toxic 2,4-D conjugates and elimination from cells that may have occurred, in vitro, prior 
to the exposure time points of 24, 48 and 72 hrs.   
 The significant increases in HepG2 cell viability observed following exposure to 
1mM of either form of 2,4-D was a unique observation in the present study that has not 
been observed in previous studies investigating the effects of 2,4-D on cell viability, in 
vitro.  For instance, using the neutral red assay, Bharadwaj et al. (2005) illustrated that 
24 hrs of exposure to 1 mM of commercial 2,4-D (the same commercial form used in the 
present study) induced a significant decrease (70%) in HepG2 cell viability.  Kaioumova 
et al. (2001b) reported that approximately 45 and 55% of Jurkat T cells underwent 
apoptosis following exposure to 1 mM of 2,4-D DMA for 24 hrs, as determined by the 
nicoletti and annexin-V assays, respectively.  The significant increases in HepG2 cell 
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viability observed following exposure to 1 mM of 2,4-D may be due to the reasons 
outlined below.  
 The Resazurin assay is a relatively non-toxic (O’Brien et al., 2000) reductase-
based assay that is easy to use and inexpensive (McMillian et al., 2002).  The Resazurin 
assay is the most sensitive assay, compared to other assays (i.e. MTT, neutral red assay) 
for determination of cytotoxicity (Davoren et al., 2007), in vitro.  The basis of this 
fluorometric assay is the enzymatic reduction of Resazurin (blue and non-fluorescent) to 
resorufin (pink and highly-fluorescent) (O’Brien et al., 2000).  Compared to dead or 
dying cells, viable cells are able to reduce Resazurin to resofurin (McWilliams et al., 
2002; Miret et al., 2006; O’Brien et al., 2000).   Thus, fluorescence is more pronounced 
in viable cells, compared to dead or dying cells.  However, O’Brien et al. (2000) 
explained that viable cells may further reduce resorufin (pink and highly-fluorescent) to 
hydroresorufin (colourless and non-fluorescent).  According to O’Brien et al. (2000), if 
viable cells further reduce resorufin to hydroresorufin then fluorescence will be more 
pronounced in dead or dying cells, compared to viable cells.  Thus, in the present study, 
if viable cells reduced resorufin to hydroresorufin, then fluorescence may have been 
more pronounced in dead or dying cells, compared to viable cells.  Therefore, in the 
present study, the increases in fluorescence that were observed in cells exposed to the 
toxic concentrations of 1 mM of 2,4-D may have been a reflection of decreased cell 
viability and not increased cell viability, relative to untreated control cell cultures as 
interpreted.  Compared to untreated control cell cultures, more pronounced fluorescence 
was not observed at concentrations below 1 mM.  However, in the present study, the 
theory that viable cells may have further reduced resorufin to hydroresorufin is 
challenged by the less pronounced fluorescence that was observed following exposure to 
toxic concentrations of 5 and 10 mM, compared to 1 mM of either form of 2,4-D for all 
durations of exposure.  In the present study, if viable cells were able to further reduce 
resorufin to hydroresorufin, then, theoretically, increased cell death at toxic 
concentrations of 5 and 10 mM should have been represented by more pronounced 
fluorescence, compared to concentrations equal to and lower than 1 mM.   
An increase in HepG2 cell proliferation could be the second reason for the 
increased fluorescence observed at 1 mM.  An increase in cell proliferation may have 
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been induced by exposure to 1 mM.  O’Brien et al. (2000) illustrated that there was a 
good correlation between HepG2 cell number and Resazurin reduction.  According to 
the authors, increased fluorescence indicates increased reduction of Resazurin to 
resofurin, which in turn reflects an increased cell number.  2,4-D is considered to be a 
peroxisome proliferator (Ge et al., 2002) and has been shown to induce proliferation of 
rat hepatic peroxisomes (Vainio et al., 1983) and human peripheral blood lymphocytes 
(Figgs et al., 2000; Holland et al., 2002).  Significant proliferation of lymphocytes was 
observed at a 2,4-D exposure concentration of 5 µM (Holland et al., 2002).  Thus, in the 
present study, 1 mM may have induced proliferation of HepG2 cells, which would have 
resulted in increased fluorescence due to increased reduction of Resazurin to resorufin.  
However, Bharadwaj et al. (2005) illustrated that exposure to 1mM of commercial 2,4-D 
(the same commercial form of 2,4-D used in the present study) induced a 50% decrease 
in HepG2 cell proliferation.  Furthermore, the decreased fluorescence observed 
following exposure to 5 and 10 mM, compared to 1 mM for 6 to 72 hrs is in 
disagreement with the theory that increased Resazurin reduction to resofurin reflects 
increased cell proliferation.  The reason(s) for the apparent increase in cell viability in 
HepG2 cells exposed to 1 mM of 2,4-D presently remains unclear, as the increases in 
fluorescence in cells at this exposure concentration, relative to untreated control cell 
cultures may be due to the biochemical characteristic (i.e. further reduction of resorufin 
to hydroresorufin by viable cells) of the assay or increased cell proliferation.   
  Figures 11 and 12 (A to D) illustrate that compared to HepG2, HEK293 cells 
appeared to be more susceptible to the toxic effects of either form of 2,4-D, reflected by 
more pronounced decreases in cell viability.  The first reason that may account for the 
more pronounced decreases observed in HEK293 may be due to differences in the 
biotransformation system of HepG2 and HEK293 cells.  Eaton and Klaassen. (2001) 
explained that one of the main reasons why chemicals exert different degrees of toxicity 
between organs is due to the differences in the biotransforming ability of various organs.  
The biotransforming ability ultimately determines the differences in the accumulation of 
the ultimate toxicant in organs (Eaton and Klaassen, 2001).  Xenobiotic 
biotransformation is the principal mechanism that is responsible for maintaining 
homeostasis during exposure to xenobiotics (Parkinson, 2001).  In humans, xenobiotics 
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undergo biotransformation, which generally changes the physical properties of a 
chemical to favor increased hydrophilicity and subsequent excretion in the urine or feces 
(Parkinson, 2001).  Almost all tissues in the human body are able to carry out 
biotransformation reactions (Riddick, 1998).  The liver is described as the most 
important organ of biotransformation (Riddick, 1998).   
 There are two phases of biotransformation (phase I and II) (Parkinson, 2001; 
Riddick, 1998).  Phase I reactions induce small increases the hydrophilicity of a 
xenobiotic (Parkinson, 2001), by introducing or exposing a functional group via 
oxidation, reduction or hydrolysis (Riddick, 1998).  The reactions increase, maintain or 
decrease the activity of the compound (Riddick, 1998).  Phase II reactions consists of 
synthetic or conjugation processes (Parkinson, 2001).  In phase II reactions, an 
endogenous compound (i.e. glutathione, glycine, taurine) combines with the functional 
group (originally present in the xenobiotic or introduced or unmasked in the phase I 
reaction (Parkinson, 2001)) of the xenobiotic (Parkinson, 2001).  Xenobiotics may 
undergo Phase I and II reactions sequentially; however there are exceptions to that order 
(Parkinson, 2001; Riddick, 1998).  Some xenobiotics may only undergo either a phase I 
or II reaction followed by elimination from the body (Riddick, 1998).  Some xenobiotics 
are eliminated unchanged, without prior biotransformation. 
 The chemical, 2,4-D acid, having a partition coefficient (Kow) of 2.81 (reviewed 
by EXTOXNET, 1996) is a hydrophobic compound and theoretically should be 
biotransformed in humans, to enhance its hydrophilicity and subsequent elimination.  
There is controversy regarding whether or not 2,4-D is biotransformed in humans.  
Gregus et al. (1999) and Van Ravenzwaay et al. (2003) explained that 2,4-D does not 
require biotransformation prior to its elimination in humans and following oral exposure, 
82.3% of 2,4-D is eliminated unchanged in the urine of humans (Sauerhauff et al., 
1977).  Also, it has been reported that 12.8% of 2,4-D is  excreted in the urine as an 
unidentified conjugate (Sauerhauff et al., 1977).  It has been illustrated that dietary 
exposure to 2,4-D acid induces the activity of epoxide hydrolases (phase II 
biotransformation enzymes) in the livers of mice (Lundgren et al., 1987).  Taurine and 
glycine conjugates of 2,4-D have been identified in the bile of rats and mice (Griffin et 
al., 1997) exposed to the chemical via intragastric injection.  In vitro studies performed 
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by Li et al. (2003) illustrated that 2,4-D may form a 2,4-D-CoA reactive metabolite.  Li 
et al. (2003) illustrated that synthetic 2,4-D CoA forms a glutathione conjugate or 
alternatively, it covalently binding to rat hepatic proteins, in vitro.  The results of current 
literature suggest that 2,4-D may undergo both phase I and II reactions, or only phase II 
reactions.  So how is this all relevant to the present study?   
 HepG2 and HEK293 cells are both metabolically active cells.  HepG2 cells have 
retained high levels of biotransforming enzymes (Mersch-Sundermann et al., 2004).  
Parknison. (2001) explained that biotransformation enzymes are present in large 
amounts in the liver, and to a lesser degree in other organs including the lung, eye, 
pancreas and kidney.  The promoter activity of several isoforms of the uridine 
diphosphate – glucuronsyltransferase (UGT) genes was recently found to be decreased 
in HEK293, compared to HepG2 cells (Gardner-Stephen and Mackenzie, 2007).  UGT is 
a biotransformation enzyme responsible for Phase II glucuronidation reactions 
(Parkinson, 2001; Riddick, 1998).  Therefore there are enormous differences between 
tissues in their ability to biotransform xenobiotics (Parkinson, 2001).  These differences 
may subsequently contribute to the different degrees or patterns of toxic effects induced 
by xenobiotics in different tissues/organs.  Thus, in the present study, the 
biotransformation enzyme(s) responsible for the detoxification of 2,4-D may have been 
absent or reduced in HEK293, compared to HepG2 cells.  The above may explain the 
enhanced susceptibility of HEK293 cells to 2,4-D toxicity, compared to HepG2 cells.   
The enhanced active transportation of 2,4-D into HEK293 cells may also  explain 
the more pronounced decreases that were observed in HEK293, relative to HepG2 cell 
viability.  In vivo and in vitro experimental studies performed by Charles et al. (2001) 
and González et al. (2005) suggest that in humans, various forms of 2,4-D (i..e 2,4-D 
DMA, 2,4-D ester) undergo rapid metabolic conversion to 2,4-D acid.  The 2,4-D acid is 
ionized at physiologic pH, and hence does not diffuse into cells (Garabrant and Philbert, 
2002).  The 2,4-D anion is actively transported into cells, including those of the liver and 
kidney by the organic anion transporter system (Pritchard et al., 1982).  This transport 
system may facilitate the rapid elimination of xenobiotics, and could favour the 
increased intracellular accumulation of foreign molecules (i.e 2,4-D) and subsequently 
increase toxic effects in cells that possess the transport system (Pritchard et al., 1982).  
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Results from experimental studies have identified several organic anion transporters that 
are specific to the kidney, and are responsible for the uptake of 2,4-D in rats and mice 
(Hasegwawa et al., 2003; Imaoka et al., 2004; Younghood and Sweet, 2004).  These 
organic anion transporters were not found to be expressed in other tissues, including the 
liver (Imaoka et al., 2004; Younghood and Sweet, 2004).  Therefore, in the present 
study, the increased toxicity observed in HEK293 cells may have been due in part to 
increased uptake and subsequent accumulation of 2,4-D in HEK293, compared to 
HepG2 cells.  
The mechanisms of 2,4-D toxicity have yet to be fully elucidated.  Results from 
previous experimental studies suggest that ROS and associated oxidative stress may be 
one potential mechanism involved in 2,4-D cytotoxicity.  Recently it has been shown 
that 2,4-D alters the activity of antioxidant enzymes and glutathione levels in human 
erythrocytes (Bukowska, 2003) (see section 2.1.7.5).  It has also been illustrated that 2,4-
D induces lipid peroxidation in isolated rat hepatocytes (Palmeira et al., 1995) and 
directly induced ROS (hydroxyl radicals) production and associated oxidative stress in 
yeast (Teixeira et al., 2004) (see section 2.1.7.5).  In this present study, the potential role 
of ROS in 2,4-D – induced cytotoxicity was investigated.  For the very first time, it was 
shown that high concentrations of 2,4-D directly induces significant intracellular ROS 
production in human cell cultures (HepG2 and HEK293).  Figure 18 illustrates that 
reduced amounts of ROS were produced in HEK293, compared to HepG2 cells, at all 
concentrations and durations of exposure tested.  The difference in ROS production that 
was observed between HepG2 and HEK293 cells may have been due to differences in 
the antioxidant defense systems between the two cells.  All eukaryotic aerobic cells have 
tremendous antioxidant systems, such as vitamins (C and E) and enzymes (SOD, 
catalase, GSH-Px) (reviewed by Kehrer, 1993; Kohen and Nyska, 2002) that are 
responsible for the detoxification of ROS.  However, there may be variations in 
antioxidant levels or responses between cell types.  Szymonik-Lesiuk et al. (2003) 
illustrated that there are variations in antioxidant levels and responses between rat 
tissues (brain, liver, kidney and heart) following exposure to carbon tetrachloride (an 
inducer of oxidative stress).  Thus, in the present study, antioxidant levels or responses 
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may have differed between HepG2 and HEK293 cells.  Therefore, greater amounts of 
ROS may have been detoxified in HEK293, compared to HepG2 cells.   
However, cell viability studies demonstrated that HEK293 cells were more 
susceptible to 2,4-D toxicity, compared to HepG2 cells.  So why did ROS studies 
indicate that less ROS was produced in HEK293, compared to HepG2 cells?  The 
answer may be due to the biochemical nature of the ROS assay.  In contrast to O2.- and 
OH., H2O2 is considered to be the primary ROS responsible for the oxidation of the non-
fluorescent 2’,7’-DCFH molecule to the fluorescent 2’7’-DCF molecule (Bass et al., 
1983).  It has recently been shown that O2.- oxidizes the 2’,7’-DCFH molecule, but to a 
lesser degree than H2O2 (Hempel et al., 1999).  Therefore, compared to HepG2, more 
O2.- and OH. species may have been produced in HEK293 cells resulting in less 
oxidation of 2’,7’-DCFH to 2’,7-DCF and less fluorescence.  Nevertheless, the 
observation that 2,4-D directly induces ROS production in HepG2 and HEK293 cells is 
an intriguing one, that suggest a potential role for ROS and associated oxidative stress in 
2,4-D – induced cytotoxicity.   
 The results from RT-PCR assays revealed that 24 hrs of exposure to low 
environmental concentrations (0.1 to 100 nM) of commercial 2,4-D induces alterations 
(< 2 fold increases and decreases) in FTL and FTH1 mRNA expression in HepG2 and 
HEK293 cells.  A concentration-dependent increase or decrease in mRNA expression 
was not observed over the concentration range of 0.1 nM to 1 mM.  The regulation of 
mammalian ferritin gene expression is complex and poorly understood (Torti and Torti, 
2002).  Previously, studies have illustrated that ferritin expression was mainly regulated 
at the translational level in response to intracellular levels of iron (Arosio and Levi, 
2002; Leibold and Guo, 1992).  However, ferritin expression may also be regulated at 
the transcriptional level in response to increased iron levels (Tacchini et al., 1997; White 
and Munro, 1988).  Several studies illustrate that in addition to iron, several other 
regulatory factors (i.e. tumor necrosis factor (TNF), oxidative stress, and ROS (O2.- and 
H2O2)) may also be directly involved in the regulation of ferritin gene expression at the 
transcriptional or translational levels (for review see Torti and Torti, 2002).  Several 
authors have suggested that increases in FTL and FTH1 mRNA and protein expression 
may be responsive to oxidative stress (Balla et al., 1992; Cairo et al., 1995; Epsztejn et 
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al., 1999; Lin and Girotti, 1997; Orino et al., 2001; Regan et al., 2002; Tsuji et al., 
2000).  Tsuji et al. (2000) explain that the increase in transcription of cytoprotective 
genes in response to oxidative challenge is termed the antioxidant response.  Currently, 
there is an absence of relevant and supportive scientific literature to explain the 
repression of FTL and FTH1 mRNA expression that was observed in HepG2 (FTL 
mRNA: 0.1 nM to 1 µM; FTH1 mRNA: 1 nM) and HEK293 (FTL mRNA: 1 nM, 100 
nM and 10 µM; FTH1 mRNA: 0.1 nM to 100 µM) cells.  However, in the present study, 
the observed increases in FTL and FTH1 mRNA expression may have been a 
cytoprotective response to ROS production and associated intracellular oxidative stress 
in HepG2 (FTL mRNA: concentrations > 1 µM, FTH1 mRNA: concentrations > 1 nM) 
and HEK293 (FTL mRNA: 0.1 nM, 1 µM, 100 µM and 1 mM; FTH1 mRNA: 1 mM) 
cells.  
The more pronounced magnitude of increases in FTL mRNA expression in 
HEK293 may be due to the action of O2.- on ferritin protein. Biemond et al. (1984) 
illustrates that O2.- derived from polymorphonuclear leukocytes mobilizes iron from 
human ferritin.  Subsequent studies (Thomas et al. (1985) and Agrawal et al. (2001)) 
illustrated that O2.- induces the release of iron from ferritin protein, in vitro.  The release 
of iron being mediated by the reduction of Fe3+ to Fe2+ by O2.- and subsequent release 
from the ferritin molecule (Agrawal et al., 2001).  Biemond et al. (1986) and Thomas 
and Aust. (1985) illustrated that O2.- produced by xanthine oxidase releases iron from 
ferritin during the conversion of xanthine to uric acid.  Furthermore, Biemond et al. 
(1986) illustrated that, compared to H2O2 or OH., O2.- is specifically responsible for 
release of iron from ferritin and the release was inhibited by superoxide dismutase, an 
enzyme that is specifically involved in the detoxification of O2.- (Gregus and Klaassen, 
2001).  Therefore, in the present study, the possible increased presence of O2.- in 
HEK293 cells may have served as a fuel for increased ROS production and associated 
oxidative stress via release of iron from ferritin.  The increased concentration of released 
iron may have been subsequently involved in the generation of noxious ROS via its 
participation in the Haber-Weiss reaction.  The effect may have induced more 
pronounced increase in FTL mRNA expression in HEK293, compared to HepG2 cells as 
an antioxidant response. 
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Results from western blot and densitometric analyses illustrated that low 
environmental concentrations of 2,4-D induces alterations (< 2 fold increases and 
decreases) in ferritin protein expression in HepG2 (Fig. 28 (A) and (B)) and HEK293 
(Fig. 29 (A) and (B)).  The induction of ferritin protein expression in HepG2 and 
HEK293 cells may have been a protective response to increased ROS production and 
possible oxidative stress conditions.  The induction of ferritin protein expression serves 
as a protective mechanism against oxidative stress via sequestration of excess free iron.  
Excess free iron participates in Haber-Weiss reaction to produce noxious ROS and 
associated oxidative stress conditions (Biemond et al., 1988; Chiancone et al., 2004; 
Harrison and Arosio, 1996; McCord, 1998; Papanikolaou and Pantopoulos, 2005).  
Ferritin expression is known to be regulated at the translational level in response to 
intracellular levels of iron (Arosio and Levi, 2002; Leibold and Guo, 1992).  Several 
studies have shown that ferritin protein expression may also be regulated at the 
translational level in response to increased intracellular ROS production and associated 
oxidative stress (Balla et al., 1992; Epsztejn et al., 1999; Lin and Girotti, 1997; Orino et 
al., 2001; Regan et al., 2002; Tacchini et al., 1997; Tsuji et al., 2000) (see section 2.2.3).  
In the present study, the increased expression of ferritin protein in exposed cells may 
have been a protective response to increased ROS production and possible oxidative 
stress conditions.   
The degradation of oxidized ferritin protein may have been a possible reason for 
the above observed repression of ferritin protein expression that was observed in 
HEK293 cells (0.1 nM to 10 nM, 1 µM to 1 mM).  The ROS can cause oxidative 
damage to proteins (for review see Kohen and Nyska, 2002).  Oxidized proteins are then 
targeted for proteolytic degradation (Davies et al., 2001).  Rudeck et al. (2000) have 
shown that exposure to oxidants including H2O2, induce ferritin protein degradation in 
human erythrocytes.  In the present study it was shown that 2,4-D exposure induced 
ROS production in both HepG2 and HEK293 cells.  The production of ROS may also 
have induced some oxidative damage to ferritin protein in HepG2 cells exposed to 
concentrations of 100 µM and 1 mM, as the magnitude of increases in ferritin protein 
expression in HepG2 cells decreased over the concentration range of 10 µM to 1 mM.     
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 Similar to FTL and FTH1, the induction of PCNA mRNA expression in HepG2 
(0.1 nM to 100 µM) and HEK293 (0.1 nM) cells may have been a response to oxidative 
DNA damage.  Repression of PCNA mRNA expression was also observed in HepG2 (1 
mM) and HEK293 (concentrations < 0.1 nM) cells.  However the reasons for the 
repression of PCNA mRNA expression in HepG2 and HEK293 cells in the present study 
remains unclear due to a lack of relevant and supportive scientific literature.  The 
protein, PCNA, an acidic nuclear protein (Mathews et al., 1984) plays an integral role in 
nucleic acid metabolism (Kelman, 1997), including DNA replication, repair and cell 
cycle regulation (Kelman, 1997; Schurtenberger et al., 1998).  Several in vivo and in 
vitro experimental studies utilized PCNA protein expression as a potential marker of 
oxidative DNA damage (Balajee et al., 1999; Holmes et al., 2002; Savio et al., 1998) 
(see section 2.3.3).   
Repression (< 2 fold) of PCNA protein expression was observed in HepG2 cells 
exposed to 0.1 nM to 1 µM, 100 µM and 1 mM.  Induction (< 2 fold) of PCNA protein 
expression was observed in HepG2 (10 µM) and HEK293 (0.1 nM to 1 mM) cells.  
Increased PCNA protein expression has been observed in response to oxidative stress 
(Balajee et al. (1999), Holmes et al. (2002) and Savio et al. (1998)) (see section 2.3.3).  
The authors suggest that due to its involvement in DNA repair, the induction of PCNA 
protein expression may be indicative of oxidative damaged DNA.  Therefore, in the 
present study it may have been possible that the increased ROS production in HEK293 
cells resulted in oxidative damage to DNA, which subsequently induced PCNA protein 
expression to aid in the repair of damaged DNA.  If this is true, then why did 2,4-D 
repress PCNA protein expression in HepG2,  compared to HEK293 cells?   In the 
present investigation, ROS studies illustrated that 2,4-D induced ROS production in both 
cell types, with more pronounced production in HepG2, compared to HEK293 cells.  A 
possible reason for the intracellular repression of PCNA protein expression may be due 
to the increased expression of the protein, p21.  As a protective mechanism during 
oxidative stress, there is activation of mechanisms that arrest the progression of the cell 
cycle at specific checkpoints (Russo et al., 1995).  The arrest in cell cycle progression 
allows time for the repair of damaged DNA (Russo et al., 1995).  The results from 
several in vitro studies have shown that oxidative stress induces G1 arrest in human lung 
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epithelial (Gehen et al., 2007; Rancourt et al., 2001) and human colon carcinoma cells 
(Helt et al., 2001).  Tuschl and Schwab. (2003) and (2004) reported that exposure to 4, 8 
and 16 mM of 2,4-D acid for 24 hrs induced G1 arrest in HepG2 cell cycle.  The 
activation of G1 arrest during oxidative stress is mediated through p53 tumor suppressor 
protein (Russo et al., 1995).  The p53 transcription factor subsequently binds to the 
promoter regions of several genes, with activation of gene transcription (Russo et al., 
1995).  Russo et al. (1995) explains that the gene, WAF1/CIP1 is amongst the genes 
whose transcription is activated by p53.  The WAF1/CIP1 gene encodes a 21kDa protein 
(p21) that is required for progression from G1 into S phase of the cell cycle (Russo et 
al., 1995).  The enhanced expression of p21 protein during oxidative stress inhibits 
PCNA-dependent DNA synthesis (Gehen et al., 2007).  Bendjennat et al. (2003) 
illustrated that p21 inhibited PCNA-dependent DNA synthesis by inhibiting PCNA 
loading onto DNA.  However, Gehen et al. (2007) illustrated that during oxidative stress 
conditions, in addition to inhibiting PCNA function, p21 directly controlled the 
abundance of PCNA protein.  Thus, in the present study, enhanced intracellular ROS 
production and associated oxidative stress may have induced more pronounced increases 
in p21 protein expression and reduction of PCNA protein abundance in HepG2, 
compared to HEK293 cells. 
Results from western blot and densitometric analyses from the present study 
illustrated that low environmental concentrations of 2,4-D induce alterations (< 2 fold) 
in Hsp72 protein expression in HepG2 (Fig. 34 (A) and (B)) and HEK293 (Fig. 35 (A) 
and (B)).  Induction of Hsp72 protein expression was observed in HEK293 exposed to 1 
nM.  Induction of Hsp72 protein expression in HepG2 and HEK293 cells may have been 
a protective response to increased ROS production and possible oxidative stress 
conditions.  Hsp72 belongs to the family of heat shock protein 70 (Hsp70) (for review 
see Morimoto et al., 1992; Pelham et al., 1986).  The protein family is involved in 
several intracellular processes, including signal transduction, cell cycle regulation, cell 
differentiation and programmed cell death (Mayer and Bukau, 2005).  There is a 
diversity of physiological and chemical conditions that induce Hsp biosynthesis.  The 
conditions that result in Hsp70 gene expression are classified into three categories; (1) 
environmental stress (i.e. heat shock, amino acid analogues, transition heavy metals), (2) 
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pathophysiological state (i.e. fever, inflammation, ischemia, viral and bacterial infection 
and (3) non-stressful conditions (i.e. normal cell growth and differentiation) (for review 
see Morimoto et al., 1992).  Morimoto et al. (1992) have explained that Hsp72 protein 
expression may be induced by oxidative stress.  
 In humans, Hsp72 gene expression is regulated at the transcriptional level in 
response to binding of the heat shock transcriptional factor 1 (HSF1) to the heat shock 
element (HSE) in the promoter region of the Hsp72 gene (Baler et al., 1992).  Briefly, 
under normal, non-stressed conditions HSF is maintained in a non-DNA binding form 
through interactions with Hsp70 proteins.   In contrast, in response to stress, the 
accumulation of misfolded or abnormal proteins competes with HSF for binding to 
Hsp70 proteins.  The released HSF undergoes oligomerization to its DNA binding form.  
The HSF subsequently binds to HSE, with increased transcriptional activity of the 
Hsp70 gene.  The return to normal un-stressed conditions results in the dissociation of 
HSF from DNA and the conversion of HSF to its non-DNA binding form (reviewed by 
Morimoto et al., 1992).   
 In the present study, exposure to 2,4-D elicited ROS production in HepG2 and 
HEK293 cells.  Several studies have reported that increased Hsp72 protein expression 
may be a protective response to oxidative stress (Ferrante et al., 2006; Gorman et al., 
1999; Oh et al., 2006; Ohkawara et al., 2006; Seo et al., 2005).  Ochratoxin (fungal 
metabolite) – induced lipid peroxidation induced Hsp72 protein expression in peritoneal 
macrophages of mice (Ferrante et al., 2006).  Increased Hsp72 protein expression 
inhibited morphological alterations, growth reduction and cell death in human colon 
cells (CaCo2) following exposure to the oxidant, H2O2 (Ohkawara et al., 2006).  
Additionally, Gorman et al. (1999), Oh et al. (2005) and Seo et al. (2005) have shown 
that ROS may be directly involved in the induction of Hsp72 protein expression.  
Gorman et al. (1999) illustrated that in the presence of either pyrrolidine 
dithiocarbamate, 1,10-phenanthroline or N-acetyl-L-cysteine (NAC) antioxidant 
molecules; Hsp72 protein expression was repressed in heat-shocked human myelocytic 
cells (HL-60).  Seo et al. (2005) exposed cultured rat glioma cells (C6 cells) to sodium 
salicylate (an anti-inflammatory agent).  The protein expression of Hsp72 was induced 
in cells, following recovery from sodium salicylate exposure.  Pre-treatment with NAC, 
 172
abolished Hsp72 protein expression, and inhibited HSF1 DNA binding.  Thus, 
suggesting that ROS played an integral role in the induction of Hsp72 protein expression 
(Seo et al., 2005).  Oh et al. (2005) illustrated that methyl jasmonate (a plant hormone) 
induced intracellular O2.- and H2O2 and mitochondrial ROS production in human C6 
glioma cell cultures.  Increased intracellular and mitochondrial Hsp72 protein expression 
was observed following recovery from exposure to methyl jasmonate.  There was 
repression of Hsp72 protein expression and HSF1 DNA binding following pre-treatment 
with NAC (non-specific antioxidant), catalase (antioxidant specific for detoxification of 
H2O2), and sodium formate (antioxidant specific for detoxification of OH.).   
 In the present study, the magnitude of induction of Hsp72 protein expression was 
less pronounced in HEK293 cells, compared to HepG2 cells (Fig. 36).  The differences 
in the effects could be due to the probable constitutive expression of Hsp72 in HEK293 
cells, compared to HepG2 cells.  Western blot analyses of untreated HEK293 control 
cells illustrated that there appeared to be a high constitutive expression of Hsp72 in 
HEK293 (Fig. 35(A)).  Yaglom et al. (2007) explained that Hsp72 protein may be 
constitutively expressed in many tumor cell lines.  The HEK293 cells have been 
transformed with a human adenovirus, with elaboration of a virus-specific tumor antigen 
and are capable of inducing tumors in mice (Graham and Nairn, 1977).  Therefore, 
HEK293 cells appear to a tumor cell line which constitutively expresses Hsp72 protein.  
Baler et al. (1996) suggested that Hsp70 may act as a negative regulator of HSF1, and 
illustrated that over expression of Hsp72 inhibited induced Hsp72 gene expression in 
heat stressed monkey cells (COS).  The authors explained that over expression of Hsp72 
may have inhibited HSF1 activation.  Baler et al. (1996) postulated that the inhibition of 
HSF1 activation by over expression of Hsp72 protein may have been due to the 
stabilization of HSF1-Hsp72 complexes formed in the presence of excess Hsp72.  Thus, 
in the present study, the high constitutive expression of Hp72 protein expression in 
HEK293 cells may have resulted in the increased presence of stable HSF1-Hsp72 
protein complexes.  The effect may have inhibited large increases in Hsp72 protein 
expression in HEK293 cells at concentrations equal to and greater than 1µM.  The above 
may also explain the repression of Hsp72 protein expression in HEK293 cells exposed to 
lower 2,4-D concentrations.  The induction of Hsp72 protein expression at 
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concentrations equal to greater than 1 µM may have been due to the possibility that the 
inhibitory effect was partially removed following exposure to higher concentrations, due 
to more pronounced stressed conditions, presence of abnormal proteins and enhanced 
competition with HSF1 for binding Hsp72.  Released HSF1 would have subsequently 
undergone oligomerization and triggered transcription of Hsp72 gene to increase mRNA 
and protein accumulation levels. 
 The preceding paragraphs discussed the many interesting findings that were 
revealed in the present study.  However, as with all experimental research, several 
strengths and weakness could be identified in the present investigation.  In the study, a 
concentration range of 0 to 10 mM (cell viability analyses) or 0 to 1 mM (ROS, RT-PCR 
and western blot analyses) was used.  The concentrations that were used reflected low 
environmental and toxic concentrations of 2,4-D.  However, the main purpose of the 
present study was to assess the toxic effects of low environmental concentrations of 2,4-
D.  Thus, a smaller range of concentrations (i.e. 0, 0.1 nM, 1 nM, 10 nM, 100 nM and 1 
mM) could be assessed in future.  One purpose of the present study was to determine if 
more pronounced toxic effects would be observed with longer durations of exposure to 
low environmental concentrations of 2,4-D.  However, the present study was truly an 
acute toxicity study and thus the design was unable to efficiently assess the chronic 
effects of low concentrations of 2,4-D.  Acute toxicity effects refer to the immediate 
effects that are observed 0 to 7 days after a single exposure of a chemical (PAN 
Pesticides Database, 2000).  Humans who use groundwater as a source of drinking water 
are typically exposed to daily concentrations of 2,4-D from groundwater.  Thus, ideally, 
a repeated daily exposure sub-acute, sub-chronic or chronic toxicity study could be 
performed in future.  However, the use of cell models, such as HepG2 cells, limits the 
ability to perform sub-acute, sub-chronic or chronic toxicity studies, in vitro.  The 
metabolic capacity of immortalized cells is reduced as cells differentiate over long 
durations of times, thus compromising their accurate correlation with toxicity (Fabre et 
al., 2003).     
  In the present study, HepG2 cells were considered an ideal cell model to use for 
in vitro assessment of 2,4-D – induced toxicity.  However, Fabre et al. (2003) recently 
made a novel discovery that revealed that HepG2 cells actually contain lower levels of 
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phase I and II biotransformation enzymes, compared to primary hepatocytes or the new 
human hepatoma cell line, HBG BC2.  Thus, in future studies, HepG2 and other cell 
models (i.e HBG BC2) could be used to assess 2,4-D toxicity, in vitro.  Data from the 
present study revealed that more pronounced decreases in HepG2 and HEK293 cell 
viability were observed following 6 hrs, compared to 24 to 72 hrs of exposure to either 
form of 2,4-D.  Thus, alterations in gene expression could be assessed following 
exposure to 2,4-D for 6 hrs, in contrast to 24 hrs.  More pronounced alterations in FTL, 
FTH1 and PCNA gene expression, both at the level of mRNA and protein accumulation 
may be observed at 6 hrs, compared to 24 hrs of exposure. 
 The present study reported preliminary data for mRNA and protein expression.  
The results illustrate that 2,4-D induced inconsistent patterns (i.e. increases and 
decreases) in mRNA and protein expression.  Target mRNA and protein expression were 
expressed as the mean of triplicate assays from one experiment, however, there were 
variations between individual RT-PCR and western blot assays.  Thus, mRNA and 
protein analyses should have been performed on RNA and protein extracts obtained 
from at least 3 separate 2,4-D exposure experiments to determine reproducibility and 
significance of data.   
 As described above, several strengths and weakness were identified in the 
present study.  The identification of the above aids in the design of future studies that 
would expand on results obtained from cell viability, ROS, RT-PCR and western 
analyses in the present study.  In the present study, HepG2 and HEK293 cells were used 
as cell models to assess the cytotoxic effects of 2,4-D.  Their use allowed for the 
determination of the cell specificity of 2,4-D – induced toxicity.  However, in future 
studies, HepG2 cells would be used to evaluate the cytotoxic effects of 2,4-D, in vitro.  
HepG2 cells have been used in a vast array of in vitro toxicological studies.  
Additionally, compared to other immortalized human cells, HepG2 cells retain high 
levels of biotransforming enzymes (Mersch-Sundermann et al., 2004).  HepG2 cells 
have been described as the most desirable in vitro model capable of portraying a more 
realistic reflection of xenobiotic metabolism in humans (Mersch-Sundermann et al., 
2004).   
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 Performing in vitro toxicology studies using primary cell cultures of human 
hepatocytes would be the most favourable in vitro model.  Primary cell cultures of 
human hepatocytes obtained from organ donors have been used extensively in both 
academic and industrial laboratories for evaluating the hepatic metabolism of 
xenobiotics (LeCluyse, 2001).  Thus, they would be the ideal model for extrapolation of 
the cytotoxic effects of 2,4-D, in vitro to humans.  Additionally, Zhang et al. (2006) 
illustrated that there are marked differences between responses in HepG2 cells and 
primary human hepatocytes cell cultures in response to xenobiotic exposure.  The 
authors reported that exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted 
in a more exacerbated adverse response in HepG2 cells, compared to primary human 
hepatocytes cell cultures.  Zhang et al. (2006) explained that the observation warrants 
the need for caution to be taken when extrapolating and interpreting the results obtained 
from cell based models.  However, although, the use of primary cell cultures of human 
hepatocytes would be ideal for conducting future in vitro toxicology studies, they are 
less convenient to obtain and work with, compared to HepG2 cells.  Other disadvantages 
of primary cell cultures include their ability to; (1) rapidly lose their xenobiotic 
metabolizing capacity (Riddick, 1998), (2) undergo limited number of cell divisions 
(Knasmüller et al., 1998; Mersch-Sundermann et al., 2004) and (3) contain different cell 
types (Mersch-Sundermann et al., 2004).  Toxicity can be cell specific and thus, 
cytotoxic effects can differ between cell types (Eaton and Klaassen, 2001) of the same 
organ. 
 Two forms of 2,4-D were used in the present study.  In future studies only the 
commercial form of 2,4-D should be employed, since this is the form that humans are 
more likely to be exposed to from the environment.  In future studies, cell viability 
results should be supported with other commonly used cell viability assays (i.e MTT, 
neutral red, or trypan blue exclusion assay).   
 In the present study, it was shown for the first time that 2,4-D induces ROS 
production in human cell cultures.  However, the present study did not illustrate that 
exposure to 2,4-D induces oxidative stress.  Previously discussed, ROS may mediate 
oxidative stress through lipid, protein or DNA oxidation (for review see Kohen and 
Nyska, 2002).  Therefore, in future studies, the induction of oxidative stress in cells 
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exposed to 2,4-D would be investigated.  Measurement of oxidative stress in the present 
thesis would have provided additional evidence for the association between oxidative 
stress and the induction of FTL, FTH1 and PCNA mRNA or protein expression.  The 
most commonly used techniques for determination of oxidative stress are those that 
measure the end-products of lipid peroxidation (Dotan et al., 2004).  Thus, in future 
studies, the traditional TBA assay would be performed.  The TBA assay measures 
malonialdehyde end-product of lipid peroxidation (Halliwell and Chirico, 1993) and has 
been employed in many toxicological studies.   
 Depending on the results of cell viability studies, in future, the alterations in 
PCNA gene expression patterns at the time point that induced the most pronounced 
decreases in cell viability would be assessed.  Balajee et al. (1999), Holmes et al. (2002), 
Savio et al. (1998) and Xu et al. (1999) provided evidence to suggest that up-regulation 
of PCNA mRNA or protein expression is a cytoprotective response to DNA damage.  
Thus, unlike FTL or FTH1, the choice of studying PCNA would help focus on one 
pathway involved in 2,4-D – induced cytotoxicity, which may involve ROS mediated 
oxidative DNA damage.  Three concentrations (no treatment (untreated control cell 
cultures), the concentration where there is the smallest degree of induction of mRNA 
expression and the concentration where there is the greatest degree of induction of 
mRNA expression) would be used to assess alterations in PCNA gene expression 
patterns in future studies.  The design would help to determine concentration-dependent 
effects.  If the results of RT-PCR and western blot analyses are consistent, then the 
underlying cell and molecular pathways that may be involved in the up-regulation of 
PCNA would be investigated.  To begin this investigation, nuclear transcription assays 
would be performed to determine if increased PCNA mRNA accumulation is due to 
increased transcriptional rate of the PCNA gene.  The determination of the 
mechanism(s) of 2,4-D – induced activation of PCNA gene transcription would then be 
of interest, and thus examination of the promoter region of the PCNA gene would 
follow.  Theoretical knowledge of the transcription factors that are involved in inducing 
PCNA gene transcription during DNA repair and the DNA sequences of the promoter 
region of the PCNA gene that these factors bind would then be obtained.  Next, one 
transcription factor and its DNA binding sequence would initially be chosen for further 
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investigation.  A plasmid construct containing the DNA sequence of interest would then 
be transfected into HepG2 cells.  Cells would be exposed to the respective 
concentrations of 2,4-D.  Following 2,4-D exposure, cells would be harvested and 
luciferase assays would be performed to determine gene induction.  This would be 
followed by performing electrophoretic mobility shift assay (EMSA) to determine 
specific DNA-protein interactions in the promoter sequence, of interest.  The above 
experimental design would enable for identification of a sequential molecular pathway 
involved in oxidative DNA damage during 2,4-D – induced cytotoxicity. 
  In addition to the above, in future studies, the comet assay would also be 
employed.  The comet assay is a sensitive and rapid method for the detection of DNA 
strand break (Fairbairn et al., 1995).  DNA strand break may be induced by ROS (for 
review see Kohen and Nyska, 2002).  The use of the comet assay will also provide 
additional evidence for 2,4-D – induced intracellular oxidative stress conditions.  
Compared to lipids, DNA are more significant targets of oxidative damage (Halliwell 
and Chirico, 1993).  Additionally, the authors explained that lipid peroxidation often 
tend to occur late in the injury process.  Thus, the TBA assay may not reflect the true 
extent of oxidative injury induced following exposure to 2,4-D.     
 The current study was performed using in vitro cell models.  Zhang et al. (2006) 
explained that caution must be taken when extrapolating and interpreting the results 
obtained from cell based models.    So what are the implications of the data obtained 
from the present study?  How do the findings of the present in vitro toxicology study 
relate to the real world, where humans may be exposed to environmental concentrations 
of 2,4-D?  Cell viability data suggest that low environmental concentrations of 2,4-D 
may induce limited cytotoxic effects.  The present data suggest that the effects may not 
be concentration-dependent and that more pronounced adverse cytotoxic effects are not 
likely to be observed following longer durations of exposure (up to 72 hrs) to low 
environmental concentrations of 2,4-D.  The observation that similar patterns of 
cytotoxicity were induced following exposure to low environmental concentrations of 
either technical or commercial 2,4-D, in vitro, suggests that  toxicity is induced directly 
by 2,4-D and that ‘inert ingredients’ in commercial preparations of 2,4-D have limited 
ability to synergistically act with 2,4-D to enhance toxicity.  2,4-D appeared to induce 
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cell specific effects; toxic effects were enhanced in HEK293, compared to HepG2 cells, 
in vitro.  Thus, the results suggest that in humans, 2,4-D may induce cell or tissue 
specific toxic effects.  The results also suggest that in humans, the kidney may be a more 
significant target organ of 2,4-D – induced toxicity, compared to the liver.  Kidney 
failure is a symptom of 2,4-D poisoning in humans (PAN Pesticide Database, 2004).  
 The inability of low environmental concentrations of 2,4-D to induce significant 
ROS production, in vitro implies that low concentrations of 2,4-D  encountered by 
humans in the environment may be insufficient to induce  significant amounts of cellular 
and/or tissue stress or damage.  Nevertheless, the results from ROS assays are intriguing 
and suggest a potential role for ROS and associated oxidative stress 2,4-D – induced 
toxicity.   
 Preliminary results from mRNA and protein studies suggest that low 
environmental concentrations of 2,4-D may induce subtle alterations at the cell and 
molecular levels.  The results also serve to highlight a potential mechanism of 2,4-D – 
induced toxicity, which may involve ROS and associated oxidative stress.  Thus, the 
results of the present study imply that low environmental concentrations of 2,4-D may 
only have minimal impact on the health of exposed humans.    
 Several interesting conclusions can be drawn from results of the present study.   
Firstly, it can be concluded that that low environmental concentrations (0.1 to 100nM) of 
2,4-D induces limited, but significant cytotoxic effects that does not become more 
pronounced with increasing concentrations or times.  However, it should be mentioned 
that although the present study illustrates the low environmental 2,4-D concentrations 
induces statistically significant cytotoxic effects; the effects may not be biologically 
significant.  Exposure to 2,4-D induced cell specific effects, that were reflected by the 
more pronounced decreases that were observed in HEK293, compared to HepG2 cell 
viability, in vitro.  Exposure to either technical or commercial 2,4-D induced similar 
cytotoxic effects.  Concluding that toxicity is induced directly by 2,4-D and that the 
presence of ‘inert ingredients’ in commercial 2,4-D had limited ability to act 
synergistically with 2,4-D and enhance the magnitude of cytotoxic effects.  Compared to 
higher concentrations, exposure to low environmental concentrations of 2,4-D does not 
induce significant intracellular ROS production.  The results also highlight a role for 
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ROS and associated oxidative stress in 2,4-D – induced cytotoxicity.  Preliminary results 
revealed that low environmental concentrations of 2,4-D are sufficient to induce subtle 
alterations (< 2 fold) in FTL, FTH1 and PCNA gene expression patterns at the levels of 
mRNA and protein accumulation; an interesting revelation in the present study that also 
serve to highlight underlying cell and molecular pathways of 2,4-D – induced 
cytotoxicity that involves ROS and associated oxidative stress.  The results also provide 
direction for future studies aimed at elucidating a molecular pathway involved in 2,4-D 
– induced cytotoxicity.  Thus, taken all together, the results reported in this thesis 
suggest that exposure to low environmental concentrations of the herbicide, 2,4-D in 
groundwater may have a minimal impact on the health of exposed humans. 
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